A STORY TOLD IN PICTURES: NEPAL’S DEVASTATION, BRAVERY AND HOPE AFTER THE EARTHQUAKE

The April 2015 Nepal earthquake killed more than 8,800 people and injured more than 23,000. It devastated this beautiful country and its people; historical monuments have disappeared, villages destroyed and communities left damaged and filled with pain and lost.   Korean Rescue Team The Korean rescue team worked tirelessly in hope of a rescue, but all that is left is the dead. The first floor of a building had collapsed and the restaurant that occupied that space now gone along with those who died whilst eating lunch on this normal day before the quake. Survivors Most have lost a family member or friend, but what is clear and inspiring is none have lost hope. These pictures are all an exchange of respect and compassion for the victims’ terrible loss. One survivor says, "My house is destroyed, but I'm alive and thankful and I will rebuild it and my life again".   Refugees and Villages Here are the courageous and unbreakable individuals, families and communities who keep strong while facing their realities and being thankful to be alive.  Some live in refugee camps, others under tents and many still stuck in their destroyed villages. All have one thing in common; they are striving to rebuild their homes and lives somehow. Reconstruction  The mobilisation and collaboration of aid and reconstruction in Nepal is immense and touching to see. Everyone who has two hands helps, the old and young Nepalese work alongside foreign aid workers to clear bricks away. All are part of a human chain that is helping to rebuild the magic of Nepal. Photographs copyright Ottavia Fabbri - please credit ‘Ottavia Fabbri’ More images available on request For images, press and media enquires please contact: Emma-Louise O’Neill emmalouise@elonpr.com +44 7515 136909

Good performance and positive market conditions result in good operating EBIT

The total volumes harvested in Q2 2015 were 14,182 tonnes gutted weight, which is a record high harvest in a quarter for Bakkafrost. The guidance for harvest volumes for 2015 is unchanged. The farming segment delivered an operational EBIT of DKK 248 million in Q2 2015. The VAP segment, which produced 5,064 tonnes in Q2 2015, made an operational EBIT of DKK 31 million. The FOF segment delivered an EBITDA of DKK 53 million in Q2 2015. Commenting on the result, CEO Regin Jacobsen said: “Bakkafrost harvested over 14 thousand tonnes in Q2 2015, which is the highest quarterly harvest ever for Bakkafrost. This together with good operational performance and positive market conditions re­sulted in a record high operating EBIT in Q2 2015. Bakkafrost’s focus on the operational performance is reflected in the investment of the new wellboat, “Hans á Bakka”. “Hans á Bakka” was delivered in July and started operating in August 2015, which marks a milestone in salmon farming in the Faroe Islands.” Bakkafrost released 1.4 million smolts in Q2 2015, which is in line with the company’s smolt release plan. The good catch of pelagic fish around the Faroe Islands in Q1 2015 continued into Q2 2015. Havsbrún has purchased 86 thousand tonnes of raw material in Q2 2015. Havsbrún’s purchase of raw material in first half 2015 amounts to 161 thousand tonnes. Bakkafrost’s net interest bearing debt at the end of Q2 2015 was DKK 302 million, compared with DKK 233 million at year-end 2014. Bakkafrost had undrawn credit facilities of approximately DKK 721 million at the end of Q2 2015, and the equity ratio was 61%. OUTLOOK Market The salmon market’s global demand growth has increased the last years due to high growth rate in emerging markets and a stable growth in other markets. Expected global supply growth in 2015 is around 4-5% and 2-3% in 2016. Production capacity is close to full utilization and further expansion relates to high investments. Farming Bakkafrost expects to harvest 49,000-51,000 tonnes gutted weight in 2015. Bakkafrost’s forecast for smolt release in 2015 is 10.4 million pieces. The estimates for harvesting volumes and smolt releases is as always dependent on the biological situation. Value added products (VAP) Bakkafrost’s long-term strategy is to sell around 40-50% of the harvested volumes of salmon as value added products on fixed price contracts. The contracts last for 6 to 12 months. Bakkafrost has signed contracts covering around 75% of the VAP capacity for the rest of 2015. Fish oil, -meal and feed (FOF) The outlook for the production of fishmeal and fish oil has improved as the available raw material for the production has increased. The quotas for catching blue whiting in the North Atlantic have in-creased. With increased quotas, Bakkafrost is optimistic that the raw materials needed for our pro­duction of high quality salmon feed will be available. Havsbrún’s sales of fish feed in 2015 is expected to be at 73,000 – 77,000 tonnes. This is a reduction from the previous outlook at 83,000 – 87,000 tonnes, as the sale of fish feed to external customers has been reduced. The expected feed purchase from Bakkafrost’s farming segment in 2015 is un­changed. Investments Bakkafrost has announced an investment plan for the period until 2017, latest updated in August 2014. The purpose of the investment plan is to continue to have one of the most costs efficient value chains in the farming industry, carry out organic growth, increase flexibility and reduce the biological risk to meet the future consumers’ trends and to be more end-customer orientated. The total investments for the period 2014-2017 were announced to be DKK 1,370 million including maintenance CAPEX. Investments in 2015 are expected to be DKK 550 million. Financial Improved market balances in the world market for salmon products and costs effective production will likely improve the financial flexibility going forward. A high equity ratio with the Group’s bank financing and the issuance of bonds makes Bakkafrost’s financial situation strong. This enables Bakka­frost to carry out its investment plans to further focus on strengthening the Group, M&A’s, organic growth opportunities and fulfil its dividend policy in the future. Please find enclosed the Company’s Q2 2015 report and presentation. Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. About Bakkafrost: Bakkafrost is the largest salmon farmer in the Faroe Islands. The Group is fully integrated from feed production to smolt, farming, VAP and sales. The Group has production of fishmeal, fish oil and salmon feed in Fuglafjørður. The Group operates licenses on 14 farming fjords. The Group has primary pro­cessing in Klaksvík, Strendur, Kollafjørður, and secondary processing (VAP) in Glyvrar and Fuglafjørður. The headquarter is located in Glyvrar, and the company has a total of around 700 employees. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities. The securities referred to herein may not be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933, as amended. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada or Japan.

Sims Recycling Solutions Receives ISO 50001:2011 Accreditation

Sims Recycling Solutions, the leading global provider of IT and electronics reuse and recycling has received ISO 50001:2011 accreditation. The objective of this standard is to continuously improve energy-related performance and identify energy-reduction opportunities through the development of an energy management system (EnMS). These efforts will not only save money and help conserve resources, but will also contribute to the company’s overall efforts (http://www.simsrecycling.com/About-Us/Global-Certifications?utm_source=press%20release&utm_medium=cisionwire&utm_content=germany%20iso%2050001&utm_campaign=Press%20Release%20-%20August%202015) to improve quality and environmental management.  “Our customers expect excellence from us so we are always looking for ways to further minimize our environmental impact and enhance our security features,” stated Marc Affüpper, managing director of Sims Recycling Solutions, Germany. “We are proud to be one of the first in our industry to achieve the ISO 50001 standard and look forward to creating the path for the rest to follow as we continue to identify best practices.” To achieve this standard the Sims Recycling Solutions site in Bergkamen had to create and implement the following: -        Energy management integration into existing management systems -        Energy policy -        Energy consumption reduction targets -        Detailed action plan to reach targets -        Internal energy auditing program “It is very important to us, as a company, to stay committed to improving the quality of our services which includes environmental management,” stated Steve Skurnac, president of Sims Recycling Solutions. “This standard will help us perform more efficiently and stay on top of our energy consumption.” As a part of this accreditation, Sims Recycling Solutions’ Bergkamen site set a goal to have a 10 percent reduction of energy consumption per metric ton of processed material within seven years. Many efforts have already been enforced to move toward this target which included upgrading to more energy-efficient equipment, investigating air consumption and implementing monthly quality checks for use of diesel, electricity and natural gasoline consumption.

BillerudKorsnäs investigates opportunities for growth

BillerudKorsnäs is a leading supplier of renewable fiber based packaging materials and solutions. Within liquid packaging board and other virgin fiber cartonboard, the company is one of the world leaders. Driven by global megatrends, the demand for these types of board is increasing. BillerudKorsnäs therefore wants to investigate the possibility of installing a new board machine at the production unit in Gruvön. The investigation is a part of BillerudKorsnäs strategy for volume growth within business area Consumer Board. It is also in line with the strategies for the business areas Containerboard and Packaging Paper. The machine would become one of the most cost efficient in the world with a capacity of approximately 500 000 t/a of liquid packaging board, cartonboard, food service board and white kraftliner. In addition to growth in attractive board segments, an investment decision would also include a streamlining of the production structure within the business area Packaging Paper as the current production of kraft papers at the Gruvön production unit would be discontinued and replaced by production at other BillerudKorsnäs units. A potential investment decision can be made at the earliest during 2016. Simultaneously, BillerudKorsnäs is launching an investigation into the possibilities of further structural change and growth in selected attractive kraft paper segments. The investigation includes exploring the possibility of moving the MG paper machine in Finnish Tervasaari, unintegrated to pulp production, to Swedish Skärblacka, which is an integrated unit. The investigation also includes investment in further value adding surface treatment capacity at existing MG paper production in Skärblacka. If implemented, the investments would strengthen Skärblacka’s position as one of the world's most efficient production units for white MG papers while also opening up opportunities in attractive market segments within medical papers, food packaging and release liners. The investigation will be completed during the first half of 2016 and after a potential decision is taken about a year is required to carry out the investment in surface treatment capacity and one and a half years for a potential paper machine move. “These two investigations clearly indicate that we have our sights set on growth. We carefully compare all different growth scenarios to each other. Right now, we consider conditions for organic, investment driven, growth in our own production structure as the most favorable. These investigations do not exclude the possibility of further acquisitions”, says Per Lindberg, President and CEO, BillerudKorsnäs. The investigations are independent of each other. Also independent of the outcome of the investigations, BillerudKorsnäs invites to union negotiations regarding a possible closure of the BillerudKorsnäs production at Tervasaari. For more information, please contact: Per Lindberg, President and CEO, +46 (0)8 553 335 00 Henrik Essén, SVP Communication and Sustainability, +46 (0)8 553 335 00 The information is such that BillerudKorsnäs Aktiebolag (publ) is obligated to publish under the Swedish Securities Market Act. Submitted for publication at 06.30 CET, August 25th  2015.

Catella AB – Interim Report second quarter 2015

Second quarter 2015 · Total income SEK 421 M (349) · Net sales SEK 419 M (348) · Operating profit/loss* SEK 46 M (45) · Profit/loss before tax SEK 57 M (86) · Profit after tax SEK 50 M (85), of which attributable to parent company owners SEK 48 M (85) · Earnings per share** SEK 0.59 (1.04) · Equity was SEK 1,251 M (1,050) · Equity per share** SEK 14.40 (12.56) First half-year 2015 · Total income SEK 839 M (617) · Net sales SEK 832 M (610) · Operating profit/loss* SEK 95 M (63) · Profit/loss before tax SEK 109 M (112) · Profit after tax SEK 93 M (100), of which attributable to parent company owners SEK 83 M Corporate Finance · Second quarter: total income SEK 161 M (141), of which net sales SEK 160 M (141) · Second quarter: operating profit/loss* SEK 25 M (23) · Second quarter: property transaction volumes of SEK 15.9 Bn (11.6), of which Sweden SEK 9.3 Bn (6.0), France SEK 3.6 Bn (5.1) and Germany SEK 0.8 Bn (0.0) · First half-year: total income SEK 248 M (211), of which net sales SEK 246 M (211) · First half-year: operating profit/loss* SEK 11 M (15) Asset Management and Banking · Second quarter: total income SEK 265 M (210), of which net sales SEK 264 M (209) · Second quarter: operating profit/loss* SEK 29 M (31) · Second quarter: assets under management increased by SEK 0.5 Bn (6.5), amounting to SEK 131.8 Bn (66.6) as of 30 June 2015. Net inflows were SEK 3.2 Bn (4.7) · First half-year: total income SEK 599 M (408), of which net sales SEK 593 M (401) · First half-year: operating profit/loss* SEK 101 M (62) “The Group’s total income, excluding IPM, increased by 12% year-on-year, mainly driven by increased Corporate Finance activity and growing volumes in our card operations”, says Knut Pedersen, Catella’s CEO and President. The information in this Report is manda-tory for Catella AB (publ) to publish in accordance with the Swedish Financial Instruments Trading Act and/or the Swedish Securities Markets Act. This information was submitted to the market for publication on 25 August 2015 at 7:00 a.m. (CET).

H&M Conscious Foundation gives €1 million grant to pioneering ideas closing the loop for fashion

Five winners, chosen by an expert jury, will share a grant of €1 million and get access to a tailor-made innovation accelerator. The global public will be invited to distribute half of the total grant through an online vote. The result will be revealed at a grand award ceremony in Stockholm, in February 2016. “The question for fashion is no longer “What is the new black?” but rather “What innovative ideas can close the loop?” The Global Change Award is looking for ideas that will protect the earth’s natural resources, and I am excited to be part of it,” says Rebecca Earley, Professor in Sustainable Textile and Fashion Design at University of the Arts London, Director of its Textile Futures Research Centre and member of the Global Change Award Jury. The H&M Conscious Foundation is a non-profit global foundation, funded by the Stefan Persson family − founders and main owners of the Swedish fashion company H&M. The mission of the Foundation is to drive long-lasting positive change and improve living conditions by investing in people, communities and innovative ideas. The Global Change Award takes on one of the biggest challenges facing today's fashion industry – to create fashion for a growing population while reducing its impact on the environment. Neither the Foundation nor the company H&M will take any equity or intellectual property rights in the innovations. “Ground-breaking, game-changing ideas can come from anywhere, so the challenge is open to anyone. Each year the Global Change Award aims to find the truly brave and bold ideas that make change. I’m also eager to see how the fashion industry as a whole will embrace the challenge of closing the loop,” says Karl-Johan Persson, board member of the H&M Conscious Foundation and CEO of H&M. The innovation accelerator − a collaboration with Accenture and KTH Royal Institute of Technology in Stockholm − will give the five winners the support and knowledge they need to actualize their ideas. Starting off with an innovation boot camp in Stockholm, provided by KTH Innovation, it will be followed up by guidance from Accenture Strategy on how to develop the winning ideas further. This includes the provision of a one-year training and coaching programme with a particular focus on circular economy.  The innovation accelerator will also provide exclusive fashion industry access and offer possibilities to build networks and try out the ideas within the fashion value chain. Information about the Global Change Award, how to apply for a grant and updates on the challenge are available at globalchangeaward.com (http://www.globalchangeaward.com). Notes to editorsMembers of the jury                                       Dr. Michael Braungart Academic Chair “Cradle to Cradle for Innovation and Quality” at Erasmus University Rotterdam; Professor at Leuphana University Lüneburg; Scientific Director of EPEA Hamburg.Prof. Rebecca Earley Professor in Sustainable Textile and Fashion Design at University of the Arts London and Director of its Textile Futures Research Centre (TFRC).Mr. Ma Jun Director, Institute of Public and Environmental Affairs, China.Ms. Eva Kruse CEO, Danish Fashion Institute; CEO, Copenhagen Fashion Week.Prof. Johan Rockström Director of the Stockholm Resilience Centre (SRC) and Professor in Environmental Science with emphasis on water resources and global sustainability at Stockholm University.Mr. Ellis Rubinstein President and CEO, The New York Academy of Sciences.Ms. Franca Sozzani Editor in Chief (https://en.wikipedia.org/wiki/Editor-in -chief) of Vogue Italia (https://en.wikipedia.org/wiki/Vogue_Ital ia).Ms. Amber Valletta Supermodel, Actress & Entrepreneur. Key dates           25.08.2015 First ever Global Change Award is launched and application opens at globalchangeaward.com (http://www.globalchangeaw ard.com).31.10.2015 Application closes.01.02.2016 Five winners, selected by the expert jury, are revealed. Each winner is guaranteed €100,000. The global public is invited to distribute the other half of the total grant through an online vote.07.02.2016 The online vote closes. Half of the total grant has been distributed between the five winners.10.02.2016 The result of the vote is revealed at a grand award ceremony in Stockholm. Close the Loop and Circular EconomyIn a world with increasingly constrained resources and environmentalchallenges, the circular approach represents a radical departure from the oldlinear “take, make, waste” production and consumption models to a model whereproducts and resources are designed to have more than one life. Closing theloop for fashion means finding new approaches in the whole value chain of theindustry; changing the way garments are designed, produced, shipped, bought,used and recycled. The theory about circular economy may be the biggestrevolution in the global economy in 250 years as it challenges companies torethink their business models and customer relationships by detaching growthfrom the single-use of natural resources and environmental impact. Thiscreates new business opportunities as well as an unassailable competitiveadvantage.

ICA Gruppen AB announces a cash offer to the shareholders of Hemtex AB

Summary of the Offer · ICA Gruppen offers 7.50 Swedish krona in cash for each share in Hemtex[1] (http://file:///C:/Users/h00ofl/Desktop/Projekt%20H/150824%20PRM%20Project%20H%20ENG%20FINAL.docx#_ftn1). The Offer values all outstanding shares in Hemtex to approximately 719 million Swedish krona[2] (http://file:///C:/Users/h00ofl/Desktop/Projekt%20H/150824%20PRM%20Project%20H%20ENG%20FINAL.docx#_ftn2). · The Offer represents a premium of:  · 44 per cent compared with the closing price for Hemtex’ share on 24 August 2015 of 5.20 Swedish krona and · 38 per cent compared with the volume weighted average price paid for the share during the last 30 calendar days prior to the announcement of the Offer of 5.44 Swedish krona. · ICA Gruppen today holds 65,655,195 shares in Hemtex, corresponding to 68.5 per cent of capital and votes. · Bomax AS and AB Industrivärdens särskilda pensionsstiftelse, together representing 16.3 per cent of the capital and votes in Hemtex, have, subject to certain conditions, irrevocably undertaken to accept the Offer. ICA Gruppen will as such, together with its own shareholding, achieve an ownership of at least 84.8 per cent of the capital and votes in Hemtex if the Offer is completed. · The Board of Hemtex will evaluate the Offer and revert with its opinion of the Offer and the reasons for this opinion no later than two weeks before expiry of the acceptance period. · The acceptance period for the Offer is expected to commence 3 September 2015 and end 1 October 2015. Background to and reasons for the Offer Hemtex has been a strategic holding for ICA Gruppen since the acquisition of the shares and the companies have during recent years further strengthened their relationship with joint purchasing and the joint customer offering ICA Home by Hemtex. Hemtex has in recent years undergone an extensive transformation plan to improve profitability and efficiency throughout the organisation. The transformation plan has resulted in both increased sales and improved profitability, but it is ICA Gruppen’s belief that Hemtex as a wholly owned subsidiary to ICA Gruppen is given better preconditions to continue the efforts to strengthen the offering and achieve continued positive sales development through an increased number of sales channels and through continued rationalisation of the business further improve the profitability. ICA Gruppen places great value on Hemtex’ management and employees, who are important for a successful development of the business. ICA Gruppen does not anticipate any significant effects from the Offer for the Company’s employees, whether in terms of conditions of employment or employment at the locations where the Company conducts its business. There are no plans to significantly alter the existing strategy for Hemtex. The Offer ICA Gruppen offers 7.50 Swedish krona in cash for each share in Hemtex[3] (http://file:///C:/Users/h00ofl/Desktop/Projekt%20H/150824%20PRM%20Project%20H%20ENG%20FINAL.docx#_ftn3). No commission will be charged in connection with the Offer. The total value of the Offer amounts to approximately 719 million Swedish krona based on a total of 95,835,506 outstanding shares in Hemtex. The Offer represents a premium of:  · 44 per cent compared with the closing price for Hemtex’ share on 24 August 2015 of 5.20 Swedish krona and · 38 per cent compared with the volume weighted average price paid for the share during the last 30 calendar days prior to the announcement of the Offer of 5.44 Swedish krona. The acceptance period for the Offer is expected to commence 3 September 2015 and end 1 October 2015. Settlement is expected to take place on 6 October 2015, provided that the conditions for the Offer have been fulfilled or waived. The acquisition of Hemtex does not require approval from any competition authorities. Opinion from the Board of Hemtex and fairness opinion The Board of Hemtex has been provided with the terms of the Offer and will evaluate the Offer and revert with its opinion about the Offer and the reasons for this opinion no later than two weeks before expiry of the acceptance period. Two Board members of Hemtex, Stein Petter Ski and Liv Forhaug, are also senior executives of ICA Gruppen, which means that the related party rules in section III.3 of Nasdaq Stockholm’s Takeover rules (the “Takeover rules”) are applicable. These executives may not participate and have not participated in Hemtex’ handling of the Offer. The Board will also, in accordance with section III.3 of theTakeover rules, obtain a fairness opinion from an independent expert, which will be made public no later than two weeks before expiry of the acceptance period. The Board’s opinion and the fairness opinion will if possible be reproduced in its entirety in the offer document that will be prepared and published by ICA Gruppen. ICA Gruppen’s shareholding in Hemtex ICA Gruppen owns 65,655,195 shares in Hemtex, corresponding to 68.5 per cent of capital and votes. ICA Gruppen does not hold any other financial instruments that provide a financial exposure to Hemtex’ shares. ICA Gruppen has not acquired or agreed to acquire any shares in the Company during the last six months prior to the announcement of the Offer. ICA Gruppen may during the acceptance period acquire, or enter into arrangements to acquire, shares in Hemtex. Such acquisitions or agreements shall be in accordance with applicable Swedish laws and regulations. Irrevocable undertakings Bomax AS and AB Industrivärdens särskilda pensionsstiftelse, together representing 16.3 per cent of the capital and votes in Hemtex, have, subject to certain conditions, irrevocably undertaken to accept the Offer. The commitments expire in the event a third party, before expiry of the acceptance period for the Offer, announces a public offer to acquire shares in Hemtex that exceeds the price per share in the Offer, given that ICA Gruppen does not revise its offer to at least the same level as the competing offer within five working days of its announcement. The commitments are to the longest in force up to and including 31 December 2015. ICA Gruppen will as a result of the irrevocable undertakings, together with its own shareholding, achieve an ownership of at least 84.8 per cent of the capital and votes in Hemtex if the Offer is completed. Terms and conditions for completion of the Offer Completion of the Offer is conditional upon: (i)             the Offer being accepted to such extent that ICA Gruppen will become the owner of more than 90 percent of the total shares in Hemtex; (ii)            no circumstances that materially adversely affects, or may reasonably be expected to materially adversely affect, Hemtex’ sales, results, liquidity, solvency, equity or assets, and which ICA Gruppen was not aware of at the time of announcement of the Offer, have occurred; (iii)           neither the Offer nor the acquisition of Hemtex is wholly or partly prevented or materially adversely affected by any legislation or other regulation, court decision, public authority decision or similar circumstance, which is, or may be expected, and that ICA Gruppen could not reasonably have foreseen at the time of the announcement of the Offer; (iv)          Hemtex does not take any action that is likely to impair the prerequisites for making or completing the Offer; (v)           Hemtex has published all the information Hemtex has to publish and no information published by Hemtex is materially inaccurate, incomplete or misleading; and (vi)          no other party announces an offer to acquire shares in Hemtex on terms that are more favourable to the shareholders of Hemtex than the terms of the Offer. ICA Gruppen reserves the right to withdraw the Offer in the event it becomes clear that any of the above conditions are not fulfilled or cannot be fulfilled. In regards to condition (ii) - (vi), a withdrawal may further only be made given that non-fulfilment of such conditions is of material importance for ICA Gruppen’s acquisition of Hemtex. ICA Gruppen reserves the right to, wholly or partly, waive one or more of the above conditions, which inter alia includes the right for ICA Gruppen to complete the Offer at an acceptance level of less than 90 per cent. Overview of ICA Gruppen and the financing of the Offer ICA Gruppen AB (corp. reg. no. 556048-2837) is a leading retail company with a focus on food and health. The Group includes ICA Sweden and Rimi Baltic, which mainly operates grocery stores, ICA Fastigheter which owns and manages properties, and ICA Banken which offers financial services. Since January 2015, Apotek Hjärtat which conducts pharmacy operations, is included in the Group. The Group also includes two wholly or partly owned portfolio companies; inkClub and Hemtex. In 2014, ICA Gruppen had revenues of approximately 87 billion Swedish krona and had over 19,000 employees, mainly in Sweden and the Baltic countries. Approximately 50,000 persons work within ICA Gruppen, in offices, in logistics, or in any of ICA Gruppen’s wholly owned stores or stores owned by independent ICA retailers. ICA Gruppen’s share is listed on Nasdaq Stockholm, Large Cap, since 8 December 2005. ICA Gruppen will finance the Offer with existing cash. The Offer is thus not subject to any financing condition. Due diligence ICA Gruppen has not undertaken, and will not undertake, any due diligence investigation of Hemtex in relation to the Offer. Related parties ICA Gruppen is the parent company of Hemtex (and Hemtex is a subsidiary of ICA Gruppen) and two members of Hemtex’ Board of Directors, Stein Petter Ski and Liv Forhaug, are also senior executives of ICA Gruppen, which means that the related party rules in section III.3 of the Takeover rules are applicable. These executives may not participate and have not participated in Hemtex’ handling of the Offer. Furthermore, the acceptance period will run for at least four weeks and Hemtex must obtain and announce a fairness opinion. Preliminary timetable 2 September 2015 Announcement of the offer document3 September-1 October 2015 Acceptance period6 October 2015 Estimated settlement ICA Gruppen reserves the right to extend the acceptance period, as well as to postpone settlement of the Offer. ICA Gruppen will announce any such extension of the acceptance period, and/or postponement of the settlement by a press release in accordance with applicable laws and regulations. Compulsory redemption and delisting As soon as possible after ICA Gruppen has acquired shares representing more than 90 per cent of the capital and votes in Hemtex, ICA Gruppen intends to initiate compulsory redemption of the remaining shares. In relation herewith, ICA Gruppen intends to promote a delisting of Hemtex’ shares from Nasdaq Stockholm. Governing law and regulations The Offer and the agreements entered into between ICA Gruppen and Hemtex’ shareholders in relation to the Offer, shall be governed by and interpreted in accordance with Swedish law. Disputes concerning, or arising in connection to the Offer, shall be settled exclusively by Swedish courts, with the Stockholm District Court of first instance. The Takeover rules and the Swedish Securities Council's rulings and statements regarding interpretation and application of the Takeover rules, and, where appropriate, the Securities Council's rulings and clearance regarding interpretation and application of the Swedish Industry and Commerce Stock Exchange Committee's rules previously applicable to public takeover offers on the stock market, are applicable to the Offer. ICA Gruppen has, in accordance with act (2006: 451) concerning public takeover offers on the stock market, on 19 August 2015 entered into an agreement with Nasdaq Stockholm to comply with mentioned rules, rulings and statements, and to adhere to the sanctions that Nasdaq Stockholm may impose on ICA Gruppen for breach of the Takeover rules. ICA Gruppen has on 25 August 2015 informed the Swedish Financial Supervisory Authority about the Offer and about the above obligations to Nasdaq Stockholm. Advisors Handelsbanken Capital Markets is financial advisor and Gernandt & Danielsson Advokatbyrå is legal advisor to ICA Gruppen in connection to the Offer. For more information ICA Gruppen press service, Telephone number: +46 10 422 52 52 Frans Benson, Investor Relations ICA Gruppen: +46 8 561 500 20 ICA Gruppen AB (publ) is a leading retail company with a focus on food andhealth. The Group includes ICA Sweden and Rimi Baltic which mainly conductgrocery retail, ICA Real Estate which owns and manages properties, ICA Bankwhich offers financial services and Apotek Hjärtat which conducts pharmacyoperations. The Group also includes the wholly owned portfolio company inkCluband the partly owned portfolio company  Hemtex. For more information seeicagruppen.se ICA Gruppen discloses the information provided herein pursuant to the Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 8:00 a.m. (CET) on 25 August 2015. IMPORTANT INFORMATION This press release has been published in Swedish and English. In the event of any discrepancy between the two language versions, the Swedish version shall prevail. The Offer, pursuant to the terms and conditions presented in this press release, is not being made to persons whose participation in the Offer requires that an additional offer document is prepared or registration effected or that any other measures are taken in addition to those required under Swedish laws and regulations. This press release and any related Offer documentation are not being distributed and must not be mailed or otherwise distributed or sent in or into any country in which the distribution or offering would require any such additional measures to be taken or would be in conflict with any law or regulation in such country – any such action will not be permitted or sanctioned by ICA Gruppen. Any purported acceptance of the Offer resulting directly or indirectly from a violation of these restrictions may be disregarded. The Offer is not being and will not be made, directly or indirectly, in or into, or by use of mail or any other means or instrumentality of interstate or foreign commerce of, or any facilities of a national securities exchange of, Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States. This includes, but is not limited to facsimile transmission, electronic mail, telex, telephone, the internet and other forms of electronic transmission. The Offer cannot be accepted and shares may not be tendered in the Offer by any such use, means, instrumentality or facility of, or from within Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States or by persons located or resident in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States. Accordingly, this press release and any related Offer documentation are not being and should not be mailed or otherwise transmitted, distributed, forwarded or sent in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States or to any Australian, Hong Kong, Japanese, Canadian, New Zealand, South African or U.S. persons or any persons located or resident in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States. Any purported tender of shares in an Offer resulting directly or indirectly from a violation of these restrictions will be invalid and any purported tender of shares made by a person located in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States or any agent fiduciary or other intermediary acting on a non-discretionary basis for a principal giving instructions from within Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States will be invalid and will not be accepted. Each holder of shares participating in the Offer will represent that it is not an Australian, Hong Kong, Japanese, Canadian, New Zealand, South African or U.S. person, is not located in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States and is not participating in such Offer from Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States or that it is acting on a non-discretionary basis for a principal that is not an Australian, Hong Kong, Japanese, Canadian, New Zealand, South African or U.S. person, that is located outside Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States and that is not giving an order to participate in such offer from Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States. ICA Gruppen will not deliver any consideration from the Offer into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States. For purposes of this section “United States” and “U.S.” means the United States of America, its territories and possessions (including Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Wake Island, and the Northern Mariana Islands), any state of the United States of America and the District of Columbia. Forward-looking information Statements in this press release relating to future status and circumstances, including statements regarding future performance, growth and other projections as well as benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of ICA Gruppen. Any such forward-looking statements speak only as of the date on which they were made and ICA Gruppen has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations. ---------------------------------------------------------------------- [1] (http://file:///C:/Users/h00ofl/Desktop/Projekt%20H/150824%20PRM%20Project%20H%20ENG%20FINAL.docx#_ftnref1) The offered price will be adjusted if Hemtex conducts a dividend or makes any other value transfer to shareholders prior to settlement of the Offer. [2] (http://file:///C:/Users/h00ofl/Desktop/Projekt%20H/150824%20PRM%20Project%20H%20ENG%20FINAL.docx#_ftnref2) Based on 95,835,506 outstanding shares. [3] (http://file:///C:/Users/h00ofl/Desktop/Projekt%20H/150824%20PRM%20Project%20H%20ENG%20FINAL.docx#_ftnref3) See footnote 1 above.

Coor Service Management Holding AB – Interim Report 25 August 2015

A second quarter on track Second quarter 2015 · Net sales increased by 9 per cent in the second quarter, to SEK 1,786 (1,642) million. · The operating profit (adjusted EBITA) improved by SEK 6 million to SEK 88 (82) million. The operating margin (adjusted EBITA margin) was 5.0 (5.0) per cent. EBIT was SEK -42 (11) million, mainly due to listing costs of 78 MSEK. · Earnings after tax were SEK 128 (-69) million. The change compared with the previous year is due to the recognition of tax losses. · Earnings per share were SEK -1.81 (-8.16). Adjusted for the new capital structure and one-off costs in conjunction with the listing, earnings per share amounted to SEK 1.97 (-0.72). · Operating cash flow improved by SEK 153 million to SEK 45 (-108) million. First half year 2015 · Net sales during the period grew by 15 per cent to SEK 3,634 (3,149) million. · The operating profit (adjusted EBITA) improved by SEK 25 million to SEK 188 (163) million. The operating margin (adjusted EBITA margin) was 5.2 (5.2) per cent. EBIT was SEK 9 (26) million. · Earnings after tax were SEK 140 (-107) million. · Earnings per share were SEK -7.70 (-15.18). Adjusted for the new capital structure and one-off costs in conjunction with the listing, earnings per share amounted to SEK 2.10 (-1.12). · The operating cash flow improved by SEK 139 million to SEK 14 (-125) million. · The net addition to the contract portfolio during the period was approximately SEK 350 million in annual net sales. CEO comments Coor continued to perform well in the second quarter of the year, and the company is reporting earnings in line with plan. Revenues grew by 9 per cent over the quarter while our operating margin (adjusted EBITA) remained unchanged at 5.0 per cent compared with the same period the year before. Cash flow improved significantly, both year on year and quarter on quarter. We are entering the second half of the year with a strong financial position. The main bright spots of the second quarter are the extension of our Nordic contract with Ericsson, one of our largest customers, and the new IFM contract that we signed with Frontica for services to Aker Solutions and other customers at Fornebu in Norway. Coupled with the new contracts that we concluded and extended in the first quarter, notably with AB Volvo (Sweden), Volvo Cars (Sweden) and Statoil (expanded IFM contract for five oil platforms outside Norway), this means that we achieved a very strong sales performance in the first six months, which will have a financial impact as contract deliveries commence in the second half of 2015. The big increase in revenues in the second quarter is due to the new contracts that were signed in 2014, particularly the contract with Statoil in Norway, our largest to date, which was rolled out gradually, reaching full volume in September 2014. This contract will have a significant impact on sales growth in our Norwegian business until September 2015. However, due to the initially higher costs for the Statoil contract, our operating margin in Norway as expected was slightly lower in the second quarter compared with the first. In our Danish business, too, sales are up year on year and the operating margin is stable. Our Swedish business continues to report high margins, although sales are down slightly, chiefly due to the termination of a major cleaning contract following a public procurement in 2014. In addition to our new contracts, one of the big events during the period was of course the listing of the company’s shares on Nasdaq Stockholm on 16 June, and I would like to take this opportunity to welcome all our new shareholders to Coor. A consequence of the listing is that we incurred transaction costs for the listing in the second quarter. The economic outlook in the Nordic countries is still relatively good. We are seeing good overall demand, especially in the IFM segment but also for bundled FM services and single services. Activity in the FM market is especially strong in the oil and gas industry in Norway and in the public sector throughout the Nordic region. Some of our largest customers have announced cutbacks in their operations, which will have a negative impact on volumes in the latter half of 2015, primarily in the Swedish and Norwegian operations. Temporarily this will also have a negative impact on our operating margins, further weakening the seasonally weaker third quarter slightly. On the whole the outlook for long-term sales and earnings growth in line with our targets are good. This means that over the course of an economic cycle we expect to achieve annual organic growth of 4 – 5 per cent and an annual operating margin (adjusted EBITA margin) of 5.5 per cent. With a continued focus on developing integrated facility management solutions for major customers coupled with initiatives in cleaning, company restaurant and property services, we are strengthening our position as the leading provider of FM services in the Nordic region. This means that we are in a good position to take advantage of the opportunities that arise in the Nordic FM market. Stockholm, 25 August 2015 Mikael StöhrPresident and CEO,Coor Service Management The Interim Report is attached and available via the link at the end of this press release. The information is disclosed pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication on August 25, 2015 at 08:00 CET. Invitation to Press and Analyst’s webcastTo participate in the webcast, please register via the following link http://edge.media-server.com/m/p/yoadp2yd before the meeting. If you wish to listen to the presentation via the telephone, please call +46 8 566 426 96 (Sweden), +47 235 002 53 (Norway), +45 823 331 76 (Denmark), +358 981 710 492 (Finland) or +44 203 428 14 09 (United Kingdom). The presentation and the on demand webcast will be published on our website www.coor.com/investors/reports and presentations (http://www.coor.com/investors/reports%20and%20presentations) after the meeting. Please findmoreinformation,images etc.atwww.coor.comor contact Thomas IR, Coor Service +46 thomas.backteman@coor.comBackteman Management 70 831 11 66Olof CFO, Coor Service +46 olof.stalnacke@coor.comStålnacke Management 10 559 59 20Mikael Stöhr CEO, Coor Service +46 mikael.stohr@coor.com Management 10 559 59 35Åsvor Communications and +46 asvor.brynnel@coor.comBrynnel Sustainability 10 559 Manager, 54 04 Coor Service Management Coor Service Management (Coor) is a leading provider of facility management services in the Nordics, focusing on integrated and complex service undertakings (IFM). Coor offers specialist expertise in workplace services (soft FM), property services (hard FM) and strategic advisory services for development of customers’ service activities. Coor creates value by executing, leading, developing and streamlining its customers’ service activities, ensuring that they provide optimal support to the core business over time. Coor’s customer base includes many large and small companies and public-sector organisations across the Nordic region, including AB Volvo, Aibel, Det Norske Veritas, DR (Danish Radio), E.ON, Ericsson, EY, ICA, NCC, Politiet (Danish Police), Saab, Sandvik, SAS, Skanska, Statoil, TeliaSonera, Swedish Transport Administration, Vasakronan and Volvo Cars. Coor was founded in 1998 and is listed on Nasdaq Stockholm since 2015. At 30 June 2015 the company had 6,600 employees based mainly in Sweden, Denmark, Norway and Finland, and annual sales of SEK 7,300 million (rolling twelve-month basis). Coor takes responsibility for the operations it conducts, in relation to its customers, employees and shareholders, as well as for its wider impact on society and the environment. Read more at www.coor.com

Hansa Medical Interim report January – June 2015

January – June 2015 in summary  Operations Summary  Q1 Phase II clinical study of IdeS in highly sensitized patients awaiting kidney transplantation successfully completedCooperation initiated with leading US transplantation expert Dr Stanley Jordan at Cedars-Sinai Medical Center, Los AngelesDevelopment of a new generation of IdeS molecules for repeat dosing initiatedPreliminary application for listing on Nasdaq Stockholm submitted  Q2 IdeS Phase II study initiated at Uppsala University Hospital and Karolinska University Hospital. The first patient treated with IdeS was subsequently transplanted from a deceased donorInvestigator sponsored Phase II study with IdeS initiated at Cedars-Sinai Medical Center, USHansa Medical established a US medical advisory boardGöran Arvidson new President and CEO of Hansa MedicalHansa Medical secured MSEK 246 in funding through a fully subscribed rights issue  Financial Summary Q2 and Year to Date Net sales for the group in Q2 amounted to MSEK 0.5 (0.3). YTD: MSEK 4.4 (1.5)Operating result in Q2 was MSEK -22.5 (-4.8). YTD: MSEK -33.2 (-10.7)Consolidated net result in Q2 was MSEK -22.5 (-4.8). YTD: MSEK -33.2 (-10.8)Earnings per share before and after dilution in Q2 was SEK -0.70 (-0.18). YTD: SEK -1.11 (-0.42)Cash position on June 30, 2015, of MSEK 209.1  Significant events after the reporting period IdeS Phase I data published in the scientific journal PLOS ONEFirst patient treated with IdeS and subsequently transplanted in an investigator sponsored US Phase II study at Cedars-Sinai Medical Center, Los Angeles  CEO Statement In the second quarter of 2015, we continued to build on the good start of the year, when we took some important steps – both financially and in clinical development – to shape Hansa Medical’s future. Ultimately, we want to create a strong biopharmaceutical company with life-saving pharmaceuticals on the market. I feel certain that we are on the right track.  Our lead project IdeS has attracted a lot of attention in the international scientific community. The results from the earlier clinical Phase I trial of IdeS were published in the scientific journal PLOS ONE in July. Among other things, the study results showed that a single dose of IdeS rapidly and efficiently inactivates IgG in humans, which could make it a very attractive therapeutic approach for acute IgG driven conditions.  In June, we announced that the first patient after treatment with IdeS in a clinical Phase II study was successfully transplanted from a deceased donor. The study will evaluate the safety, tolerability and efficacy of IdeS in kidney transplantation of sensitized patients. It is also aimed at identifying the appropriate dose that in the majority of patients will result in anti-HLA antibody levels acceptable for transplantation within 24 hours from dosing.  In parallel with the ongoing Phase II study in Sweden, other studies are being initiated, one of which is run by Professor Stanley Jordan, a leading expert in transplant immunology, at Cedars-Sinai Medical Center in Los Angeles. It is an open-label study to assess the safety and efficacy of IdeS in eliminating donor specific antibodies and thus prevent antibody-mediated rejection in sensitized patients.  This important collaboration with Dr Jordan is a further acknowledgement that IdeS is an exciting project, quoting Dr Jordan: “IdeS has the potential to revolutionize the whole area of transplantation, especially in sensitized patients.” We are also planning for further studies in transplantation and other IgG mediated indications where there is a significant unmet medical need.  As you will see in this report, we have summarized and in more detail explained our projects and the various studies we have conducted and are conducting at the moment. We will continuously update this information on the website.  During the period, we also strengthened our scientific network. In May, we announced the formation of a US medical advisory board for IdeS in kidney transplantation. This board is connected with the previously initiated advisory board of leading transplantation experts in Europe. These advisory boards are valuable components in establishing IdeS as a potential pharmaceutical product of great importance.  Early in April, we announced that the MSEK 246 rights issue was fully subscribed, which means that we now have the means to finance the next exciting phase, the clinical development of IdeS and our other research projects. We believe that IdeS has other potential medical indications, including relatively rare and serious – even life-threatening – acute immune diseases.  We have also continued to strengthen the organisation in and around the company, in time for the planned change of market place to Nasdaq Stockholm’s main market. At the annual general meeting on 2 June, Hans Schikan was elected new board member, adding more first-class biotech experience to the board. The management was also strengthened with Steven Glazer as CMO and Eva-Maria Joed as CFO.  On November 13, 2015, we will have the honor to summon interested shareholders and research partners to a combined investor and research day in Stockholm. During this event some of the prominent US and European clinical experts we collaborate with will give us a review from their daily practice and present their view on the potential of IdeS. We will get back shortly with more details about this event and how to attend.  The development of Hansa Medical in the first half of this year shows that we are in an excellent position to build a biopharmaceutical company of lasting value with important, life-saving products.  Göran Arvidson President and CEO

Studsvik expanding core competence within Fuel and Materials Technology Business Area

“This integration further strengthens the Business Area for our expanding customer base, by providing a more efficient, broader spectrum of solutions, focused specifically on optimizing the fuel cycle - from design to post operation and reactor core management”, says Camilla Hoflund, President of the Fuel and Materials Technology Business Area. The Studsvik Fuel and Materials Technology Business Area already provides world-leading services related to fuel and materials integrity, water chemistry, reactor physics and reactor core management to the commercial nuclear industry supporting the entire fuel cycle. ALARA Engineering further complements these solutions by providing thermal hydraulic and safety analysis expertise. The integration into the Fuel and Materials Technology Business Area is a natural progression in Studsviks ever-expanding materials and reactor analysis offerings. “We are focused on providing complete solutions to help our customers realize improved safety and cost efficiencies in the design and operation of the nuclear fuel cycle. Studsvik’s unmatched experience and facilities give Studsvik an exclusive position to offer these safety and cost efficiencies by providing integrated solutions”, Camilla continues. For further information please contact: Camilla Hoflund, President of Fuel and Materials Technology, phone + 46 155 22 10 66 or Michael Mononen, CEO Studsvik AB, phone + 46 155 22 10 86 Facts about Studsvik Studsvik offers a range of advanced technical services to the international nuclear power industry in such areas as waste treatment, consultancy services, and fuel & materials technology. The company has over 65 years experience of nuclear technology and radiological services. Studsvik has 800 employees in 7 countries and the company’s shares are listed on the Nasdaq Stockholm. Studsvik is publishing this information pursuant to the Securities Market Act and/or the Financial Instruments Trading Act. The Information was released for public disclosure on August 25, 2015 at 08:15 AM CET. www.studsvik.com

Cantargia Interim Report for the period 1 Jan 2015 – 30 June 2015 available

Significant events in the second quarter of 2015 Notice of the Annual General Meeting was published on the Company’s website in April. The Annual General Meeting was held at Medicon Village on 22 May 2015 and a report from the AGM was published on the same date. At the AGM a resolution was adopted authorising the Board of Directors to decide on the issuance of new shares, on one or several occasions, during the period until the next Annual General Meeting. In April Cantargia published its annual report for the financial year 2014. The annual report is available for download at the Company’s website, www.cantargia.com. In May Cantargia announced that the Company had received notice that the European Patent Office (EPO) had issued an “intention to grant” for Cantargia’s patent application for IL1RAP as a target molecule for antibody therapy and leukemia diagnostics. Intention to grant essentially means that the EPO is likely to approve the patent application. Before final notice of approval can be received, however, further actions will be required by both parties. On 1 June 2015 Lars Thorsson took up the position of Vice President Clinical Development at Cantargia. Before joining Cantargia Lars Thorsson worked at Novo Nordisk A/S, where he held the role of Senior Clinical Pharmacology Scientist with responsibility for preparation and implementation of clinical pharmacological studies in development projects. In June Cantargia received a non-exclusive license to use BioWa’s POTELLIGENT® technology platform for production of its CAN04 drug candidate. BioWa Inc. is a wholly owned subsidiary of Kyowa Hakko Kirin Co., Ltd., a leading Japanese pharmaceutical company. Significant events after the end of the period At the beginning of July Cantargia announced that the Company had concluded an agreement with Glycotope Biotechnology GmbH for production of Cantargia’s CAN04 drug candidate. Glycotope Biotechnology will be responsible for process development and manufacture in accordance with good manufacturing practices and will produce CAN04 for use in future toxicological studies as well as clinical trials. In August the respected international journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) published a scientific article on the use of Cantargia’s antibodies in preclinical models of acute myeloid leukemia (AML). The article, entitled “Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia”, documents that Cantargia’s antibodies targeted at IL1RAP have a potent antitumour effect in preclinical models of AML. First half (1 Jan. 2015 – 30 June 2015) • Other operating revenue was KSEK 0 (0).• Earnings after financial items were KSEK -9,059 (-3,707).• Earnings per share were approximately SEK -0.68 (-20.15).• The equity/assets ratio was approximately 90 (63) per cent. Second quarter (1 April 2015 – 30 June 2015) • Other operating revenue was KSEK 0 (0).• Earnings after financial items were KSEK -5,432 (-1,839).• Earnings per share were approximately SEK -0.41 (-10.00). Definitions • Earnings per share: Profit for the period divided by 13,394,874 shares as of 30 June 2015.• Equity/assets ratio: Equity divided by total capital.• Figures in parentheses refer to same period in the previous year. For further information, please contact: Cantargia ABGöran Forsberg, Ph.D.CEOTelephone: +46 46 275 62 60E-mail: goran.forsberg@cantargia.com Website: www.cantargia.com

Interim Report 2 2015, 1 January – 30 June

Important events after the end of the quarter: In July Cherry added strategic acquisitions to its core business · In July, Cherry acquired 71 percent of the shares in the Malta-based company Almor Holding Limited (Almor) – a leading online casino in German speaking markets. The business will be consolidated by Cherry from July 1. Cherry already has the right to the profits from May 1, and the business has developed positively during May and June. This will strengthen the cash position of Cherry with about EUR 700,000. · On July 27, Cherry-owned Game Lounge acquired a prominent Finnish affiliate’s domains and affiliate agreements. The acquisition is expected to increase EBITDA figures by more than EUR 600,000 annually, bring in more than 10,000 new depositing customers to Cherry and other operators over three years and quickly increase volumes on current Cherry brands. The acquisition is fully financed by Game Lounge operations and the deal is expected to generate ROI in less than two years. The business will be consolidated from the third quarter. · In July, Online Gaming has been developing positively with good growth and positive EBIT, also when excluding Almor. The business area is expected to show a positive EBITDA for the third quarter CEO comments on the second quarterThe second quarter showed continued strong growth and the Group’s turnover increased by 40 percent. We have improved our earnings considerably, which is a result of the growth Cherry has had primarily within Online Gaming but also because of strong improvements within Restaurant Casino. Cherry’s online business continues to grow and now represents 63 percent of group sales and is expected to grow faster than the market going forward. We see that the steps Cherry has taken, focusing on core business and supporting strategic acquisitions, is now beginning to show results. Today, Cherry’s business area Online Gaming is well positioned, with a well-functioning and flexible platform, where new products can easily be integrated and new skins added. We can therefore, with limited costs, increase both volume and profits. After the reporting period, Cherry has added some strategic acquisitions to its portfolio, partly through the acquisition of 71 percent of Almor Holding, an online casino with a leading position in the German speaking markets. The acquisition has, during the first six months, reported an EBITDA of approximately EUR 1,000,000. The acquisition will contribute strongly both in terms of increased growth and increased profits for Cherry. In addition to this Game Lounge, owned by Cherry, has acquired a leading Finnish affiliate’s domains and affiliate agreements. This is expected to increase EBITDA with more than EUR 600,000 per year and bring in more than 10,000 new depositing customers to Cherry and other operators during a three year period, rapidly increasing volumes of existing brands. If Almor Holding had been consolidated during the second quarter, the Group, as well as Online Gaming, would have reported positive EBITDA. Almor Holding and the acquired Finnish domains and affiliate agreements will be consolidated as of the third quarter. During the second quarter, Online Gaming has shown a strong growth by 61 percent, and significantly improved its earnings. Our work to improve the gaming experience, to deliver joy of playing and strengthen customer loyalty, now begins to show results. We see strong growth in mobile gaming and will continue to improve our mobile offerings. During the quarter, we launched our first white label brand, SveaCasino.com, and re-launched EuroLotto.com, now hosting the biggest lotteries in the world. Cherry currently has three licenses via Malta, Curacao, and Schleswig Holstein and intends to obtain local licenses in those markets where Cherry has a large volume or in new markets where Cherry expects a strong growth. In July, Online Gaming has been developing positively with good growth and a positive EBIT, also when excluding Almor. Cherry expects to report a positive EBITDA for the business area for the third quarter. Yggdrasil has increased its revenues by 119 percent, and signed two new contracts, including BetClic Everest Group. Yggdrasil’s roadmap for 2015 looks exciting and, during the quarter, slot games "Cyrus The Virus" and “Joker Millions” were released. Joker Millions is Yggdrasil’s first progressive jackpot game and today three operators are live, of which two went live late early in the third quarter. After the quarter, the new game "Chibeasties" was released, which has so far been a success. Yggdrasil has taken the decision to release all of the games on the new iSENSE 2.0 platform, based on HTML5, providing the opportunity to release the games simultaneously on computer, tablet and mobile, and giving the games a better and faster performance. This allows operators a greater opportunity to reach their players in connection with marketing campaigns. A proof of Yggdrasil’s success came in June, when they won "Software Rising Star" at the EGR B2B Awards. There’s much more to come with Yggdrasil, as we roll out their full library of games to operators. As new operators are deployed, additional games are launched to existing customers, and the game portfolio grows, Yggdrasil’s revenues will increase. Restaurant Casino continues to impress with a positive developments. In the second quarter, the business delivered stable growth and increased its profits by 39 percent. In July, the payroll taxes for young people were raised, which over time will affect the industry and Restaurant Casino’s profitability. The increase in payroll taxes for young people will be shared with the restaurateurs but it will also lead to more gaming locations becoming unprofitable. Therefore, a raise in stake, within Restaurant Casino, from today’s SEK 70 to SEK 200, is required. With this raise the industry could generate around 1,000 new entry-level jobs. Cherry will lobby for a stake raise. A new order is required on the Swedish gaming market. Sweden has quite rightly been taken to the European Court, after having too long delayed a re-regulation. The latest development is a new Swedish gaming legislation that will be in place by July 1, 2018. Cherry welcomes a gaming market that is open for everyone with transparent and responsible stakeholders. We want to eliminate the anachronistic and failed gaming monopoly. We want to create more jobs and compete on fair conditions. Cherry’s goal is to grow faster than the market both through acquisitions and organically, focusing on rapidly increasing profitability. Now we look forward to continue to spread joy of playing, both online and at the pub! Fredrik Burvall, CEO For further information please see the full Interim Report 2, 2015.http://cherry.se/en/financial-reports/ TranslationThis is a translation of the Swedish original. Stockholm, August 25, 2015Fredrik BurvallCEO Cherry AB (PLC)Telephone +46 8-514 969 52, +46 709 279 632, fredrik.burvall@cherry.se

Orc extends connectivity to Borsa İstanbul to enable access from next-generation trading platform

“Turkey is becoming an increasingly attractive market, with a steady rise in trading activity and demand from the region,” said Jonas Hansbo, Chief Strategy Officer, Orc Group. “We are delighted to offer all Orc clients high-performance connectivity to Borsa İstanbul and to have our first Turkish users of Orc’s next-generation trading platform active on Borsa İstanbul.” Orc’s Execution Bricks platform combines global market access to over 150 exchanges, brokers and alternative liquidity pools with the execution tools needed to manage, control and execute high volume, latency sensitive customer order flow. By consolidating market access to Orc, clients gain access to global markets efficiently while extending the reach of their trading infrastructure. Orc’s pre-trade risk capabilities enable firms to stay compliant and in control without sacrificing latency or functionality. “We are pleased to see Orc, a distinguished software vendor offering enhanced connectivity to Borsa İstanbul,” said Muammer Çakır, Head of Derivatives Market-VIOP, Borsa İstanbul. “Orc is highly regarded for their sophisticated trading and electronic execution solutions, and we strongly believe that their development efforts help make Borsa İstanbul an even more attractive trading venue.” Orc’s Trading Bricks platform was designed from the ground up to be fast, and is also built for change. With an app-based, modular architecture, Trading Bricks provides an easily extendable and fully customizable trading platform which is inherently low latency. Orc is a pioneer in trading automation and Trading Bricks facilitates any initiative to deploy new ideas and taking proven, profitable trading strategies to new markets. About OrcOrc is the global market leader in electronic trading technology for listed derivatives. Successful trading desks of premier institutions rely on Orc to stay ahead in increasingly dynamic and competitive markets. We deliver unrivalled next-generation solutions for advanced trading, market access and electronic execution to leading trading firms, market makers, banks and brokers worldwide. With 200 customers in more than 30 countries, access to over 150 trading venues and offices in each of the world’s key financial centers, Orc offers true global capabilities. Orc is owned by Orc Group Holding AB which in turn is majority-owned by Nordic Capital Fund VII. www.orc-group.com About Borsa İstanbulBorsa İstanbul, with historical roots going back to 1873, is the sole provider in Turkey of trading, settlement, custody and registry services for a wide range of products such as equities, debt securities, repo, sukuk, warrants, options, futures, certificates, and exchange traded funds (ETFs). Following the successful completion of horizontal integration (via the acquisition of the derivatives and gold exchanges), and of vertical integration (via control of the two domestic post trade firms), Borsa İstanbul demutualized in 2012. Through its markets, Borsa İstanbul offers corporates, investors and traders in the region a broad range of financial products suited to their needs, and efficient access to extensive capital markets. Post trade and depository services are offered by its majority-owned subsidiaries of Takasbank (Istanbul Settlement and Custody Bank) and MKK (The Central Securities Depository). Borsa İstanbul calculates 360 indices that measure and benchmark equity and fixed income markets in Turkey. Borsa İstanbul is a shareholder in Sarajevo, Baku, Kyrgyz Republic, and Montenegro Stock Exchanges, as well as LCH. Clearnet.  For further information, please visit Borsa İstanbul at http://www.borsaistanbul.com/ For further information, please contact:Lee Griggs, President EMEA, Orc, Tel. +44 20 794 209 58Rickard Davidsson, VP Sales EMEA, Orc, Tel. +44 20 794 209 56Amal Ahmed, Marketing Manager EMEA, Orc, Tel. +44 20 794 209 86

Paolo Astarita appointed as new Senior Vice President Human Resources for the Trelleborg Group

Paolo Astarita has been appointed as the new Senior Vice President Human Resources for the Trelleborg Group from October 1, 2015. He will also be a member of the Group Management. He succeeds Sören Andersson who will act as Senior Advisor Human Resources during the period 1 October to 31 December 2015 and then retire. Paolo Astarita has since 2001, held the position as Vice President Human Resources for the business area Trelleborg Wheel Systems and has in addition been in charge of Talent Management for the Group since 2011. His previous experience includes various positions in HR in Pirelli and Manuli Rubber. “We are delighted to have the possibility to promote Paolo. He has an excellent profile and experience to further develop the Human Resources function within the Trelleborg Group,” says Peter Nilsson, President and CEO of Trelleborg. “I am glad for this appointment. I am committed to taking on this new responsibility, leveraging experience gained during 14 years of intense involvement in the business”, says Paolo Astarita. Sören Andersson has worked as Senior Vice President Human Resources for the Trelleborg Group since 1998. “I want to extend my heartfelt thanks to Sören Andersson. Through his competence and long experience in Human Resources, he has been a great asset in the development of the Group during his time at Trelleborg,” concludes Peter Nilsson.

MICHELIN FARM TYRE PRESSURE APP NOW AVAILABLE FOR iOS DEVICES

Michelin’s free agricultural tyre pressure calculator app is now available for iOS devices, giving even more farmers and contractors access to on-the-spot bespoke tyre pressure advice. Compatible with iPhone, iPad and iPod Touch devices, the Michelin Pressure Calculator app (https://itunes.apple.com/gb/app/michelin-pressure-calculator/id1022853620?mt=8) instantly works out the most appropriate tyre pressure settings for desired load and speed on any farm tractor in just three easy steps. Firstly, the user must enter the tractor’s front and rear axle load and tool weight, and then select the size of Michelin tyres fitted to both the tractor’s axles from a simple drop-down menu. Finally, a quick snap with the device’s integrated camera allows the app to calculate the precise load distribution and the length of the overhang, measured from the wheels, to define the tractor’s optimum pressure recommendations. The tyre pressure results calculated and pictures taken for each tractor can be saved in the app’s ‘My Tractor’ menu, and shared by email – ideal for sending pressure calculation results back to the office from the field. Mike Lawton, Commercial Director of Michelin’s Agricultural Division in the UK and Ireland, says: “The free pressure calculation app has been well received on Android devices, and we’re delighted to extend that same capability to iOS users. “Farmers today can enjoy a wealth of technological assistance with their work, and our development team saw a chance to make sure any tractor fitted with Michelin tyres is running at the optimum tyre pressures. Getting your pressures spot on can help reduce soil compaction and leave shallower ruts – and the fact that such a capability can sit next to a farmer’s keys in his pocket is remarkable.” The free Michelin Pressure Calculator app is available for devices with iOS 7.0 or later and Android devices (https://play.google.com/store/apps/details?id=com.michelin.agpressurecalculator) in four languages: English, French, German and Spanish. For more information about the range of Michelin farm tyres available visit www.michelin-agricultural-tyres.co.uk. ends Michelin, the leading tyre company, is dedicated to sustainably improving the mobility of goods and people by manufacturing, distributing and marketing tyres for every type of vehicle. It also offers innovative business support services, digital mobility services and publishes travel guides, hotel and restaurant guides, maps and road atlases. Headquartered in Clermont-Ferrand, France, Michelin is present in 170 countries, has 112,300 employees and operates 68 production plants in 17 countries. The Group also has a Technology Centre, responsible for research and development, with operations in Europe, North America and Asia. (www.michelin.com) For further press information please contact: David Johnson, Michelin Press OfficeTel: + 44 (0) 1782 402341      Email: d.johnson@uk.michelin.com James Keeler or Beth Laws, Garnett Keeler PR, Inver House, 37-39 Pound Street,Carshalton, Surrey, SM5 3PGTel: +44 (0)20 8647 4467   Fax: +44 (0)20 8544 4711   E-mail: james.keeler@garnettkeeler.com or beth.laws@garnettkeeler.com MICHA/136/15

POUF DADDY FOUNDER PAWNS OWN YACHT TO DESIGN HIGH-END BEAN BAGS! LIVE ON CHANNEL 4 TOMORROW NIGHT  - WEDS 26TH SEPTEMBER @ 8PM

LONDON, UK – 25th August 2014: Crazy, inspired and eccentric are all words that could be used to describe Steve Crompton's bid to fund a new designer bean bag venture – POUF DADDY. Tomorrow night (Weds 26th September@ 8pm) Channel 4's ‘Posh Pawn’ series shows him pawning his yacht in bid to fund his bean bag business!  The Posh Pawn team James Constantinou and the London-based Prestige Pawnbrokers jet off to sunkissed Palma to investigate Steve’s yacht, thought to be worth £150,000. Speaking about parting with his yacht Steve said, “It was my pride and joy, the ultimate boys toy, but you can make a lot of beans bags for the price of a yacht so it had to be done to get the business afloat. I'm delighted and business is already booming, so I am hoping to buy it back some day soon”.  Businessman Steve is one half of the recently launched flexible furniture brand POUF DADDY, his partner Ben Sowton is owner and founder of renowned dance music record label – Seemless Recordings.  With many years of experience between them in events, restaurants, design and music, the entrepreneurs met in Mallorca and spotting a gap in the market over drinks one evening the POUF DADDY concept was born. Launching earlier this month, this new business is off to a promising start, just where can this venture go next after selling a yacht to finance the start up?  Keep all eyes on these purveyors of luxury lounging; this brand is certainly one to watch!   Coming soon...POUF DADDY’S Christmas Gift Guide to Luxurious Lounging For enquires please contact Emma-Louise O’Neill  emmalouise@elonpr.com +44 7515 136909 www.poufdaddy.co.uk

New food-to-go innovations at lunch! 2015

lunch! – the multi-award winning trade event for the food-to-go sector, has released its latest preview of exhibitor show highlights. An essential visit for thousands of trade buyers from across the UK’s retailing, hospitality, snacking, convenience, and catering sectors, lunch! returns to the Business Design Centre in London on 24-25 September with 350 exhibitors (a 25% increase for 2015).  The following is just a taste of some of the new food innovations on show: Exhibiting for the first time ever at a trade show, award-winning dessert specialist Marston Foods is launching a new afternoon tea range at lunch!.  Products include Gooey pots, moist cakes and tarts, in flavours like Raspberry and Rose, Victoria Sponge and Billionaires (stand F221). Making their debut at lunch!, The Real Soup Co’s new 380g, single serve pots of fresh, ready to heat and serve soup for the food-to-go sector.  Available in five popular flavours (including Thai chicken and tomato & basil), they can be heated in the microwave in minutes (stand A202). Jax Coco is launching its new Coconut Chips exclusively at lunch!.  Available with sea salt, wasabi or chilli & lime, the Chips are vegan, gluten and trans fat free, and made from the nutritious flesh of hand-cut premium coconuts (stand U212). Mom's Fabulous Hot Dogs is launching its new Beefy Dog at lunch! – a skinless quarter pounder made from prime cuts of beef with a firm, smooth texture and a meaty flavour.  Also showcasing their highly successful portfolio of premium quality hot dogs, offering a variety of tastes and textures (stand M334). Launching at lunch! Ingenious Foods is introducing Gourmosa, a range of food-to-go from the sub-continent with a modern twist.  Popular snacks include Samosa Pie – a puff pastry pie in an open samosa shape available in chicken, beef and paneer; Samosa Pot (they’ve separated the filling and the pastry into two convenient on the go pots); Oven Bake Samosa; and Chaat - Super food salads (stand F306a). New exhibitor Traybakes has been making traybakes by hand for 25 years.  Their new Sharing Slice range – launching at lunch! – is available in 25 different flavours.  Generously proportioned, they are ideal to share with friends and family, or to give a gift (stand A307). Honeyrose Bakery/Kent & Fraser gluten-free is launching its new range of twice-baked Toasts in September.  Made in the UK in their artisan bakery, flavours include Cherry, Pecan & Poppy Seed Toast, Cranberry & Almond Toast, and Olive, Walnut & Pimenton Toast.  All available in 110g packs (stand M547). Devonvale Bakery is launching its new 'unch brand at lunch!.  Featuring three eye-catching outers (BrUnch, CrUnch and FrUnch), these hand-baked, sweet cake bar snacks include Choc Mint Crunch and Apple & Raspberry Crumble flavours (stand F302). The Living Food Kitchen is unveiling three new autumn launches at lunch!.  Almond Shakes (a range of HPPed dairy free drinks) and Coconut Flapjacks, made with gluten free oats, coconut sugar and coconut butter, are available from October.  Whilst November sees the introduction of Truly Raw organic chocolate from Indonesia in 25g snack bars (stand A309). Launching at lunch! Proper Pudding is introducing five premium, sugar or refined sugar free, chilled puddings (available in individual, 140ml portions).  Flavours include Lemon Jelly with Lime & Coconut Pudding; Orange & Honey Posset and Strawberries & Cream.  Also available as dairy-free, using coconut milk instead of cow’s milk (stand IZ-03). New exhibitor Pietercil Group – Beliès specialises in fresh Mediterranean delicacies including unpasteurised olives, antipasti and tapenades.  It’s showcasing its new ‘on the go’ Greek olives snack pack (with fork).  Products are free from colourings, flavourings and aromas (stand U115) Nina Bakery’s new artisan pitas are launching at lunch!.  Ideal for foodservice – they don’t tear easily, are clean label, come in a variety of sizes from mini-pita to XL, and can hold fillings for up to 48 hours (stand U107). Crown Foods – WAT KITCHEN is launching new classic Indian flavours to its pan-Asian to-go range of ambient Chicken & Rice and Chicken & Noodle combos.  With no water, fridge or fuss required, caterers, or customers, simply empty the sachets in the take-out style boxes and microwave in just 2½ minutes (stand G5). The Coconut Collaborative is showcasing its dairy-free coconut milk yoghurts at lunch!, including their soon-to-be-launched bulk range of Natural and Coconut & Almond yoghurts.  All products are free from dairy, soya and gluten (stand F103). Cakesmiths is launching a new Artisan Loaf Range (including Smashing Pumpkin, Banana and Chocolate Bread, Poached Pear and Ginger, and Lemon & Courgette) this autumn.  It will also be previewing its Christmas range at lunch!.  Cakes are portioned and frozen to ensure maximum quality and usability with minimum waste (stand A208). PERKIER Foods is launching two all-natural, gluten, wheat and dairy free snack bars made with on trend ingredients, such as quinoa, goji berries, cacao, sprouted grains, cashew nuts and chia seeds.  The Quinoa bars come in three varieties: Cashew, chia & pumpkin seeds; Goji & Cranberry; and Cacao & Cashew.  Whilst the Cranberry & Cashew Oat Bars are enhanced with sprouted buckwheat (stand A415). Real Handful’s new trail mix snacks are made with flavour-infused dried fruits, raw nuts and belgian chocolate.  Currently available in Banoffee and Mochaccino blends, with new Strawberries and Cream and Chocolate Orange flavours launching at lunch! (stand IZ-10). Swiss-based Rhythm108 (108 Foods SARL) is introducing its range of 100% organic, gluten-free Good-for-You dessert bars and tea biscuits to the UK.  Flavours include Banana Muffin, Lemon Cake, Coconut Macaroon, Apple Pie and Coco-Walnut Brownie (stand G1). Calbee UK is showcasing its category innovation savoury snacks - Yushoi Snapea rice sticks. Baked and made using green peas, they are inspired by Japan and available in four flavours: Lightly Salted, Smoked Salt & Szechuan Pepper, Sweet Chilli & Lemon and Soy & Balsamic Vinegar.  Olympic gymnast and winner of Strictly Come Dancing, Louis Smith MBE is celebrity ambassador for the product, which launched in June (stand F301). The Soho Sandwich Company is showcasing their new menu, launched on the 27 July.  The new menu features a range of popular classics 'with a twist', plus innovative new recipes featuring a range of great artisan breads and deli rolls.  Other new additions include Cavatappi Pasta Salads, Super Foods Salads, and Wraps of the World (stand F122). URBAN eat’s latest product development brings microwavable Burritos to the food to go fixture.  The four flavour-packed varieties (Spicy Pulled Beef, Chipotle Chicken, BBQ Pulled Pork & Vegetarian Spicy Bean) have been created to authentic Mexican recipes to ensure they pack a real Mexican punch (stand M140). Tideford Organic Foods is unveiling two new luxury Christmas sauces at lunch! – Organic Cranberry & Port sauce and Organic Rum sauce (gluten and wheat free).  Tideford will also be showcasing their Winter super-food soups, which are all organic, gluten, wheat and dairy free (stand A315). Pidy has three new launches for 2015, including a crumbly and buttery gluten free pastry range, sweet and neutral short pastry (which includes mini cups, mini tartlettes and larger cases), plus a savoury choux range, which can be eaten sweet or savoury, for breakfast, lunch or dinner (stand M418). New exhibitor Jeronimo Martins is the largest food distribution group in Portugal and Poland.  Their new products for 2015 include Great Taste award winning Tuna Fillets in Organic Olive Oil (fished from The Azores) and Chocolame – a chocolate and biscuit cake made with Port Wine (stand U208) nutrii is launching a new range of premium, all-natural, protein-packed tubs of quark; available in four different flavours.  Blended with fruits, nutrii quark is virtually fat free, low in carbs and the highest in protein in its category (stand IZ-12). Surfer-inspired The Phat Pasty Co has unveiled a fresh new look to be launched at this year’s lunch!.  With new point of sale materials and concept support packages, they help operators provide an on-trend branded offer for customers.  Phat’s premium pie range includes a steak and cornish ale pie, and a vegetarian sweet potato, spinach and goats’ cheese option (stand M239). Emily Fruit Crisps is introducing new 15g packs at lunch!.  Available in Crunchy Banana, Crunchy Pineapple and Great Taste award-winning Crunchy Apple, the snacks combine the goodness of real fruit with the crunch of a crisp (stand F316). Food Attraction’s Naanster is showcasing its rebranded packaging and new Chicken Jalfrezi flavour at lunch!.  Spicy, succulent curry wrapped in fluffy naan with a little mango chutney, Naansters are ideal for eating on-the-go or at home, and are ready in just 90 seconds (stand M534). Pizza Cone is showcasing a new addition to its product range at lunch!  The Whole-Wheat Pizza Cone enables consumers to enjoy a healthier twist on their convenient pizza-to-go option (stand F314).  Leading handmade Cornish pasty manufacturer, Proper Cornish is sampling its newly launched range of four handheld pies: Steak & Ale, Chicken, Bacon & Leek, British Pie awarded Asparagus & Mushroom, and the hybrid-inspired Pork Pie.  Each pie is made with short crust pasty before being filled with quality ingredients, which are sourced locally where possible (stand G4). Artisan premium crisp brand, Burts Potato Chips is showcasing their hugely popular Lentil Waves (available in Sour Cream & Chive, Thai Sweet Chilli and Lightly Salted) alongside recent launches like Devon Roast Beef (created with the Well Hung Meat Company) and Hobgoblin Spit Roast Steak (with the Wychwood Brewery) (stand M341). TOP Taste – a major producer of crispy onions in The Netherlands, is showcasing two new additions for 2015: Crispy Pepper made from fresh bell pepper, and Crispy Gherkins made from fresh dill pickles.  They can be used as innovative extra ingredient on sandwiches, with sauces, on hotdogs, on burgers and more (stand U204). Pulsin' is promoting its new Organic Sunflower Protein (45% protein).  Raw, vegan and gluten free, with no added sugars, it can be used to fortify sweet and savoury foods and is certified organic (stand M132). Joe & Seph's Gourmet Popcorn is showcasing its Caramel Sauce range, made using the same caramel recipe they use for their popcorn.  Available in six innovative flavours (including chocolate, sticky toffee, and gin & tonic), it can top desserts, be used for spreading or dipping, and stirring in to milkshakes and coffee (stand M337). Oli & Zoe's Food Co recently launched the UK’s first healthy popcorn range for children.  Made by parents to combat the rising child obesity problem (the UK has the highest obesity rate in Western Europe), it contains minimal sugar and salt content.  Currently available in two flavours: slightly sweet and slightly sweet & salty (stand U223). Walkers Shortbread is sampling its new Gluten Free Shortbreads in 30g Minipacks.  Ideal for the lunch impulse market, they will appeal to the growing number of consumers looking for certified gluten free products (stand M141). Tanpopo Japanese Food has launched some new snacking items this year, including their innovative Onigiri rice balls.  Already hugely popular in Japan, Tanpopo’s new flavours include Curried Salmon, Fried Tofu & Tempura Rice, Salmon & Dill, Hijiki Seaweed & Soybean, Sweet Chilli Tuna (stand A107). As seen recently on the BBC’s Dragon's Den, Chika's Foods is showcasing its vegan and gluten-free West African snacking range.  Products include Smoked Almonds, Plantain Crisps, Salt and Black Pepper Cashews, plus new Chickpea Crisps (stand IZ-16). Pumpkin Tree is promoting its recently launched Toasted Oat Crush.  The fruity snack is made with only natural ingredients and omes in three flavours – Raspberry & Blueberry, Apple & Cinnamon, and Mango & Passionfruit (stand U109). Go2Grocery is showcasing ape crispy coconut curls.  Launched this summer, these healthy snacks are made with just coconut and all natural seasoning.  They have no added sugar, are gluten, dairy, wheat and soy free, are high in fibre, and count as part of your 5 a day (stand M348). Scott Farms Chip Company is showcasing its newly launched Orange, Purple and White Sweet Potato Chips.  A market first to have three varieties of sweet potato, all grown from seed on the Scott’s family farm, in one bag.  Grown in the US, made in England; Scott Farms offers absolute provenance (stand F204). Two-time Great Taste Award winner, Pop Notch Popcorn has just launched its range of snack packs with new packaging.  Pop Notch Kids is completely unique to the market. Both are perfect for the food-to-go industry. Gluten-free. All-natural ingredients. (stand F326). Cake is exhibiting at lunch! for its second year, showcasing their diverse traybake, cake and scone offerings.  New products for 2015 include a White Chocolate and Raspberry Scone, Linzer Biscuit, and a twist on a traditional round cookie – the Extra Chocolatey Square Cookie Tray (stand M432). Metcalfe’s skinny is showcasing its gluten-free Popcorn Crisp range, available in three flavours: Kettle Original, Sweet Chilli and Say Cheese.  Created through an innovative flash-griddled process, Popcorn Crisps have 35% less fat than the average tortilla chip (stand A321). New for 2015, UCD is presenting Maison Routin 1883 Chocolate Cookie Syrup.  Evenly balanced between soft chocolate and biscuit, its aroma captures the irresistible appeal of fresh-baked cookies right out of the oven.  It can be used with pastries and ice cream, smoothies, milkshakes, coffee, and cocktails (stand A217). Southover Food Company is showcasing its Great Taste award winning pulled ham hock.  Described by the judges as 'moreish', it is gathering interest for its 'flavour and tenderness'.  This versatile product is suitable for busy delis and catering kitchens alike (stand U103). Award-winning American cult brand Y3K LCC is introducing its range of rich, super-concentrated ice-cream, pre-portion ice-cream cakes, and American bakery.  They’ll be launching a selection of new products at lunch!, alongside their water baked cheesecakes (finalist at this year’s Café Life Awards and winner of Best Bakery and Confectionery Product at Gulfood), and ice creams/desserts (nominated for innovation awards at SIAL Middle East) (stand A212).  For 2015, Ginger Bakers are paying particular attention to the health benefits of some of the ingredients they use.  Their new gluten free Berry & Beetroot Brownie is rich and fudgy, with fresh juicy raspberries and the fantastic health benefits of earthy beetroot (stand F107). Mallow & Marsh is exhibiting its recently launched 100% natural marshmallow bars.  The range includes Raspberry Marshmallow coated in 70% dark chocolate; Vanilla Marshmallow coated in milk chocolate; and Coconut Marshmallow (stand IZ-08). Oats brand MOMA has recently introduced a new Mango and Passionfruit Bircher Muesli to their range of healthy, balanced breakfasts.  It’s made from a blend of low fat natural yoghurt, British wholegrain jumbo oats soaked in apple juice and exotic real fruit (stand M522). Impress Sandwiches has launched new stand-out shelf packaging for their sandwich wedges and other items across food-to-go.  Featuring Mr Impress and friends they are designed to make consumers smile.  New Wrapido World Wraps in eight flavours are hot-to-go for the autumn too (stand M102). Launched earlier this year, Two Chicks is showcasing its Chirps – high protein egg white bites.  With the bite of a crisp that is high in protein, they are lower in fat and carbohydrate.  Chirps contain egg white, which is one of the highest quality protein sources available (stand F331). Brontë Bigger Eat Biscuits are a new range being shown by Paterson Arran at lunch!.  Available in three flavours (All Butter Shortbread, Ginger Snap and Double Chocolate Chip) Brontë Bigger Eat Biscuits are ideal for cafés, coffee shops, restaurants and bars (stand M323). lunch! returns to the Business Design Centre in Islington, London, on Thursday and Friday, 24-25 September.  For further information and to book a free trade pass in advance, please visit www.lunchshow.co.uk and quote priority code PR1 (direct link: www.eventdata.co.uk/Visitor/Lunch.aspx?TrackingCode=PR1) ###

York resident new to gardening wins county-wide competition

A woman from Elvington is one of the winners in a county-wide gardening competition despite never having had a garden before. “Gardening has changed my life,” claims Mrs Houlden who got her first garden last year when she moved from Wheldrake into a one-bedroom bungalow at Jubilee Court in Elvington.  Then the back garden was nothing more than a square area of grass, today there are trees, flower beds, a patio and even a fountain!  To go along with her eye-catching garden, Mrs Houlden is now the proud recipient of the ‘Most Improved Garden’ award in the annual York Housing Association In Bloom Competition.  She beat other gardeners, from Scarborough to Rothwell and Beverley to York, who took part in this year’s competition.  “When I first moved here and saw the size of the garden it was a bit daunting but I thought don’t let this beat you, just get on with it and with the help of my godson it’s all come together.  I told him what I wanted, he said you must be joking this is what you can have, and together we made it happen.  My next-door neighbour knows about plants and gardening and has been a big help too,” said Mrs Houlden. Raised beds, including a stunning three-tier rose bed, are a key feature of the garden and the different levels add variety and interest to the overall look, while the manicured lawn is dotted with colourful displays of containers, pots and hanging basket tree stands.  The raised beds have a practical function too, as a means to improve the quality of the soil and make it easier for Mrs Houlden to garden from her wheelchair. “The transformation Mrs Houlden has made to her garden is amazing – especially when you consider it’s all happened from scratch in less than a year – and she’s a beginner!  It’s obvious she’s put a lot of thought and effort into what to plant where; the combination of hanging baskets, raised beds, plants, trees, and seating areas, means there’s lots of variety and interesting little features that break up the large space.  She really deserves her prize,” comments chief executive, Julia Histon.  The award was presented by YHA board member, Sue Walters Thompson, who was fortunate to visit all the prize-winning gardens.  “It’s such a privilege to be able to see these beautiful gardens and meet the people who create them.  I’m always inspired by these gardeners and what they manage to achieve whatever the weather!  Not only do they get a lot of pleasure from their efforts but they give a lot of pleasure too – there’s nothing like the sight of a colourful mass of beautiful flowers to brighten up the day,” says Sue.  Having been bitten by the gardening bug Mrs Houlden is already planning her next project: “I’m new to gardening but now I can’t get enough of it!  Maybe I’ll have a go at the front of the house next.  There’s a weeping cherry tree but nothing else – so watch this space!” Other York winners in the 2015 annual York Housing Association In Bloom Competition are Mr Wannell, of Holgate Road, who took the award for ‘Best Low Budget’ garden and Mrs Whitehead of Faber Street, who won the ‘Best Low Maintenance’ category. For more details, or to see some of the photographs of the winning gardens, please visit www.yorkha.org.uk ENDS Links to photographs can be found below, with many more images of YHA In Bloom 2015 winners available from http://news.cision.com/york-housing-association For further media information or photographs, please contact: Jay Commins or Samantha Orange Pyper York Limited Tel:         01904 500698 Email:    jay@pyperyork.co.uk

Rothwell residents win county-wide gardening competition for second year running!

There must be something in the soil in Rothwell where two people who live on the same street beat nearly 1000 other gardeners across Yorkshire and North Lincolnshire to win top awards in a gardening competition for the second year running. Mr Stuart Howcroft, of 108 Pasture View Road, was judged Best Overall in this year’s York Housing Association (YHA) in Bloom competition, making him YHA’s 2015 gardener of the year, and he also won the title for Most Creative Garden.  His neighbour, Jennifer Hammill, who lives down the road at number 140, won the Best Container category for the third time in the last six years, bringing her total tally of trophies in the competition to seven.  Most of the flowers and vegetables in Stuart Howcroft’s garden have been grown from seeds he saves from the previous year’s crop, such is his passion for gardening.  “I’m always planning the next stage of my garden and I’m always looking out for new ideas.  I follow all the gardening shows on the telly and always have some paper, a pencil and a tape measure on me when we go out anywhere in case I see something I want to try and recreate at home.  I like the garden to have a bit of colour and I get a kick out of seeing everything grow and flower.  And when my neighbours opposite wake up they’ve got something nice to look at too!” says Stuart.  In a garden that is packed with beetroots, carrots, courgettes, potatoes, tomatoes, cucumbers, raised flower beds, and feature displays, it’s hard to single out a favourite aspect but Stuart is particularly proud of the bank of hanging baskets that adorn half the back wall of the house.  “It sets off the whole garden and transforms the look of the house during the summer – it’s like the house becomes an extra part of the garden,” he says. Jennifer Hammill has used hanging baskets, pots and troughs to provide a vivid blast of colour round the front door, over the balcony railings and up the steps to her first floor flat.  The planting scheme includes a vibrant mixture of fuschia, honeysuckle, clematis, geraniums and busy lizzies, that climb up and tumble down, blanketing the area. “I do it for the pure joy of it and seeing the flowers, in fact the doing is better than the winning.  When I first started doing my hanging baskets in 2008 I won the runner-up prize and that encouraged me to try again, and each year I got a bit braver, and it’s gone on from there,” comments Jennifer, who hasn’t let undergoing treatment for cancer stop her from tending her flowers. “What Mr Howcroft and Mrs Hammill have done with their gardens is absolutely amazing.  It just goes to show it doesn’t matter how big or small your garden is you can still create colourful displays that literally stop people as they walk past.  They obviously put a lot of thought and hard work into planting and looking after their plants and really deserve their prizes,” comments chief executive, Julia Histon.  The award was presented by YHA board member, Sue Walters-Thompson, who was fortunate to visit all the prize-winning gardens.  “It’s such a privilege to be able to see these beautiful gardens and meet the people who create them.  I’m always inspired by these gardeners and what they manage to achieve whatever the weather!  Not only do they get a lot of pleasure from their efforts but they give a lot of pleasure too – there’s nothing like the sight of a colourful mass of beautiful flowers to brighten up the day,” says Sue.  For more details, or to see some of the photographs of the winning gardens, please visit www.yorkha.org.uk ENDS Links to photographs can be found below, with many more images of YHA In Bloom 2015 winners available from http://news.cision.com/york-housing-association For further media information or photographs, please contact: Jay Commins or Samantha Orange Pyper York Limited Tel:         01904 500698 Email:    jay@pyperyork.co.uk

Merriment brings JORVIK Medieval Festival to York city centre

All the fun – including fighting and falconry – of the medieval fair will come to the Merchant Adventurers’ Hall in York city centre for a special Bank Holiday Monday of historic crafts and demonstrations as the finale event of the JORVIK Medieval Festival. The event will see the grounds of the 650 year old building taken over by characters from the period, bringing the ambience of a medieval holiday to life at the heart of the city. “The medieval timeline stretched over several centuries, from the Viking era right through to the last Plantagenet king, Richard III, so this is a fantastically rich period of history to recreate,” comments festival director, Danielle Daglan of the JORVIK Group of Attractions & Events.  “In medieval England, the concept of having leisure time was virtually unknown, with workers dedicating their Sundays to worship, and every other day spent working, so religious holidays or feast days – when everyone downed their tools and came together with their neighbours for fun and games – were absolutely cherished and a hugely important part of life.” 21stcentury visitors to the event will be able to enjoy a taste of many different branches of medieval life, from chivalrous knights hosting have-a-go sword-fighting sessions, to archers demonstrating and teaching essential skills with a bow.  Anyone feeling overcome with the excitement of the event will be invited to visit the Barber-Surgeon, a gentleman tasked with removing far more than just whiskers, as he also served as a medieval ‘doctor’ – though many of his cures may well have involved the removal of blood or even limbs! Also in the grounds, a ‘hawk mews’ will enable visitors to see some noble birds of prey up close, and hear about how important these animals were throughout the medieval period, not only in the sport of kings, but also to deliver fresh game to the dinner table for many rural families.  The falconers and historic interpreters will also be joined by modern day swords-people using historical methods,  and there will be lots of opportunities for children to get hands-on with crafts and activities Medieval Merriment runs from 10.00am to 4.00pm on Bank Holiday Monday 31 August.  Admission to the event is free, although there is a small charge for some of the activities. For more information, please visit www.jorvikmedievalfestival.com ENDS For further media information or photographs, please contact: Jay Commins Pyper York Limited Tel:         01904 500698 Email:    jay@pyperyork.co.uk

Advanced Laser-Hybrid Welding Station Delivered to Savonia University of Applied Sciences

PEMA Welding station purchased was a part of an investment plan of laser welding from European Regional Development Fund. The bidding project defined clearly all functional requirements for the welding station. Limiting values were determined for welding seams and grooves, welding material and materials to be cut, as well as for welding thicknesses and maximum measures for work pieces. Bids were evaluated by the evaluating team, among who were Mr. Esa Jaaskelainen, R&D Manager and Project Engineers Mr. Aku Tuunainen and Kari Solehmainen. After a very agile bidding process, Savonia University decided to get PEMA laser-hybrid welding station that fulfilled not only the technical requirements, but also was the most economical solution. PEMA Laser-Hybrid Welding Station PEMA laser-hybrid welding station includes PEMA Head and Tailstock HS 1500R-1, 1-axle gantry on rails, PEMA cell control W700, PEMA WeldControl 300 and CC 350. There are also laser welding head Laser Scanning tool Precitec Scantracker, welding robot Yaskawa Motoman and handling robot, protective cover and fume extraction. Joining the R&D of Local Companies Laser technology in welding – and in particular laser-hybrid welding connected to robotized welding – is still a pretty un-used method. Savonia University aims to lower the step of various companies to utilize new high-quality and effective welding methods. There are already four mid-size companies joining the research project. The target is to study e.g. differences in welding seams of cold temperature machinery, in cases when seams have been welded by arc-welding, hybrid welding or laser welding. The seam quality will be studied from the R&D and production point of view and considering the characteristics of end products. This project has been started in the summer of 2015 and will continue up till the end of 2016, after which Savonia University will publish a final report on the study. Materials used are constructional steel, high strength steel and aluminum. ”Our target is to reach new levels in welding technology with PEMA welding station,” says Mr. Kari Solehmainen, Project Engineer in Savonia. ”We have always made our studies bearing in mind the context of application. Companies need to benefit from the studies. And companies have been very keen on participating in our projects, since the benefits are so clear.” From Practical Studies to Productive Welding By the growing knowledge of welding processes, it has become clear that welding is a science that can also be developed to more economical methods and more flexible ways in practical production. Automated welding is still left obscure to many manufacturers, or they do not know enough of its possibilities. It is, though, well known fact that increasing welding automation increases productivity and helps in labor shortage. Therefore, also Savonia University has taken the automation in welding project into their program. The welding laboratory with its modern equipment and professional staff can perform weldability studies, welding tests and development planning of complex work pieces. The university defines together with companies cost structure of welding, and estimates what kind of development actions need to be taken. More information: Jaakko Heikonen, Pemamek Oytel. +358 40 596 4091 Esa Jaaskelainen, Savonia University of Applied Scienciestel. +358 44 785 6271

Trigon Agri A/S: Invitation to 2Q 2015 results presentation

Trigon Agri will publish its interim report for the second quarter 2015 on Monday, August 31, 2015 at 8:00 CET. Analysts, investors and media are invited to attend a telephone conference that will be held at 10:00 CET on the same day. Program: Joakim Helenius, Chairman of the Board, and Ülo Adamson, President and CEO, will present and comment upon the results. There will also be an opportunity to ask questions. To participate in the telephone conference, please call one of the following numbers: SE: +46 8 505 564 74 UK: +44 203 364 5374 US: +1 855 753 2230 FI: +358 981710460 NO: +47 235 002 10 DK: +45 354 45 580 CH: +41 225 675 541 The presentation material will be available on www.trigonagri.com before the telephone conference starts. A recording of the telephone conference will be available afterwards on www.trigonagri.com. Investor enquiries: Mr. Ülo Adamson, President and CEO of Trigon Agri A/S, Tel: +372 66 79200, E-mail: mail@trigonagri.com About Trigon Agri Trigon Agri is a leading integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Trigon Agri’s shares are traded on the main market of NASDAQ OMX Stockholm. Trigon Agri is managed under a management agreement by Trigon Capital, a leading Central and Eastern European operational management firm with around USD 1 billion of assets under management. For subscription to Company Announcements please contact us: mail@trigonagri.com. If you do not want to receive Trigon Agri press releases automatically in the future please send an e-mail to the following address: unsubscribe@trigonagri.com (mail@trigonagri.com).

More Releases Ultra Thin iPhone 6S and 6S Plus Case and Hard Back Covers Ahead of iPhone Release

A slim line new iPhone 6S and iPhone 6S Plus case joins the first ever collection for the new Apple handset at More today – fusing an ultra-low profile with sky high protection. Designed ahead of the official release date for the iPhone 6S model, More has flouted all of its Apple knowhow to create the covetable collection of stylish, sleek and minimalistic iPhone 6 covers. Guaranteed to fit, More is the first designer to announce pre-orders for compatible cases, as others await a retail launch date and final specifications to be revealed. The Ultra Thin BumperLicious Case + Hard Back for iPhone 6S & iPhone 6S Plus (http://more-case.co.uk/products/more-ultra-thin-bumperlicious-case-clear-hard-back-series-for-iphone-6s) is designed to let the iPhone 6S do the talking. In a sizzling cornucopia of seven stand out shades, options include a summery yellow and pretty pink, a sophisticated gun metal grey and two blue hues. The Ultra Thin BumperLicious design features a clear back case so the aesthetics of the handset take centre stage. A high-grade soft thermoplastic polyurethane (TPU) case hugs each contour while the flexible back ensures the device is protected against bumps, knocks and scratches. With its super slim appearance, the iPhone 6S case helps to maintain the streamlined curves of the phone, without compromising on protection. Cutouts have been carefully sized to provide easy access for third party accessories such as Beats by Dre and non-Apple lightning chargers, without interrupting the smooth lines of the case itself or allowing dust or debris beyond the case and into the handset. Sleek and slim profiling meets premium protection with the BumperLicious’ transparent bumper case, which uses proven TPU materials alongside easy touch technology for super responsive power and volume buttons. Made product designer, Theo Rotkins said, “We’re very excited by the next generation of iPhone technology and delighted with our Ultra Thin BumperLicious Case + Hard Back designs. Our iPhone 6S covers and iPhone 6S Plus cases are infused with all of our style and protective know-how, giving fantastic looks and unbeatable protection. They are the first of their kind and the first to market. No-one knows when the iPhone 6S will be available to buy but we do know our cases will fit.” More has also released Duo Tough Extreme iPhone 6S and 6S Plus cases (http://more-case.co.uk/pages/new-iphone-6s-iphone-6-plus-cases-and-covers-from-more-uk), made from a tough shatter proof polycarbonate frame with shockproof TPU inner layer. To find out more and browse the collection visit http://more-case.co.uk/pages/new-iphone-6s-iphone-6-plus-cases-and-covers-from-more-uk

Rejlers contributes to major new data centre in Norway

Rejlers is proud to have been chosen to provide technical assistance to the development project for what is one of Europe's largest, most future-oriented data centres, located in Måløy. With its keen focus on renewable energy, electricity and telecom, Rejlers is set to be a supplier and help realise a leading-edge data centre that promises huge benefits in terms of energy savings and the environment.- In developing a product for the global market, we are looking to collaborate only with the best and those who have already demonstrated success in major projects. Rejlers has great expertise in the data centre field and we know that we can depend on their high quality, says Jørn Skaane, CEO of Lefdal Mine. For further information:Peter Rejler; President and CEO, +46 70 602 34 24, e-mail: peter.rejler@rejlers.seMorten Thorkildsen; CEO Rejlers Norge, +47 951 82 695, e-mail: morten.thorkildsen@rejlers.noRejlers is one of the largest engineering consultancy firms in the Nordic region. Our 1,800 experts work with projects within the areas of Building and property, Energy, Industry and Infrastructure. With us, you will meet specialist engineers with the breadth, cutting edge expertise and not least energy to create the results you want. We are continuing to grow rapidly and our activities are spread across 80 locations in Sweden, Finland and Norway. In 2014, Rejlers had revenue of SEK 1.7 billion and its Class B share is listed on Nasdaq Stockholm.

Photovoltaic Simulator Provides Higher Output Current and Power, Increasing Rack Space Power Density by 50%

SAN DIEGO – AMETEK Programmable Power, the global leader in programmable AC and DC power test solutions (programmablepower.com), has expanded its industry-leading Elgar Terrestrial Solar Array Simulators (TerraSAS™) line of standalone photovoltaic (PV) simulators. With the newest Embedded TerraSAS™ (ETS), users can now test isolated and non-isolated string inverters with voltages (Voc) up to 1,000 VDC and currents (Isc) up to 15 A, resulting in a 50% increase in output power compared to the prior 1000X ETS model. The new ETS1000Y is available in three configurations: [5kW] 1,000 VDC @ 5 A, [10kW] 1,000 VDC @ 10 A and [15kW] 1,000 VDC @ 15 A. The TerraSAS™ PV simulator consists of an agile high-performance, programmable DC power supply with control software and GUI interface, high output isolation, and a unique embedded PV simulation engine that provides the I-V curve in a single standalone unit. The power supplies in the TerraSAS™ PV simulators are typically ten times faster than standard power supplies, allowing users to test even the most advanced solar inverters. In addition to this industry-leading performance, the new ETS now offers improved Over-Voltage Protection (OVP) and Over-Current Protection (OCP). This allows the device to be used for sensitive simulation applications without tripping, such as inverter testing in electrically “noisy” environments. AMETEK Programmable Power developed the TerraSAS™ line for testing microgrids, energy storage and inverter test applications.  The TerraSAS™ series photovoltaic (PV) simulators are specifically designed to emulate the dynamic electrical behavior of a terrestrial PV solar array. They offer low output capacitance and high closed loop bandwidth to keep up with the advanced Maximum Power Point Tracking (MPPT) algorithms used in today’s grid-tied inverters. The new ETS versions can be configured to use a 3-phase AC input voltage of 187-242 VAC, 342-440 VAC, or 396-528 VAC. Output voltage noise is less than 0.6 Vpp, and output current noise is less than 200 mApp. About AMETEK Programmable Power AMETEK Programmable Power designs, manufactures and markets precision, AC and DC programmable power supplies, electronic loads, application specific power subsystems, and compliance test solutions for customers requiring and valuing differentiated power products and services. It offers one of the industries' broadest portfolios of programmable power products under the Sorensen (http://www.programmablepower.com/brands/sorensen.htm), Elgar (http://www.programmablepower.com/brands/elgar.htm), California Instruments (http://www.programmablepower.com/brands/california-instruments.htm) and AMREL (http://www.programmablepower.com/brands/amrel.htm) brands. For more information on any of AMETEK’s programmable power supplies (http://www.programmablepower.com/) and programmable loads, contact an authorized AMETEK Programmable Power sales representative by visiting programmablepower.com/contact/ (http://www.programmablepower.com/contact/). AMETEK Programmable Power also can be contacted directly toll free at 800-733-5427 or 858-458-0223, or by email: sales.ppd@ametek.com. AMETEK Programmable Power  (http://www.programmablepower.com/)is a business unit of AMETEK Electronic Instruments Group, a leader in advanced instruments for the process, aerospace, power and industrial markets and a division of AMETEK, Inc., a leading global manufacturer of electronic instruments and electromechanical devices with 2014 annual sales of $4.0 billion. For further information contact: Craig Frahm Tel: (858) 678-4459 E-mail: craig.frahm@ametek.com Website: www.programmablepower.com  

Yindi Curls Launches Crowdfunding Campaign to Fund

A passionate natural haircare expert is teaching little ones to love their locks with an online series that promotes self-esteem, self-respect and above all, self-love. Designed for parents and caregivers of kids with terrifically twisted hair, Yindi Curls is fun, fashionable and informative. To get the concept up and running founder Roxanne Wright has launched a crowdfunding campaign calling on the public to support the corkscrew cause. Wright Founder said, “Big hair deserves big imagination, not simply run of the mill products and techniques. Yindi Curls exists to celebrate all things kinky, curly, wavy, coiled, twisted, crimped and everything in-between!” While black and mixed heritage families are the primary audience, Yindi Curls is open to all parents, caregivers and kids that want to learn more about wonderfully wavy locks. The project encompasses a variety of different segments that shed light on a wealth of techniques, products and tools needed to care for natural hair. This includes video tutorials, online workshops, social media platforms and an animated book. Already, the concept has attracted attention from O2’s high profile Think Big project. As well as the £300 it secured from this application Yindi Curls is also assembling an Indiegogo crowdfunding campaign to raise the remaining money. The page will go live on September 1 2015 and will aim to secure £4,000 in 40 days. With the cash, Yindi Curls will film a series of Yindi Hair A-Z videos. The content will feature an alphabetised list of hair terms, abbreviations and phrases that are used in the natural hair care and styling sphere. Every week a short video will be posted via the Yindi Curls social media platforms. Once a month Yindi Curls will also host hair workshops that offer attendees insight into grooming tools, maintenance tips, fashion trends and more. In exchange for their generous support Yindi Curls will be offering a myriad of tiered perks. These include exclusive copies of the Yindi Curls book and doll, private screening of initial episodes, Yindi Curls merchandise and more. The concept came to light when Roxanne noticed her quartet of cousins struggling with managing their beautiful curls. The girls are of Thai and Caribbean heritage, which sees them, blessed with extremely varied hair textures that high street products simply couldn’t cater to. Inspired to share her expertise with the world, Wright launched Yindi Curls in a bid to help both parents and children learn to love their locks. To find out more about Yindi Curls and support the crowdfunding campaign, go to: http://igg.me/at/yindi https://twitter.com/yindicurls   

Orexo’s Upcoming Presentations at Events during Second Half 2015

Uppsala, Sweden – August 25, 2015 – Orexo AB (publ) informs today that the company will be presenting at the following events during the fall of 2015. August 28:            Pareto Securities’ 6th Annual Health Care Seminar, Stockholm September 3:        Redeye Open Investor Forum, Stockholm October 22:           Release of Orexo Q3 Interim Report followed by audio cast October 30:           ProHearings Investor Presentation, Stockholm November 18/19:  Jefferies Autumn 2015 Global Healthcare Conference, London December 15:       Guggenheim’s Boston One-on-One Healthcare Day, Boston Please visit the pages “Upcoming events” and “Investors” at www.orexo.com for details and further updated information. In case of any additional upcoming events not mentioned above, these will be announced on our corporate web site. For further information, please contactHenrik Juuel, EVP and Chief Financial OfficerTel: +46 (0)18-780 88 00, E-mail: ir@orexo.com About OrexoOrexo is a specialty pharmaceutical company commercializing its proprietary product Zubsolv® for treatment of opioid dependence in the US. Zubsolv is an advanced formulation of buprenorphine and naloxone using Orexo’s unique knowledge and expertise in sublingual drug delivery. R&D is focusing on reformulation of known substances to new improved products that meet great unmet medical needs by using its patented proprietary technologies. Orexo’s share is listed on Nasdaq Stockholm Exchange Mid Cap (STO: ORX) and is available as ADRs on OTCQX (ORXOY) in the US. Orexo’s global headquarters and R&D are based in Uppsala, Sweden. www.orexo.com. For information about ZUBSOLV and opioid dependence, please visit www.zubsolv.com and www.outthemonster.com

NEW SCHMITZ CARGOBULL MULTI-TEMP FRIDGE TO GET UK PREMIERE AT TCS&D SHOW

Schmitz Cargobull will give the multi-temp version of its flagship S.KO COOL EXECUTIVE its UK premiere at the Temperature Controlled Storage & Distribution (TCS&D) Show next month, the first chance for British customers to get hands-on experience of the very latest in refrigerated trailer technology. The S.KO COOL EXECUTIVE is Schmitz Cargobull’s top-of-the-range temperature controlled trailer, exclusively featuring its own-brand temperature controlled refrigeration unit. The launch of the multi-temp system follows the 2014 domestic launch of the mono-temp model in the UK. Visitors to Schmitz Cargobull’s stand (D26) will be able to see how the multi-temp refrigeration unit precisely controls up to three compartments within a single trailer, providing pharmaceutical-grade monitoring and cooling. Paul Avery, Managing Director, Schmitz Cargobull UK, says: “The TCS&D Show is the jewel in the crown for showcasing the latest in reefer technology and as such it’s the perfect venue to premiere our unique multi-temp S.KO COOL EXECUTIVE. With this addition to our capabilities, we’re now truly a one-stop shop for fleets looking for the latest in temperature controlled technology and trailers.” Built in Vreden, Germany, the S.KO COOL EXECUTIVE incorporates Schmitz Cargobull’s unique roof evaporator, which has an ultra-compact design to provide maximum interior load capacity. Unparalleled evaporator efficiency means Schmitz Cargobull’s skilled engineers have reduced the number of cooling ribs required to control the temperature, leading to up to 50 per cent fewer defrosting cycles. Complete control is available at the touch of a button through a simple to use control panel, which also records alerts, mileage and maintenance intervals. Because the fridge unit has been designed by Schmitz Cargobull to work in perfect harmony with the German trailer manufacturer’s innovative trailer bodies, the evaporator operates under continuous speed control to ensure the correct temperature is maintained within narrow margins, regardless of load size, and with much smaller deviation than that associated with stop-start systems. The S.KO COOL EXECUTIVE incorporates Schmitz Cargobull’s integrated TrailerConnect temperature and mapping telematics package. This allows the recording and monitoring of all temperature data, door opening times and other pieces of vital information, in real time. This can be used to demonstrate that goods have been kept at the specified set point during transit, protecting the cold chain at all times. The system also bolsters fleet security by constantly tracking the trailer’s location, with the telematics unit and sensors fitted in secure areas to protect against tampering. It is programmed to relay all warnings to the operator via a text message or email. Furthermore, the trailer incorporates Schmitz Cargobull’s low-weight, low-maintenance FERROPLAST® panels and the easy-to-clean PIEK-certified MF6 Multifunction Floor for ultra-quiet loading. Joining the S.KO COOL EXECUTIVE is the M.KO rigid bodied reefer built on a 26 tonne Scania chassis. Brought over especially from Denmark for the show, this demonstrator vehicle showcases Schmitz Cargobull’s capabilities in rigid trucks, using FERROPLAST® technology to build a body with a long life expectancy that is easy to recycle at the end of its working life. Available in multiple configurations, the M.KO will demonstrate the latest load restraint technology and incorporates Schmitz Cargobull’s ‘airline’‎ floor with integrated load restraint feature. Thanks to the company’s extensive manufacturing capabilities, up to 15 of the rigids can be produced each day, meaning that even customers placing large orders can fit out their fleet in very short lead times. The TCS&D Show will be held 16-17 September at the Peterborough Arena. ends Editor’s notes: Schmitz Cargobull (UK) is a subsidiary company of the German-owned Schmitz Cargobull Group, the biggest and leading manufacturer and supplier of semi-trailers in Europe. The Schmitz Cargobull Group has manufacturing plants in Germany, Spain, Lithuania, Russia and China, and employs over 5,100 people. In the last financial year (2013/2014), Schmitz Cargobull had a turnover of approximately €1.624 billion and produced more than 45,300 trailers. A number of additional services complete the company profile: Cargobull Finance for leasing and lease purchasing; Schmitz Cargobull Parts & Services for vehicle servicing and spare parts; Schmitz Cargobull Service Partners for repairs and maintenance; Schmitz Cargobull Telematics for trailer telematics and Schmitz Cargobull Trailer Store for used trailers. Schmitz Cargobull refrigerated units are constructed using the company’s FERROPLAST® Thermo Technology modular steel-skinned panels to keep loads at the desired temperature. Visit Schmitz Cargobull UK’s dedicated online press room at http://news.cision.com/schmitz-cargobull Press Contact UK:                                                                    James Keeler or James Boley   Garnett Keeler PR            Tel: 020 8647 4467Email: james.keeler@garnettkeeler.com / james.boley@garnettkeeler.com Company Contact Europe: Gerd Rohrsen, Corporate Public RelationsSilke Hesener, Manager Public RelationsTel: +49 02558 811501Email: silke.hesener@cargobull.com SCB/140/15

NORDIC NANOVECTOR: RESULTS FOR THE SECOND QUARTER AND HALF YEAR 2015

Oslo, Norway, 26 August 2015: Nordic Nanovector ASA (OSE: NANO), a company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, announces its results for the second quarter and half year 2015. A presentation of the results by Nordic Nanovector’s senior management team will take place today at 8:30am CEST in Oslo, details are below. Luigi Costa, CEO of Nordic Nanovector, said: “Following the great start to 2015, which saw the Company complete an upsized and oversubscribed IPO, we continue to execute the clinical development strategy for Betalutin®, our lead Antibody-Radionuclide-Conjugate (ARC), which has been designed to become an important new treatment option for patients with non-Hodgkin’s lymphoma. With funding secured, we are now making progress towards starting a pivotal Phase 2 clinical study with Betalutin® in follicular lymphoma and to initiate new clinical studies in a second NHL indication, diffuse large B-cell lymphoma. Both indications represent major unmet medical needs and we see great potential for Betalutin to improve on and complement existing therapeutic options.” Operational Highlights – Q2 and First half 2015 • Updated results from the now fully enrolled part 1 of the Phase 1/2 study with Betalutin® in patients with relapsed/refractory CD37+ Follicular Lymphoma (FL) were presented at 13-ICML (Lugano, Switzerland) in June. The updated data confirmed the manageable safety profile of Betalutin® and its promising efficacy. New data also highlighted that clinical responses observed are sustained, with 5 out of 7 (71%) patients still in response, and duration of response ranging from 6 to 21+ months. Other key findings were consistent with those presented at the American Society of Hematology Conference in December 2014. The ongoing Phase 1/2 study continues with the intention to provide further insight on the selection of doses for the pivotal Phase 2 study. Further updates will be given in presentations at scientific and clinical congresses. • Preparations are well underway to initiate the pivotal Phase 2 study (PARADIGME) in the second half 2015. This study has been designed to meet the regulatory filing requirements for a third line FL indication. • Initial clinical studies of Betalutin® in patients with diffuse large B-cell lymphoma are being prepared to begin during the second half 2015. • A new Scientific Advisory Board, including experts in haematology-oncology and cancer drug development from leading academic/research institutions in the US and Europe, was established in May. • The over-allotment option, in relation to the Company’s upsized and oversubscribed Initial Public Offering (IPO) in March, was exercised in April adding a further NOK 75 million to the NOK 500 million raised in the primary offer. Total gross proceeds of the IPO were NOK 575 million (USD 73 million*) and will be used to advance the development of Betalutin® beyond first regulatory submission, planned in 2017. • Board changes in connection with the IPO: Gisela M. Schwab, M.D., Executive VP and CMO at Exelixis, Inc. was elected to the Board of Directors in March replacing Alexandra Morris, Portfolio Manager at Odin Fund Management. (* USD 1 = NOK 7.86 per 30 June 2015) Financial Highlights • Revenues for the second quarter 2015 amounted to NOK 141,961 (Q2 2014: NOK 118,143). Revenues for the first half 2015 were NOK 218,002 (1H 2014: NOK 236,604). • Net operating expenses for the quarter amounted to NOK 51.2 million (Q2 2014: NOK 15.8 million) and for the first half were NOK 87.1 million (1H 2014:  NOK 27.8 million). • Cash and cash equivalents amounted to NOK 817.1 million as of 30 June 2015, compared to NOK 781.4 million as at 31 March 2015. • Nordic Nanovector issued 17,968,750 new shares at NOK 32 in connection with the Initial Public Offering (including the Over-allotment Option), raising gross proceeds of NOK 575 million. There are in total 44,519,041 shares in issue following the issuance of the new shares. Outlook The focus of the Company in 2015 and beyond will be on the Betalutin® clinical development programme, with an aim to obtain a first regulatory approval in third line FL in 2018 and in parallel to run additional trials in second line FL and DLBCL. Activities focused on the commercialisation of Betalutin® are underway and will be increased as key stages in development are reached. Nordic Nanovector is also evaluating options for the expansion of its R&D pipeline. Second Quarter and Half Year 2015 Results Presentation and Webcast A presentation by Nordic Nanovector’s senior management team will take place today at 8:30am CEST at: Thon Hotel Vika AtriumMunkedamsveien 450250 Oslo Meeting Room: NYLAND The presentation will be recorded as a webcast and will be available after the event on www.nordicnanovector.com in the section: Investor Relations/Webcast. The results report and the presentation are attached this press release and will be available at www.nordicnanovector.com in the section: Investor Relations/Reports and Presentation/Quarterly Reports. ###For further information, please contact:Luigi Costa, CEO, or Tone Kvåle, CFOTel: +47 22 18 33 01ir@nordicnanovector.com  Media EnquiriesMark Swallow/David Dible (Citigate Dewe Rogerson) Tel: +44 207 282 2948/+44 207 282 2949mark.swallow@citigatedr.co.uk / david.dible@citigatedr.co.uk About Nordic Nanovector Nordic Nanovector is a biotech company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology. The Company’s lead clinical-stage product opportunity is Betalutin®, the first in a new class of Antibody-Radionuclide-Conjugates (ARC) designed to improve upon and complement current options for the treatment of non-Hodgkin Lymphoma (NHL). NHL is an indication with substantial unmet medical need and orphan drug opportunities, representing a growing market worth over $12 billion by 2018. Betalutin® comprises a tumour-seeking anti-CD37 antibody (HH1) conjugated to a low intensity radionuclide (lutetium- 177). It has shown promising efficacy and a favourable safety profile in a Phase 1/2 study in a difficult-to-treat NHL patient population. The Company is aiming at rapidly developing Betalutin® for the treatment of major types of NHL with first approval anticipated by the end of 2018. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets, while exploring potential distribution agreements in selected geographies. The Company is committed to developing its ARC pipeline to treat multiple selected cancer indications. Further information about the Company can be found at www.nordicnanovector.com Forward-looking statement This announcement may contain certain forward-looking statements and forecasts based on uncertainty, since they relate to events and depend on circumstances that will occur in the future and which, by their nature, will have an impact on Nordic Nanovector’s business, financial condition and results of operations. The terms “anticipates”, “assumes”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “might”, “plans”, “should”, “projects”, “will”, “would” or, in each case, their negative, or other variations or comparable terminology are used to identify forward-looking statement. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied in a forward-looking statement or affect the extent to which a particular projection is realised. Factors that could cause these differences include, but are not limited to, implementation of Nordic Nanovector’s strategy and its ability to further grow, risks associated with the development and/or approval of Nordic Nanovector’s products candidates, ongoing clinical trials and expected trial results, the ability to commercialise Betalutin®, technology changes and new products in Nordic Nanovector’s potential market and industry, the ability to develop new products and enhance existing products, the impact of competition, changes in general economy and industry conditions and legislative, regulatory and political factors. No assurance can be given that such expectations will prove to have been correct. Nordic Nanovector disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Multiconsult second quarter 2015 results: Improved billing ratio and strong earnings

“I am very pleased to see that our intensified and focused efforts to improve the billing ratio have proved successful, leading to improved profitability. We will continue to focus on strong project execution and efficiency throughout the organisation going forward”, says Mr Christian Nørgaard Madsen, CEO of Multiconsult ASA.Order backlog remains solid at NOK 1 600.0 million at the end of the quarter. Multiconsult won contracts within all business areas during the quarter, confirming the company’s strong competitive position.The group’s cash flow in the quarter was negative NOK 314.0 million, reflecting payments of ordinary and extraordinary dividends totaling NOK 275.6 million as well as one-off IPO expenses.  The group’s financial position at 30 June 2015 was strong, with total assets of NOK 1 028.9 million and total equity of NOK 295.9 million. Cash and cash equivalents amounted to NOK 190.6 million, while net interest bearing debt was negative NOK 179.7 million, i.e. an asset. In August 2015, Multiconsult entered into agreements to acquire the remaining 68 per cent of the shares in LINK arkitektur AS.  LINK represents an excellent strategic fit for Multiconsult, offering the potential for significant value creation through operational synergies as well as further strengthened value proposition to customers.  The overall market outlook for 2015 remains fairly robust, but with variations among the business areas. Competition is particularly fierce within the transportation and building sectors and this may lead to increased pressure on pricing. Multiconsult’s strong market position, flexible business model and wide service offering provides a sound base for further growth.A presentation of the second quarter 2015 results will be held today, 26 August, at 09:00 CET at Hotel Continental, Stortingsgaten 24/26, Oslo. The presentation will be held by CEO Christian Nørgaard Madsen and CFO Anne Harris. A live webcast from the presentation can be accessed at  www.multiconsult-ir.com .For further information, please contact:    Investor relations:   Mitra Hagen Negård, Head of Investor Relations   Phone: +47 95 79 36 31   E-mail:  ir@multiconsult.no   Media:   Gaute Christensen, VP Communications   Phone: +47 911 70 188   E-mail: gaute.christensen@multiconsult.no ABOUT MULTICONSULT ASAMulticonsult is a leading Norwegian multidisciplinary engineering consulting firm, with more than 1 700 employees and 30 offices in Norway and abroad. Multiconsult's home market is Norway, representing 92 per cent  of 2014 operating revenues. The Company focuses on six market areas: Buildings and Properties, Transport and Infrastructure, Energy, Oil and Gas, Industry and Environment and Natural resources. The Company has an operating history that spans more than a century, with the inception of Norsk Vandbygningskontor in 1908. In 2014, Multiconsult completed more than 8 000 projects for approx. 3 700 different customers.This announcement includes forward-looking statements which are based on our current expectations and projections about future events. Forward-looking statements involve known and unknown risks and uncertainties and are not guarantees of future performance. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading  Act.

University Hospital La Timone world’s first to treat patients with Leksell Gamma Knife Icon, Elekta’s latest generation cranial radiosurgery system

MARSEILLES, France, August 26, 2015 – On August 10, doctors at University Hospital La Timone (Marseilles, France) used their new Leksell Gamma Knife® Icon™ system to treat a metastasis in the brain of a 71-year-old female patient. This single-session treatment was the first time La Timone physicians had harnessed the system’s advanced motion management and imaging capabilities to enable therapy using mask-based head fixation instead of the traditional rigid stereotactic frame. With Icon, La Timone physicians are predicting a significant increase in the volume of patients suitable for frameless Gamma Knife radiosurgery. In the days following, doctors treated three additional patients with metastases using the same method. Then, on August 17, the hospital achieved another Icon milestone – its first patient to begin frameless, multi-session (hypofractionated) treatment of a benign tumor. “This 77-year-old female patient had a cavernous sinus meningioma that was too close to the optic nerve and chiasm to treat with a single high dose – it would have been too high of a dose to avoid threatening these sensitive structures,” says Professor Jean Régis, MD, a neurosurgeon and program director for University Hospital La Timone’s Gamma Knife program, which launched traditional frame-based Gamma Knife® radiosurgery treatments with Icon in mid-July. “Therefore, she received a hypofractionated treatment, which divided her therapy into five sessions over five days to decrease the risk of injuring visual pathways.” Icon features especially important for frameless therapyWhen performing frameless Gamma Knife radiosurgery with Icon, it is crucial that patient motion be managed and that the patient’s position can be precisely reproduced in hypofractionated treatments. Gamma Knife Icon addresses both of these imperatives. Icon provides an integrated cone-beam CT (CBCT) workflow that enables doctors to check the patient’s position against planning images. After a thermoplastic mask is custom-fitted to the patient’s head, an initial CBCT is performed to obtain a reference image, which is then fused with an MRI image to enable the clinician to develop the plan. The patient is then placed on the treatment couch with the mask. “Because the patient is never precisely in the same position as in these first scans, you acquire a new CBCT scan,” Prof. Régis explains. “In a few seconds, the GammaPlan® software automatically adapts the plan to the new position of the patient’s head and displays the dose distribution before and after this automated recalculation. This allows the physician to identify any discrepancies between the initial plan and the recalculated plan according to the new patient position. It’s important to reiterate that this is a plan correction, not physically correcting the patient’s position. So far, the differences in the plan – before and after adaptation to the patient’s latest position – have been clinically insignificant, so we haven’t rejected any of the adapted plans.” During treatment, patient motion is managed through the high-definition motion management system, which monitors the patient’s head position via infrared tracking of markers. “If the patient coughs or moves her head and that motion exceeds a safety threshold, the system automatically stops delivering the radiation,” he observes. “This is critical feature for patient safety in these frameless treatments. The on-the-fly intrafraction, automated adaptation of the planning to patient position is a new and interesting capability of Icon.” At press time, Hospital La Timone had used Leksell Gamma Knife Icon to treat a total of 33 patients using either frame-based or frameless methods. To learn more about Leksell Gamma Knife Icon, visit careforthebrain.com (http://www.careforthebrain.com/). # # # For further information, please contact:Gert van Santen, Group Vice President Corporate Communications, Elekta ABTel: +31 653 561 242, e-mail: gert.vansanten@elekta.comTime zone: CET: Central European Time Johan Andersson, Director, Investor Relations, Elekta ABTel: +46 702 100 451, e-mail: johan.andersson@elekta.comTime zone: CET: Central European Time The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on August 26, 2015. About ElektaElekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.

Interim report January - June 2015

● Revenue increased 10 per cent to SEK 1,527 M (1,387). Adjusted for currency effects and calculated on the comparable number of workdays, revenue rose 10 per cent.● EBITA rose 7 per cent to SEK 224 M (210) and the EBITA margin amounted to 15 per cent (15).● EBIT increased 8 per cent to SEK 197 M (182) and the EBIT margin totalled 13 per cent (13).● The gross margin amounted to 54.7 per cent (55.2).● Earnings per share, before and after dilution, amounted to SEK 3.74 (3.74).● Cash flow from operating activities amounted to SEK 137 M (192), of which discontinued operations comprised negative SEK 45 M (neg: 15).● Net debt at the end of the period amounted to SEK 1,841 M (1,848), compared with SEK 1,629 M at the end of the year.● Magnus Johansson took up his position as President and CEO on 15 June. CEO’s commentsFavourable performance in the second quarter The Mekonomen Group reported continued favourable growth and improved earnings for the second quarter of 2015. All of the Group companies: MECA, Mekonomen Nordic and Sørensen og Balchen posted a stronger EBIT compared with the year-earlier period. During the second quarter of 2015, revenue for the Group inceased 10 per cent to SEK 1,527 M (1,387) and EBIT rose 8 per cent to SEK 197 M (182). The posted EBIT was the highest ever for a single quarter. The performance of Mekonomen Nordic was particularly positive, where EBIT increased 20 per cent to SEK 124 M (104). MECA's export business to Denmark has reduced earnings for the second quarter.Revenue for the first six months rose 9 per cent to SEK 2,909 M (2,677) and the EBIT increased 10 per cent to SEK 339 M (309). The market was slightly stronger than in the preceding year and we expect a stable market development for the remainder of 2015. MECA:s export business to Denmark and currency effects are estimated to have a negative impact on earnings during the third quarter. In the second quarter, growth was 13 per cent in MECA, 9 per cent in Mekonomen Nordic and 7 per cent in Sørensen og Balchen. Sales to our affiliated workshops were healthy and posted growth of 15 per cent for the quarter and we recorded a continued healthy sales increase for our proprietary ProMeister brand, which accounted for about 12 per cent of spare-parts sales in the Group. I took up my position as President and CEO on 15 June and I look confidently forward toward building on and further developing the Mekonomen Group’s strong position. We have an increased focus on cost-efficiency and, moving forward, we will combine this to an increasing degree with investments in infrastructure and the organisation to continue to lead development in our industry with the aim of creating competitive advantages. We will also in greater occurence realise Group synergies to drive efficiency and growth. Ongoing projects will be complemented by new initiatives in key areas. For example is such an area a new Group-wide e-commerce platform for B2B and B2C. The Mekonomen Group’s growth builds on our ability to maintain a leading position, drive development in our industry and continuously strengthen the offering to our customers. Innovation should permeate all parts of the Group and maintain strong focus on customer-oriented business development aimed at creating growth, by strengthening our position with existing and new customers. Magnus Johansson President and CEO For further information, please contact:Magnus Johansson, President and CEO Mekonomen AB, Tel: +46 (0)8-464 00 00Per Hedblom, CFO Mekonomen AB, Tel: +46 (0)8-464 00 00Gunilla Spongh, International Business Director, Mekonomen AB, Tel: +46 (0)8-464 00 00 The information in this interim report is such that Mekonomen is obligated to publish in accordance with the Securities Market Act. The information was submitted for publication on 26 August 2015 at 7:30 a.m.

Annual General Meeting of Lagercrantz Group AB 25 August 2015

Resolutions including the following were passed by the Annual General Meeting and the ensuing statutory Board of Directors Meeting held 25 August 2015: Dividend A dividend of SEK 4.50 per share was declared in accordance with the proposal of the Board of Directors. Friday, 27 August 2015 is record day for receiving dividend that is expected to be remitted by Euroclear Sweden AB Tuesday, 1 September 2015.  Discharge from liability for the directors and the President The Annual General Meeting granted discharge from liability to the Board of Directors and the President for their management during 2014/15. Board of Directors, CEO, Vice President and Auditor The Annual General Meeting passed a resolution in accordance with the proposal of the Election Committee. The following directors were re-elected: Pirkko AlitaloMarika Rindborg HolmgrenAnders BörjessonTom HedeliusLennart SjölundRoger BergqvistJörgen Wigh, President & CEO of Lagercrantz Group. The Annual General Meeting decided a total fee of SEK 1,650,000 for the Board of Directors. The fee per director is unchanged from previous year. Anders Börjesson was re-elected by the Annual General Meeting as Chairman of the Board of Directors. At the ensuing statutory Board of Directors Meeting Tom Hedelius was re-elected to serve as Vice Chairman of the Board of Directors and Jörgen Wigh was re-appointed as President & CEO. The entire Board of Directors with the exception of the President & CEO was elected to serve as the Company’s Audit Committee. The Chairman and the Vice Chairman were appointed to serve as the Company’s Remuneration Committee with the President & CEO submitting reports. Magnus Söderlind was re-appointed as Executive Vice President. The Annual General Meeting elected KPMG AB as auditors, with head auditor George Pettersson, until the end of the Annual General Meeting 2016. Election Committee The Annual General Meeting passed a resolution in accordance with the proposal of the year’s Election Committee to authorise the Chairman of the Board of Directors to contact the largest shareholders by vote as of 31 December 2015 and ask these shareholders to appoint members who, together with the Company’s Chairman, would constitute the Election Committee. The Election Committee shall consist of five members.  Resolution regarding share split and related amendment of the Articles of Association. The Annual General Meeting passed a resolution in accordance with the proposal of the Board of Directors to: (i)     increase the number of shares in the Company by dividing each share into three (3) shares (split), after which the number of shares will increase to 69,519,927, including 3,263,802 class A shares and 66,256,125 class B shares, each share with a quotient value of SEK 0.70,  (ii)    amend § 5 in the company's articles of association regarding number of shares as follows: ”The number of shares outstanding shall be a minimum of 37,500,000 and a maximum of 150,000,000.”, and (iii)   authorise the Board to decide on the record date for the split and take any other measures necessary to implement the split. Principles for compensation to management The Annual General Meeting passed a resolution in accordance with the proposal of the Board of Directors on principles for compensation and other terms of employment for management.  Issuance of call options on repurchased shares and conveyance of treasury shares to managers and members of senior management In accordance with the proposal of the Board of Directors, and in a departure from the preferential rights of existing shareholders, the Annual General Meeting resolved to offer managers and members of senior management to acquire call options on class B treasury shares. Up to 225,000 call options giving its holders the right to acquire a corresponding number of shares may be issued. Options shall be acquired at market value. The redemption price will be 120 percent of the average market price of the share during period 31 August 2015 – 11 September 2015. In order to encourage participation in the programme, an extra compensation shall be paid corresponding to the premium paid after two years, providing that the option holder's employment with the Group has not been terminated. The Annual General Meeting also resolved to convey to the option holders up to 225,000 of the shares held in treasury at the set redemption price in conjunction with any utilisation of the of call options. Repurchase and conveyance of treasury shares In accordance with the proposal of the Board of Directors the Annual General Meeting resolved to authorise the Board of Directors to buy and sell shares in the Company, on one or more occasions, such authorisation to remain valid until the next following Annual General Meeting. The purpose of repurchases is to enable the Board of Directors to adapt the Group’s capital structure and to make possible future acquisitions of companies and businesses with payment in the form of shares in the Company, and to cover the Company’s obligations under the incentive programme resolved. Purchases shall be made via Nasdaq Stockholm at the price interval prevailing measured as the interval between the highest buy price and the lowest sale price. Purchases of own shares are limited in such a way that at no time may shares held in treasury exceed 10 percent of the number of shares outstanding in the Company. The Annual General Meeting resolved to authorise the Board of Directors to sell treasury shares, without preferential right for existing shareholders, at a market price as remuneration in connection with acquisitions of businesses or companies, or to ensure delivery of treasury shares in existing incentive programmes, but not via Nasdaq Stockholm. At the ensuing statutory Board of Directors Meeting, the Board of Directors decided to utilise the authorisation received to purchase shares in the Company during the period until the next following Annual General Meeting. Stockholm, 25 August 2015 Lagercrantz Group AB (publ)

Alfa Laval wins SEK 90 million marine offshore order

The boiler modules will be included in the power generation system of the FPSO vessel where they predominately will generate steam for the steam turbines but also provide cargo tank heating. Once built, the vessel will be anchored outside the Nigerian coast. “I am pleased to announce yet another large order from the offshore oil and gas industry, and this time for our Alfa Laval Aalborg range” says Lars Renström, President and CEO of the Alfa Laval Group. “It is another confirmation of our position as a leading supplier of reliable equipment to the oil and gas industry.” Did you know that… Alfa Laval has recently opened a new sales office in Ghana, to meet the needs of the booming West African Region? About Alfa Laval                                                                                                         Alfa Laval is a leading global provider of specialized products and engineering solutions based on its key technologies of heat transfer, separation and fluid handling. The company’s equipment, systems and services are dedicated to assisting customers in optimizing the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce food and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol. Alfa Laval’s products are also used in power plants, aboard ships, oil and gas exploration, in the mechanical engineering industry, in the mining industry and for wastewater treatment, as well as for comfort climate and refrigeration applications. Alfa Laval’s worldwide organization works closely with customers in nearly 100 countries to help them stay ahead in the global arena. Alfa Laval is listed on Nasdaq OMX, and, in 2014, posted annual sales of about SEK 35.1 billion (approx. 3.85 billion Euros). The company has about 18 000 employees. www.alfalaval.com For more information please contact:Peter TorstenssonSenior Vice President, CommunicationsAlfa LavalTel: + 46 46 36 72 31Mobile: +46 709 33 72 31Gabriella GrotteInvestor Relations ManagerAlfa LavalTel: +46 46 36 74 82Mobile: +46 709 78 74 82

Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection

RHB-105 is a new and proprietary fixed-dose oral combination therapy of two antibiotics (amoxicillian and rifabutin) and a proton pump inhibitor (omeprazole) combined into an all-in-one oral capsule with a planned indication for treatment of H. pylori infection. In June of this year, RHB-105 successfully met its primary endpoint in its first Phase III study. This complex project straddles and integrates three of Recipharm’s manufacturing facilities making it the first project of its kind within the organization.  The FDA approved facilities in Fontaine and Pessac will manufacture the Omeprazole mini-tablets, whilst in Strangnäs the final product will be encapsulated and packaged ready for final release. In order to support this project, Recipharm will invest approximately 13M SEK (1.55M USD) in manufacturing capabilities. In addition, the Strängnäs facility will be registered with the U.S. FDA. Commercial supply is expected to commence with initial launch into the U.S. market, after regulatory approval by U.S. FDA. Supply to E.U. markets is anticipated after this upon EU regulatory approval. Erik Haeffler – VP Manufacturing services Recipharm commented “This is a fantastic example of how Recipharm has been able to offer an integrated solution to solve a complex manufacturing project. We are looking forward to working on this project and supporting a successful clinical trial and launch of RHB-105”. Guy Goldberg, Chief Business Officer of RedHill, said “We are very pleased that we have entered into this partnership with Recipharm for this important and exciting product.  Recipharm is able to offer us a one stop shop solution that is fairly unique. We are confident in Recipharm’s ability to deliver and look forward to working with them.  With the successful first Phase III study we have just announced, we plan to meet with FDA in the coming months to discuss a path for approval for RHB-105.  We believe RHB-105 could provide an important solution for patients and physicians for this critical infectious disease.” Contact informationErik Haeffler, VP Manufacturing Services Recipharm, erik.haeffler@recipharm.com, +46 8 6025 285Adi Frish, Senior VP Business Development & Licensing, RedHill Biopharma, adi@redhillbio.com, +972-54-6543-112 For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on: E-mail: t.jervis@defacto.com  (t.jervis@defacto.com%20)or a.heeley@defacto.comTel: +44 (0) 207 861 3019/3043 About RecipharmRecipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 2,200 employees.  Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material including API and pharmaceutical product development. Recipharm manufactures more than 400 different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm’s turnover is approximately SEK 3.3 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on NASDAQ Stockholm. For more information on Recipharm and our services, please visit www.recipharm.com                                    About RedHill Biopharma Ltd.RedHill Biopharma Ltd. (NASDAQ/TASE: RDHL) is an emerging Israeli biopharmaceutical company primarily focused on the development of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers. RedHill’s current pipeline of proprietary products includes: (i) RHB-105 - an oral combination therapy for the treatment of Helicobacter pylori infection with successful top-line results from a first Phase III study; (ii) RHB-104 - an oral combination therapy for the treatment of Crohn's disease with an ongoing first Phase III study; (iii) BEKINDA™ (RHB-102) - a once-daily oral pill formulation of ondansetron with an ongoing Phase III study in the U.S. for acute gastroenteritis and gastritis and a European marketing application for chemotherapy and radiotherapy-induced nausea and vomiting submitted in December 2014; (iv) RHB-106 - an encapsulated bowel preparation licensed to Salix Pharmaceuticals, Ltd.; (v) ABC294640 - an orally-administered first-in-class SK2 selective inhibitor targeting multiple inflammatory-GI diseases and related oncology indications with a first Phase I/II initiated for refractory/relapsed diffuse large B-cell lymphoma (DLBCL); (vi) MESUPRON® - a Phase II-stage first-in-class uPA inhibitor, administered by oral capsule, targeting gastrointestinal and other solid tumor cancers; (vii) RP101 - currently subject to an option-to-acquire by RedHill, RP101 is a Phase II-stage first-in-class Hsp27 inhibitor, administered by oral tablet, targeting pancreatic and other gastrointestinal cancers; (viii) RIZAPORT™ (RHB-103) - an oral thin film formulation of rizatriptan for acute migraines with a U.S. NDA currently under discussions with the FDA and a European marketing application submitted in October 2014; and (ix) RHB-101 - a once-daily oral pill formulation of the cardio drug carvedilol. About RHB-105RHB-105 is a new and proprietary fixed-dose oral combination therapy of two antibiotics and a proton pump inhibitor (PPI) in an all-in-one oral capsule with a planned indication for the treatment of H. pylori infection. H. pylori bacterial infection is a major cause of chronic gastritis, peptic ulcer disease, gastric cancer and mucosa associated lymphoid tissue (MALT) lymphoma. A first Phase III study with RHB-105 is ongoing in the U.S. with positive top-line results (the ERADICATE Hp study). The study demonstrated an overall success rate of 89.4% in eradicating H. pylori, and met its protocol-defined primary endpoint of superiority in eradication of H. pylori infection over historical standard of care efficacy levels of 70%, with high statistical significance (p<0.001). RedHill plans to conduct a second Phase III study. Additional studies may be required, subject to FDA feedback. RHB-105 has been granted Qualifying Infectious Disease Product (QIDP) designation by the FDA, providing a Fast-Track development pathway, as well as Priority Review status, potentially leading to a shorter review time by the FDA of an NDA, if filed. If approved, RHB-105 will also receive an additional five years of U.S. market exclusivity, on top of the standard exclusivity period, for a total of 8 years of market exclusivity.

INTERIM REPORT JANUARY–JUNE 2015

Divestment of Compressor Technology and Waste Heat Recovery business · Share purchase agreement signed concerning the sale of business activities within Compressor Technology and Waste Heat Recovery for SEK 400 million, expected closing by 30 September 2015 · Operating loss (EBITDA) before depreciation for Q2 was SEK 3.4 million ( –6.4 m) · Earnings for remaining business affected by costs attributable to divestment and over-dimensioned administration · Strategic review of remaining business has started Q2, April-June 2015, remaining business · Net sales amounted to SEK 51.8 million (35.1 m) · Operating loss (EBITDA) was SEK 3.4 million (–6.4m) · Operating loss (EBIT) was SEK 4.2 million (–7.0 m) · Loss after tax was SEK 5.9 million ( –6.7 m) · Earnings per share SEK –0.01 (–0.02) Q1-Q2, January-June 2015, remaining business · Net sales amounted to SEK 103.2 million (86.7 m) · Operating loss (EBITDA) was SEK 11.0 million (–8.8 m) · Operating loss (EBIT) was SEK 12.6 million (–10.0 m) · Loss after tax was SEK 15 million ( –9.4 m) · Earnings per share SEK –0.04 (–0.02) Events after the closing date · Extra Shareholders’ Meeting of Opcon AB approved the sale of business activities within Compressor Technology and Waste Heat Recovery to Shanghai XingXueKang Investment Partnership · Shanghai XingXueKang Investment Partnership paid the first 15% of the purchase price in accordance with the agreement · Saxlund International GmbH received an order worth around SEK 30 million from Babcock & Wilcox Vølund A/S of Denmark for delivery of a first class handling system for a bioenergy project in the UK For further information, please contact: · Rolf Hasselström, President and CEO: +46 8 466 45 00, +46 70 594 79 60 · Niklas Johansson, deputy CEO, Investor Relations: +46 8 466 45 11, +46 70 592 54 53 · Claes Palm, deputy CEO, Chief Financial Officer: +46 8 466 45 00, +46 70 545 04 95

University of North Carolina selects RayStation as its new network-wide radiation therapy treatment planning system

The University of North Carolina (UNC) recently utilized RayStation® for the first time to treat patients. Following this, two other satellite facilities have initiated commissioning of their machines for RayStation®, with the fourth set to begin soon. The selection process for a new treatment planning system (TPS) was an intense and scientific effort, with much of the UNC staff involved in performing test plans to fully assess competing systems. The project was led by Dr. Shiva Das, recently arrived at UNC from the Duke Cancer Center in Durham, North Carolina. “As our sole treatment planning system, PLUNC served the center well for several decades. With programmers employed by UNC, we had the opportunity to customize the software to fit our workflow and planning needs,” said Dr. Das, Chief Medical Physicist at UNC. “However, we also saw the future of treatment planning placing more demands on the TPS. In order to continue to provide the highest level of care to our patients, we knew we needed to team up with a partner that was forward-thinking and had more resources. We are very confident that RaySearch Laboratories is that partner.”  The main campus was the first to clinically use RayStation®, followed closely by other hospitals in the UNC network: Rex Healthcare and affiliates in Raleigh, North Carolina, McCreary Cancer Center in Lenoir, North Carolina, and High Point Regional Hospital in High Point, North Carolina.  High Point Regional Hospital is next to go live using RayStation®, with the other facilities to follow. “Implementing a new TPS requires full buy-in along with an enthusiastic and dedicated team, which UNC has. RayStation® brings a wider variety of planning techniques for our patients and new tools for our dosimetry staff to efficiently create the most advanced and customized plans,” concludes Dr. Das. “The University of North Carolina is a model for what can be achieved when people from multiple organizations, in a large-scale setting, come together and work toward a common goal.  Dr. Das and his team bring a wealth of knowledge and expertise to the table that can support future development of RayStation®,” says Marc Mlyn, President of RaySearch Americas, Inc. “We are thrilled to have UNC as a partner to advance cancer treatment moving forward,” he concludes. “We are extremely proud of the trust placed in RaySearch by the University of North Carolina. It is a major step for such an important multi-site center to replace an in-house system in use for more than 30 years, but we will make sure that is a decision they will not regret,” says Johan Löf, CEO of RaySearch Laboratories AB. About The University of North Carolina UNC’s healthcare motto is “Leading, Teaching, Caring”. The university has a longstanding and strong tradition of leadership and innovation in the field of radiation oncology. The main campus offers the following services: external beam radiation therapy with three state-of-the-art linear accelerators offering intensity-modulated radiation therapy and image guidance, one TomoTherapy® unit, one CyberKnife ® Robotic Radiosurgery treatment machine and Brachytherapy. UNC serves as the specialty oncology referral center for the entire state of North Carolina, with eighteen radiation oncologists providing services at the following treatment centers. · NC Cancer Hospital in Chapel Hill · Rex Cancer Center in Raleigh · Rex Cancer Center of Wakefield · Smithfield Radiation Oncology · Clayton Radiation Oncology · Highpoint Radiation Oncology · McCreary Cancer Center Radiation Oncology

Avinor and KONGSBERG enters into agreement on the world’s largest investment for remote towers

Kongsberg Defence Systems (KONGSBERG) and Avinor Air Navigation Services have entered into an agreement for the supply of remote towers worth 400 MNOK. KONGSBERG is prime in close cooperation with its partner Indra Navia AS. The scope contains a complete solution for remote control of tower services at a number of airports from one location. Avinor has earlier decided to introduce remote control and tower services at up to 15 airports, from one tower centre in Bodø. A further investment may include more Avinor airports. The agreement between Avinor and KONGSBERG is the most comprehensive commitment in remote towers ever launched in international aviation. KONGSBERG employs technology from defence projects and integrates them with Indra Navia’s advanced and very modern solutions for tower management. This technology includes amongst others rugged and innovative sensors, secure and redundant network based solutions for remote control of towers, as well as control of real-time data and data storage solutions. Indra Navia will deliver an integrated visualization systems based on their leading Nova Tower line supplied worldwide, amongst others to London Heathrow, Paris Charles de Gaulle, Dubai, Beijing and many more. - We look forward to a close collaboration with KONGSBERG and Indra. The companies have proven their ability to deliver the best solution for Avinor, in a fierce competition with other international suppliers. Now the work for fully establishing a remote tower center and introduce future tower services, says Avinor CEO Dag Falk-Petersen - This contract is of great importance with the highest attention in KONGSBERG, and an example on the potential in our span of technologies and possible synergies. Remote tower solutions is a market in the starting phase internationally, says President in Kongsberg Defence Systems, Harald Ånnestad. - Indra Navia is proud to be part of this important and pioneering contract, which includes a new use of our Nova-system. With more than 95% export of tower systems from Norway to the world’s leading aviation organizations and airports, we look forward to cooperating with Avinor and KONGSBERG, then provide this unique solution to a growing international market, says President in Indra Navia, Eldar Hauge. For the press:Avinor, KONGSBERG and Indra will in two weeks invite media to a presentation and technology demonstration of the project. There will be opportunities for interviews and a closer inspection of the future remote tower solution. Please register with Mr Johannes Dobson, telephone +47 906 77 262, email johannes.dobson@kongsberg.com For further information:Avinor: · Kristian Løksa, Communication Manager, telephone +47 934 52 603 Kongsberg Defence Systems: · Harald Ånnestad, President, telephone +47 920 60 087 · Eirik Lie, Executive Vice President, telephone +47 917 04 933. Indra Navia: · Eldar Hauge, President, telephone +47 907 53 975 · Andrew Paul Fiamingo, Direktør Sales and Marketing, telephone +47 971 67 361 KONGSBERG (OSE-ticker: KOG) is an international, knowledge-based group delivering high technology systems and solutions to clients within the oil and gas industry, merchant marine, defence and aerospace. KONGSBERG has more than 7 700 employees located in more than 25 countries and total revenues of NOK 16.6 billion in 2014.

Millicom appoints Cynthia Gordon as EVP, CEO Africa Division

Cynthia will be Millicom’s Executive Vice President responsible for leading the company’s six operations in Africa: Tanzania, Ghana, DRC, Senegal, Rwanda and Chad. Cynthia will focus on delivering and executing a strong and profitable organic growth plan for Africa. Cynthia will report directly to Millicom's CEO and will lead a newly created Africa Executive Committee, tasked with overseeing and driving Millicom's African operations.  Cynthia has more than 20 years of telecom sector specific experience, leading mobile, broadband and fixed-line operations in emerging markets across Asia, the Middle East, Africa and Russia. She developed her Africa experience while at Orange, where she was Vice-President of Partnerships and Emerging Markets, and Ooredoo where she was Chief Commercial Officer, reporting to the Group CEO. At Ooredoo, Cynthia was responsible for optimizing performance across marketing, distribution and customer services, and reviewing and implementing commercial strategies to drive revenue and profitable growth across the Group's footprint. Cynthia will remain on the Board of Commissioners of Ooredoo’s largest operating company Indosat, one of the largest telecommunications players in Indonesia with approximately 68.5 million customers.  Commenting on her appointment Mauricio Ramos, Chief Executive Officer, Millicom, said: “I am delighted to welcome Cynthia to Millicom. Under Cynthia’s leadership, the Africa division will be optimized to focus on delivering organic growth in the region. She knows the telecoms industry inside-out, and will bring her commercial acumen to support the delivery of our strategy to build and grow our digital services in Africa while creating value for our shareholders.” Cynthia Gordon said: “This is a transformative time for the digital and telecommunications space in Africa. I am really looking forward to joining Millicom, which is bringing a digital lifestyle, mobile access, mobile financial services, business services, and more to millions of people who increasingly see the internet as one of the most important enablers for their development.”

Rovio sharpens focus on core businesses

Rovio Entertainment today announced plans to restructure and concentrate its activities around three primary business areas: games, media and consumer products. As a result of these plans, the company will begin employee negotiations on up to 260 redundancies. The negotiations apply to the whole organization, excluding those working on the production of the The Angry Birds Movie in the United States and Canada. “While we have gathered good momentum this year, especially with the launch of the Angry Birds 2 game -- downloaded nearly 50 million times in its first month of release -- fundamental changes are needed to ensure Rovio succeeds in its global ambitions to be the leading entertainment company with mobile games at its heart,” says Rovio’s CEO Pekka Rantala. “This is personally a difficult decision. However, it is certain that a leaner and more agile Rovio is absolutely necessary to move forward and take the company to new successes in the future. We will work with and support all our employees through this period of change.” “Rovio’s growth and eagerness to explore new business opportunities over the past few years has been exceptional,” Rantala adds. “As a result, we did too many things. In our current financial condition we must now put focus on where we are at our best: in creating magnificent gaming experiences, in producing an amazing animation movie and in delighting our fans with great products.”

Evolution Gaming: Interim Report January-June 2015

Second quarter of 2015 (Q2 2014) · Revenues increased by 55% to EUR 17.9 million (11.5) · Profit for the period amounted to EUR 5.9 million (2.9) · Earnings per share amounted to EUR 0.16 (0.08) · Adjusted EBITDA increased by 89% to EUR 7.7 million (4.1), corresponding to a margin of 43% (35) Events during the second quarter of 2015 · Mobile growth in excess of 250% year-on-year · On-premise studio in Belgium with the majority of the country’s online casinos as customers · Secured rights to games and side bets from Games Marketing · Evolution wins EGR Live Casino Supplier of the Year for the sixth year in a row Events following the balance sheet date · Agreement with Genting Alderney · Live casino launched for Adjarabet and Marathonbet CEO Jens von Bahr's comments: Evolution’s strong performance continues and we again noted record revenues and earnings for the most recent quarter. EBITDA amounted to EUR 7.7 million, corresponding to a margin of 43%. We are seeing very strong growth in the market driven by increasing engagement by operators and more end users who discover live casino, particularly using mobile devices. In the second quarter, 24% of the operators’ gaming revenues via the Evolution platform were generated by mobile devices compared to 11% last year. In absolute numbers the increase was more than 250%, still without cannibalising other platforms. One of the most important events in the quarter was the agreement with Casino de Spa in Belgium, where we have built a local studio in accordance with the country’s new gaming regulations. We currently have six customers who via land-based casinos hold online casino licences from the Belgian Gaming Commission, giving us a virtual monopoly position in the market. In addition, we have a large number of customers who hold licences to operate online gaming arcades. As at our other on-premise studios, gaming is conducted locally, while software, support and surveillance are handled through Riga. The Belgian presence is well in line with our growth strategy of being the first Live Casino provider in regulated markets. By means of the studio, we have established significant entry barriers for competitors and, in terms of revenue, Belgium is expected to become our largest regulated market after the UK. Beyond our focus on regulated markets, qualitative gaming content is also key to our continued growth. During the quarter, we secured the rights to additional table games and side bets from Games Marketing’s proprietary product portfolio. The games are provided with certain preferential rights and further strengthen our leading product offering. Several of our customers have already decided to launch the new games to their end users, and we expect to go live with the first one in November. Finally, I would also like to highlight the fact that Evolution was named Live Casino Supplier of the Year for the sixth time at the EGR B2B Awards in London in June. We have won this accolade every year since the awards began in 2010 – very strong recognition of the quality of our offering. By the time this report is published, we will have progressed halfway through the third quarter. To date, we have among others signed an agreement with Genting Alderney, the online division of world leading casino operator Genting Group, providing excellent potential to capitalise on the trend whereby land-based casinos with strong brands are strengthening their online presence. In the UK alone Genting operates more than 40 land-based casinos, and I see good opportunities to develop our partnership over time. We are also continuing our drive in product innovation and, during the quarter, recruited Todd Haushalter as our new Chief Product Officer – a prestigious recruitment in the global casino industry. He will be a member of the management team for our operational entity in Malta, which, in recent months, has also been reinforced with several other influential individuals, including CEO Martin Carlesund. For the third quarter we can also note that the historical seasonality with lower activity during the summer months is no longer to be seen. Evolution has a strong tailwind and the conditions to continue strengthening our leading position in Live Casino are exceptionally good. Going forward, we will continue to focus fully on further distancing ourselves from our competitors in terms of critical factors such as product range, operational excellence and regulated markets.

Noreco announces second quarter 2015 results

Stavanger, 27 August 2015: Norwegian Energy Company ASA group (“Noreco” or the “Company”) and the subsidiary Noreco Norway AS (“Noreco Norway”) today announces results for the second quarter 2015. Further to the financial restructuring achieved, Noreco and Noreco Norway are now fully focused on implementing the renewed strategy. Noreco has taken proactive steps to deliver on its renewed strategy and is fully focused to limit future investment commitments, continue implementing cost saving measures, optimise the value of assets and reduce debt for the benefit of all its stakeholders. At the end of the second quarter, Noreco Norway has entered into an agreement to sell the Oselvar licences for NOK 201 million and Noreco has exited the Nini and Cecilie licences. These milestones allowed Noreco to complete a NOK 250 million partial repayment of debt and interest in the NOR10 bond in August, and similarly will prompt a partial repayment of the NOR06 bond when the disposal of Oselvar has been concluded. Noreco participated in three exploration wells in the second quarter. The Haribo well on the Norwegian shelf and the Niobe well in the UK have been declared dry. Hydrocarbons were discovered in the Xana well in the Danish sector, and the discovery is currently being evaluated. Average daily production in the second quarter was 4 894 barrels of oil equivalents per day, including Oselvar. Revenues were NOK 193 million. Loss before tax for the quarter was NOK 395 million after exploration cost of NOK 151 million and non-cash expenses of NOK 277 million related to revaluation of the bonds. For further information, please see attached interim financial reports from Norwegian Energy Company ASA and Noreco Norway AS and presentation material which will be referred to during an earnings call at 09.00 CET this morning. The material is also available on www.ose.no and www.noreco.com. Earnings call information: Please use telephone number 800 88 860 from Norway or +47 23 18 45 00 from abroad, and conference code 826932# to listen in. Contact: investorrelations@noreco.com

Atlas Copco supports water project in Malawi

Starting October 2015, Water for All will finance the installation of infrastructure and facilities that promote clean water, sanitation and hygiene in about a dozen villages and communities in southeastern Malawi, benefiting some 28 000 locals. The project, done in cooperation with non-profit organization ADRA, is expected to be completed by October 2018. It is financed through donations to the Peter Wallenberg Water for All Fund, where Atlas Copco is one of the larger contributors. “Atlas Copco is delighted that the many contributions made to the Peter Wallenberg Water for All Fund will be turned into true life-changing benefits for thousands of people in Malawi,” said Ronnie Leten, Atlas Copco’s President and CEO. The Malawi project was chosen as Water for All has previously worked in the area with good results. Malawi is also in the region where Peter Wallenberg Sr. was active when he worked for Atlas Copco in Africa. Water for All is Atlas Copco’s main community engagement initiative. Run by employees, the mission of the organization is to provide people in need with long-term access to clean drinking water. Through voluntary donations, boosted by the Atlas Copco Group, this non-profit organization has so far provided clean drinking water to more than 1.5 million people.  Water for All has representation in more than 40 countries and supports projects all over the world. It was founded in Sweden by Atlas Copco employees 31 years ago, on August 22, 1984.  To learn more about Water for All and the Peter Wallenberg Water for All Fund, please visit http://www.water4all.org/us/. 

Signs market frame agreement regarding magnetite

Golden Kingdom Holding is a Singapore based trading company in commodities. Delta Minerals has delivered material samples approved by the buyer during the second half of the year and the first delivery is under planning. Delta Minerals have in Golden Kingdom Holding a partner able to purchase and transport a large share of our products. The company is active in commodities in China, Russia and Africa. The agreement can also be extended to sand (such as reclamation and building materials), here too Golden Kingdom approved the samples Delta Minerals supplied. Negotiations on enhanced cooperation, which also includes supply of sand is in progress. "It is a welcome information that Golden Kingdom Holding Ltd. would like to buy magnetite from Delta Minerals as well as other products. This shows that there is a good market for our products.” says Thomas Lundgren, CEO Delta Minerals. For further information, please contactHakan Gustafsson, Chairman of the Board, hakan.gustafsson@deltaminerals.se , Mobile + 46 70 00 35 268.Thomas Lundgren, CEO, thomas.lundgren@deltaminerals.se , mobile + 46 703-97 25 24. Facts about the companyDelta Minerals AB is a Swedish public company listed on AktieTorget with the right to carry out environmental projects in the Philippines with the support of regional/local authorities. The company's goal is to begin operations in estuaries of Northwestern Philippines for the extraction of minerals and sand.

The new normal

The US is developing in line with expectations, despite the turmoil in emerging economies. New jobs are being created as the economy expands. Against that background, the Fed is on track for a first interest rate hike this year. However, the timing is still uncertain. Although recent labour market data seems to provide firm backing for such a move, the Fed will still want to feel reasonably confident that inflation will move back to its target over the medium term. Regardless of when the Fed decides to hike, interest rates are likely to be capped at low levels in a historical perspective. The eurozone faces stronger headwinds than we expected before the summer, resulting in a weaker outlook for the second half of the year. Growth in exports and corporate earnings has been on the low side. Apparently, the deteriorating conditions in many emerging economies have partly offset the positive effects of the weaker euro. Monetary policy is supportive and credit growth is starting to improve, but interest rates will have to remain extremely low as there is no room for fiscal stimulus. The case against the euro remains. The newsflow out of China has lately focused on the turmoil in the giant economy’s financial system. Most significantly, the weakening of the renminbi has had ripple effects throughout the world. Despite the correction in the equity market, we think that the authorities will be able to manage to pull off a soft landing. Growth will decline gradually over the next couple of years. Other larger emerging economies are in varying degrees of trouble. Commodity producers like Brazil and Russia are currently in recession. The longer-term outlook is also gloomy, particularly in Russia’s case given its protracted standoff with the west. India is the only member of the BRIC quartet that shines at the moment. Closer to home, the convergence plays in Central Europe remain on track, while Turkey, a country with few excuses, is facing major challenges. The Nordic countries continue to be a rather diverse group. Denmark seems to have hit a soft spot after almost two years with continuous expansion. Low productivity growth, a lack of investment, high household debt and lacklustre growth in many important export markets are holding back growth. Finland is stuck in a vicious cycle, where weak competitiveness and poor corporate profitability are threatening to turn into a chronic problem of very low trend growth. Due to the fall in oil prices, the Norwegian economy has deteriorated at a faster pace than expected. Norges Bank is likely to cut its policy rate next month as a result. In Sweden, the economy is shifting into a higher gear and is likely to approach a cyclical peak next year. While exports will grow robustly on the back of a recovery in the eurozone, domestic demand is expected to be the main driver. Given that demand is likely to expand at a faster pace than the underlying productive capacity, a positive output gap will gradually emerge. Domestic inflationary pressures are modest for the time being, but will play a more salient role ahead. However, as the Riksbank likely has an inflationary bias, the policy rate is unlikely to change until the end of next year. For further information, please contact: Jan Häggström, Chief economist, +46 8 701 10 97, +46 70 761 43 66For more information on Handelsbanken, see: www.handelsbanken.se

Results from a clinical multicenter trial with HBP-assay published in Critical Care Medicine

The study results show that the diagnostic method for assessing Heparin Binding Protein (HBP) predicts severe sepsis with significantly higher accuracy than other biomarkers available today. The study demonstrates that the HBP-assay has the potential to become a significant tool in helping predicting severe sepsis at emergency departments and infectious disease clinics. For open access to the publication, please visit: http://journals.lww.com/ccmjournal/Abstract/publishahead/Heparin_Binding_Protein_Measurement_Improves_the.97183.aspx “The results from the IMPRESSED study are promising and Axis-Shield is developing the HBP testing market globally and is working to attract major global IVD (In Vitro Diagnostics) players as potential sublicenses. In order to further strengthen the clinical validity of HBP-assay, Axis-Shield is currently coordinating additional clinical trials with HBP-assay in the US, Europe, China, South Korea and India. In addition, we are also developing alternative versions of the HBP-assay for improved routine clinical applicability.” states Anil Vasishta, Managing Director, Axis-Shield Diagnostics ”The multicenter trial indicates that the HBP-assay has the potential to become a valuable tool for Emergency Departments and Infectious Disease clinics for prediction of severe sepsis.. Hundreds of thousands of lives can potentially be saved and costly intensive care may be cut through the prediction of severe sepsis and early treatment”, states Göran Arvidson, CEO of Hansa Medical AB. Background to the studyThe HBP-assay is a novel diagnostic method developed and patented by Hansa Medical to help predict severe sepsis in patients with infectious disease symptoms.  Hundreds of thousands of patients die every year due to severe sepsis as a complication to infections like urinary tract infection and pneumonia. These infections can be effectively treated with antibiotics in order to prevent progression to severe sepsis although early prediction of risk patients is crucial for successful treatment. A seemingly stable infectious disease patient can within hours develop severe sepsis as manifested through clinical symptoms like organ failure and circulatory failure. Early prediction and treatment of risk patients is key to prevent death from severe sepsis. Study resultsThe prospective clinical multicenter trial (IMPRESSED-study) involved 759 patients admitted to Emergency Departments in Sweden and the US with infectious disease symptoms. 674 patients were diagnosed with an infection, of whom 487 did not have organ dysfunction at enrollment. Of these 487 patients, 141 (29%) developed severe sepsis within 72 hours. 78% of these patients had elevated levels plasma-HBP prior to developing severe sepsis. HBP clearly outperformed those biomarkers available today for diagnosing or predicting severe sepsis including Procalcitonin, White blood cell count (WBC), CRP, Lactate. Procalcitonin was increased in 52.5% of the patients developing severe sepsis, WBC in 57.4%, CRP in 59.3%, and Lactate in 28.1%. Samples from a Canadian validation cohort of 104 patients confirmed the results of the Sweden/USA study. The diagnostic accuracy for HBP in predicting severe sepsis in the Canadian cohort was even higher than in the Sweden/US cohort. The sensitivity was 78% and the specificity was 95% in predicting severe sepsis among infected patients in the Canadian cohort. Commercial development of HBP-assayHansa Medical and Axis-Shield Diagnostic Limited signed a collaborative agreement in 2009 for the commercialization of the HBP-assay. Axis-Shield is responsible for all clinical trials and further developments of the assay and Hansa Medical carries certain rights to royalties from Axis-Shield derived from sales of the HBP-assay as well as milestones payments and minimum royalties. Need for better tools for prevention of severe sepsisIn the 2013 report “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011” the US Department of Health and Human Services concludes that the most expensive condition treated in hospitals is sepsis, accounting for $20.3 billion in annual costs for the U.S. healthcare system. Sepsis represented 5.2 % of the national costs for all hospitalizations in 2011, resulting in nearly 1.1 million discharges from U.S. hospitals. In a commentary to the report, The Sepsis Alliance concludes that sepsis alone causes 258,000 deaths annually in the US. The information in this press release is disclosed pursuant to the Securities Markets Act or the Financial Instruments Trading Act. The information was released for public disclosure on August 27, 2015 at 12.40 CET.

Information from Q2 2015 Misen Energy AB (publ)

Following is a summary of the financial information given in the Q2 2015 report from Misen Energy AB (publ) published today. The complete report is available in both English and Swedish on the Company's website: http://misenenergy.se/en/main/investors/reports Summary of results: · During Q2 2015 production picked up due to resumed investment program but the overall production levels of H1 2015 remain stagnant when compared to H1 2014. · During H1 2015 Misen faced lower sales volumes, lower sales prices, combined with increased sub-soil charges and continuously weakening Ukrainian currency, what resulted in consolidated operating group income being lower by 74% when compared to H1 2014 and in consolidated group net turnover being lower by 12%. · Accumulated earnings per share for H1 2015 are 82% lower than for H1 2014. · Execution of JA investment program grew by 91% during H1 2015 when compared to H1 2014. Key events: · For the period of Q2 2015, the subsoil use charge for JAs operating in Ukraine was increased from 60% to 65%. · During Q2 2015, Amendment No.7 to the Joint Activity Agreement was duly registered in accordance with the applicable Ukrainian legislation. · During Q2 2015, Ukrainian currency has remained stable appreciating by 7% in its value in relation to SEK, however, the net effect during H1 2015 remains negative with the rate for UAH towards SEK decreasing by -20.0%. January – June 2015 (2014): · Consolidated operating group income: KSEK 62,192 (240,070) · Consolidated group net turnover: KSEK 401,973 (457,913) · Earnings per share: SEK 0.18 (1.03) · Production of natural gas: 339.2 million cubic meters (346) Key events after end of Q2 2015: · Starting July 2015, the subsoil use charge for the JAs was further increased to 70%. 

The University of Florida Health Proton Therapy Institute selects RayStation

UF Health Proton Therapy Institute is a 98,000 square-foot radiation medical facility that houses conventional photon radiation therapy in addition to proton therapy. At full capacity, the facility can treat up to 150 patients per day with the most advanced technology available to treat and cure cancer. Since opening in 2006, some 6,000 patients have been treated, many of whom are pediatric patients from around the world seeking the long-term benefits of proton therapy. The selection of the RayStation® treatment planning system will support workflow needs of today and the advanced needs of Pencil Beam Scanning (PBS), also known as Intensity Modulated Proton Therapy (IMPT). Dr. Zuofeng Li, Physics Director and Professor at the University of Florida College of Medicine said, “Our goal when searching for a treatment planning system for IMPT was to also identify a product that could be utilized for all of our planning needs. We found RayStation® to have superior planning tools for IMPT in terms of efficiency and quality of plans, as well as other new technologies that could help our photon planning teams. We believe features such as multi-criteria optimization (MCO), fallback planning, deformable registration and adaptive therapy will all have a significant impact on our daily planning workflow. All of this, combined with ultrafast calculation speed, made RayStation® the best choice for us.” “The advanced technologies found within the RayStation® software are a perfect match for both the advanced and more traditional planning needs found at the UF Health Proton Therapy Institute,” says Marc Mlyn, President of RaySearch Americas, Inc. “RaySearch is committed to offering best-in-class technologies for all treatment modalities, including the most advanced IMPT. We are proud to cover the entire spectrum of planning needs at UF Health Proton Therapy Institute and welcome this new partnership.” Johan Löf, CEO of RaySearch Laboratories AB comments, “We are very pleased to count UF Health Proton Therapy Institute as the 18th proton center to treat patients with RayStation®. It will be very interesting to observe the impact of RayStation® on the organization’s planning workflow, since it includes both conventional and advanced treatment techniques. We are looking forward to advancing cancer treatment together based on our unique and state-of-the-art technologies.” About the University of Florida Proton Therapy InstituteThe UF Health Proton Therapy Institute opened its doors in 2006 as the first treatment center in the Southeast U.S. to offer proton therapy. Florida residents, as well as patients from the region, country and world have access to a new cancer treatment option delivered in a supportive, healing environment. The facility boasts an IBA cyclotron with three rooms equipped with a movable proton beam on a rotating gantry and a fourth treatment room equipped with a fixed proton beam. UF Health Proton Therapy Institute is affiliated with the University of Florida and is a not-for-profit, 501(c)(3), organization for proton therapy and cancer research.

OPERATING INCOME SEK 10,0 million (6,2) JAN-JUN 2015

For the April-June period ·Net sales for the period were SEK 33.9 million (31.5). ·Operating income (EBIT) for the period was SEK 4.2 million (2.0). ·Operating margin for the period was 12 percent (6). ·Earnings after tax for the period were SEK 0.4 million (0.4). ·Earnings per share for the period, basic and diluted, were SEK 0.00 (0.00). For the January-June period ·Net sales for the period were SEK 67.6 million (62.1). ·Operating income (EBIT) for the period was SEK 10.0 million (6.2). ·Operating margin for the period was 15 percent (10). ·Earnings after tax for the period were to SEK 5.9 million (1.6). ·Earnings per share for the period, basic and diluted, were SEK 0.05 (0.01). Significant events in the second quarter and after the balance sheet date. ·No significant events occurred in the second quarter or after the balance sheet date. President and CEO Anders Karlsson’s comments on the first six months of 2015      “Sales and profitability in the company continue to grow and over the first six months of the year we have been seeing continued improvement in our operating margin, now at 15 percent (10). Operating income (EBIT) amounted to SEK 4.2 million (2.0) in the second quarter, and to SEK 10.0 million (6.2) for the first half of the year. It is gratifying to see such strong performance in the U.S, where sales were up 29 percent in the second quarter in local currency. The extensive efforts we focused on in the American market during 2014 are now bearing results, with sales increasing across the board for the company’s product portfolio. We now look forward with confidence to the launch of our new product QTYPE™, based on Real-Time PCR methodology, which will commence in the second half of 2015.” For more information please contact: Anders Karlsson, CEO Allenex AB, and ph.: +4670-918 00 10, e-mail:  (anders.karlsson@allenex.se)anders.karlsson@allenex.seYvonne Axelsson, CFO Allenex AB, and ph.: +468-508 939 72, e-mail: yvonne.axelsson@allenex.se Allenex AB discloses the information provided herein pursuant to the Securities Markets Act and /or the Financial Instruments Trading Act. The information was submitted for publication on Aug 27, 2015, at 13.00 CET. Allenex is a life science-company that develops, manufacture, market and sell products for safer transplants of organs and bone marrow on the global market. Allenex is listed on NASDAQ OMX Stockholm Small Cap (ticker: ALNX). 55 persons are employed in the Allenex group.

Oldest Pharaonic mummy from Museum of Florence finally has a face

Forensic techniques by international scientists has led to the facial reconstruction of the oldest preserved mummy in the Egyptian Museum of Florence. The research, led by Dr Matteo Borrini, forensic anthropologist and principal lecturer at Liverpool John Moores University (LJMU), applied forensic techniques on the remains to reconstruct the features of the mummy known as ‘Kent.’    The mummy was a high ranking person, a dignitary or a priest, of the XVIII dynasty (the same as Tutankhamun and Nefertiti). Until now only his name was known.  Dr Borrini devised the anatomy approximation from the skeletal structures of his skull and the reconstruction was revealed  at the International Congress of Egyptologists. Dr Matteo Borrini commented: "The research allows us to use the forensic investigation techniques for archaeological purposes to sketch the portrait of men who died millennia ago. The bust I made presents the scientific methodology in a language compatible with the needs of the museum and in harmony with the other artefacts on display.” A CT scan of the mummy revealed details that ‘Kent’ was 50 years old when he died and allowed for an exact copy of his skull to be modelled so that the individual muscles of the face could be produced.  The bandages of the mummy were never removed. The procedure adopted is the "protocol of Manchester", a standardised investigative method that Dr Borrini has already used for other reconstructions both archaeological and during his work as a criminal expert. Notes to editors CT scan and data analysis: Dr Lapo Sali (University of Florence) and Dr Sara Savasta (Leone spa). The hair, that could not be deduced from any anatomical remains, have been designed by Dr Borrini, in collaboration with Professor Donatella Lippi (University of Florence) and the Director of the Egyptian Museum Dr  Maria Cristina Guidotti, taking into account both the dynasty that the social status of the mummy. The International Congress of Egyptologists is organised by the Superintendence for Cultural Heritage of Tuscany in collaboration with the University of Florence and the Cultural Association CAMNES. Images available to download: on the media section (right hand side) of http://news.cision.com/liverpool-john-moores-university Image credits - Dr Matteo Borrini ·          The radiological team with also Donatella LIppi and Cristina Guidotti (right) ·          The mummy during the CT scan ·          The steps of the facial reconstruction and the final work Interview contact details Mail matteo.borrini@gmail.com Mobile 00393478712283

Introducing W1000Z, the latest hi-fi headphones from Audio-Technica

Today Audio-Technica introduce W1000Z, Audio-Technica’s first set of wood-constructed headphones since 2010. Audio-Technica has almost two decades’ experience when it comes to making wooden headphones and the ATH-W1000Z are the 12th set of over-the-ear wooden headphones in the company’s history. The W1000Z is also the spiritual successor to the highly popular W1000X headphones, the What Hi-Fi award-winning, five star headphones. Each of Audio-Technica’s previous sets of wooden headphones has used a different type of wood, and the W1000Z is no different. This time, the housings are made of pure natural teak sourced directly from Myanmar. One of the world’s most precious woods, teak is highly prized for its high tensile strength. In the past this made it a popular choice for boat building, and later in the construction of guitars where its ability to help create a rich, thick bass sound came to the fore. These traits make teak the ideal material for the W1000Z’s housings, where a floating mount system allows the wood’s natural acoustic qualities to shine. The W1000Z’s sub-name is “Maestoso” – an Italian musical term instructing the playing of music in a stately, dignified and majestic fashion. The W1000Z stands out for reasons other than its wood construction, of course: the 3D wing support, larger ear pads and light weight make the headphones comfortable to wear for extended periods, while the 53mm drivers, with a unified yoke that adds texture to sound, give them superior audio quality and are a compelling addition to any hi-fi fan’s collection. Combined with the latest flagship AT HA5050H headphone amplifier from Audio-Technica, below, both products represent a key step in enjoying the latest high-resolution audio formats at their very best. The Audio-Technica ATH-W1000Z is on sale now, priced at £599 (including VAT). Review samples are now available and demonstrations will be available at IFA 2015.

Annual General Meeting of Addtech AB 27 August 2015

Resolutions at today’s Annual General Meeting of Addtech AB, and the ensuing statutory Board of Directors Meeting, included the following: DividendA dividend of SEK 3.25 per share was declared. Record date for the dividend was confirmed to be 3 August 2015. The dividend is expected to be remitted by Euroclear Sweden AB 3 September 2015. Board of DirectorsAs directors Anders Börjesson, Eva Elmstedt, Tom Hedelius, Lars Spongberg, Ulf Mattsson and Johan Sjö were re-elected. New election of Malin Nordesjö. Anders Börjesson was re-elected to serve as Chairman of the Board of Directors. Tom Hedelius was re-elected to serve as Vice Chairman of the Board of Directors at the ensuing statutory Board of Directors Meeting. At the statutory Board of Directors Meeting, the entire Board of Directors except the President was designated to constitute the Company’s Audit Committee. The Chairman and the Vice Chairman were designated to constitute the Company’s Compensation Committee. Guidelines for remuneration to senior managementThe Annual General Meeting (AGM) resolved to adopt the guidelines for compensation and other terms of employment for the President and other members of Group management in accordance with the proposal of the Board of Directors. Issuing call options for bought-back shares and the transfer of bought-back shares to management personnelThe AGM resolved, in accordance with the Board of Directors’ proposal, in deviation from the shareholders' preferential rights, to offer 25 members of management personnel within the Addtech Group to acquire call options on up to 350,000 of the Company's bought-back class B shares. These entitle to acquire the corresponding number of shares during the period from 17 September 2018 to 3 June 2019 inclusive, corresponding to approximately 0.5 percent of the total number of shares and approximately 0.4 percent of the total number of votes in the Company. Acquisition of options shall be effected at market price. The purchase price for shares on exercising options shall correspond to 120 percent of the volume-weighted average of the price paid for the Company's B shares on the NASDAQ OMX Exchange in Stockholm during the period from 31 August 2015 to 11 September 2015 inclusive. In order to encourage participation in the Scheme, a subsidy shall be paid corresponding to the premium paid for each call option. This subsidy shall be paid during September 2017, providing that the option holder's employment with the Group has not been terminated and that the call options have not been disposed of prior to this point. The costs of the Scheme consist of the subsidy paid during September 2017 as detailed above and the social security charges payable on this subsidy. The total cost of the subsidy, including social security charges, has been estimated at approximately SEK 3,4 million after corporation tax, calculated based on the prevailing market conditions on 21 August 2015. Against this subsidy, the option premium corresponds to a total of approximately SEK 3,3 million which the Company will receive on transferring the call options, as a result of which the Scheme will not involve any net charge to the Company's equity. Repurchase of own sharesThe AGM resolved in accordance with the proposal of the Board of Directors to authorise the Board of Directors to buy and sell shares in the Company, on one or more occasions, such authorisation to remain valid until the next AGM. The purpose of such repurchases is to allow for adjustment of the Group’s capital structure and to enable the Company to make future acquisitions of companies or businesses with payment in the Company’s own shares. By holding shares in treasury the Company is also assuring its obligations under the share based incentive program resolved at the AGM 2012, AGM 2013 and AGM 2014 and the call option Scheme resolved at today’s AGM. Purchases shall be made on the NASDAQ OMX Exchange in Stockholm at a price within the price range registered at any given time, which is the interval between the highest purchase price and the lowest sale price. Repurchases of own shares is limited so that the Company's holding of own shares at any given time does not exceed 10 percent of the total number of shares outstanding in the Company. Sale of shares held in treasury shall be possible to make with or without preferential rights for existing shareholders, but not via the NASDAQ OMX Exchange in Stockholm. Sales may be made to finance acquisition of companies or businesses. At the ensuing statutory Board of Directors Meeting, the Board of Directors decided to exercise the authorisation given to it by the AGM held 27 August 2015 to repurchase shares in the Company. Since before, Addtech AB holds 1,490,000 class B shares in treasury, equivalent to 2.2 percent of the total number of shares outstanding, and 1.5 percent of the votes. The total number of shares outstanding in Addtech AB, including shares held in treasury, is 68,198,496. Information about the AGMInformation about the AGM is available at the Company´s website in the menu Investors/Corporate Governance/Annual General Meeting.Next reportAn interim report for the period 1 April – 30 September 2015 will be published 23 October. Executive Vice PresidentAnders Claeson was continuously appointed as Executive Vice President of Addtech AB at the ensuing statutory Board of Directors Meeting. Stockholm, 27 August 2015 Addtech AB (publ)Board of Directors For further information, contactJohan Sjö, President and CEO, +46 8 470 49 00

RaySearch awarded treatment planning installation at premier cancer center in the US

On August 18, 2015, a purchase agreement was signed, finalizing an RFP put forward by The University of Texas MD Anderson Cancer Center, this spring, to assist in the selection and assessment of new treatment planning technologies. The conclusion and rationale for the selection of the RaySearch Laboratories treatment planning system (TPS) was that “the RayStation® system offers a new environment for radiotherapy treatment planning – optimizing leading-edge hardware functionality to improve speed in TPS optimization and offer a ‘modern’ working environment. This system also offers alternative approaches to IMRT optimization using a unique technology known as multi-criteria optimization (MCO). Several other options exist in this system, such as adaptive and fallback planning, some redundant with existing systems at MDACC, but the alternative software will be explored,” stated the MD Anderson Cancer Center in the RFP statement of work. The center will implement approximately thirty licenses throughout the department, twenty for clinical use and ten for research, to fully investigate which technologies have the biggest impact on its practice. “Getting RayStation® into MD Anderson and working with the team there is a great opportunity – we look forward to developing a research relationship that can lead to novel and exciting functionality,” says Marc Mlyn, President of RaySearch Americas, Inc. “We are pleased to have the opportunity to show how RayStation® can positively impact the center’s workflow and help it achieve its patient care goals,” he concludes. “We are very pleased that such a highly respected institution as MD Anderson has selected RayStation® in direct competition with all major TPS providers. This provides strong confirmation of RayStation®’s many and unique advantages and will demonstrate the impact it can have in a large clinical setting,” says Johan Löf, CEO of RaySearch Laboratories AB.

Interim report, second quarter 2015

· Net sales increased by 3 percent to MSEK 1,341.3 (1,302.9), and by 2 percent at constant exchange rates. Net sales increased by 8 percent in Sweden, 6 percent in Denmark and decreased by 7 percent in Norway at constant exchange rates. · Adjusted operating income increased by 1 percent to MSEK 77.0 (76.3) corresponding to an adjusted operating margin of 5.7 (5.9) percent. · Income for the period amounted to MSEK 45.7 (-48.2) and earnings per share was SEK 0.76 (-0.95). · Adjusted operating cash flow amounted to MSEK 136.0 (186.6) with a reduction of working capital but not as much as last year. · Deliveries to Coop Norway under the new supply agreement, which also includes the stores acquired from ICA Norway, started as of August. · The acquisition of Huttulan Kukko Oy’s (Huttulan) factory and business in Finland was completed on 25 May. · An agreement was signed on 15 June to acquire Lagerbergs, the third largest producer of chicken products in Sweden, pending approval of the Swedish Competition Authority. MSEK Q2 2015 Q2 2014 Change H1 2015 H1 2014 ChangeNet sales 1 341.3 1 302.9 3% 2 650.9 2 656.3 0%Operating 72.8 36.9 97% 140.4 107.3 31%incomeIncome for the 45.7 -48.2 - 87.3 -18.9 -periodEPS 0.76 -0.95 - 1.45 -0.38 -Adjusted* 123.8 119.3 4% 237.8 239.4 -1%EBITDAAdjusted* 77.0 76.3 1% 144.6 154.9 -7%operatingincomeAdjusted* 5.7% 5.9% - 5.5% 5.8% -operatingmarginAdjusted* 49.0 22.2 121% 90.6 57.9 56%income for theperiodAdjusted* EPS 0.82 0.44 86% 1.51 1.15 31%Adjusted* 136.0 186.6 -27% 236.3 307.5 -23%operating cashflow *) Adjusted for non-comparable items in the quarter of MSEK -4.2 (-39.4) in EBITDA and operating income and MSEK -3.3 (-70.5) in income for the period, as well as MSEK -4.2 (-47.6) in EBITDA and operating income and MSEK -3.3 (-76.9) in income for the period for the first half. See page 3. CEO StatementTrends in sales and operating income in the quarter were similar to those in the first quarter with good sales growth and improved adjusted operating income and margins in Sweden and Denmark compensating for a weak performance in Norway. Overall, Group net sales grew by 2 percent at constant exchange rates and the adjusted operating income increased slightly from the previous year. Sales in Sweden benefitted from good market demand, strong performance of recently launched innovative products and higher sales of chilled products over frozen leading to an improved mix. The adjusted operating income and margin improved substantially, with further improvements in operating efficiencies. Sales and adjusted operating income in Denmark were positively impacted by higher export volumes at firmer prices. The margin also benefited from further cost savings in operations. The domestic Danish market was characterised by continued pressure on pricing. The Norwegian retail market for chicken products continued to be weak and declined by 4 percent* compared to the second quarter last year. This was an improvement from the first quarter when the market declined by 13 percent*. Stock levels were high across the industry. Operating margin for the Norwegian operation was negatively impacted by promotional activity and a higher proportion of sales of frozen products. We continue to believe that the market will recover but timing is uncertain. Deliveries to Coop Norway under the new supply agreement, which also includes the stores acquired from ICA Norway, started as of August. Deliveries will be phased in gradually as the newly acquired stores are absorbed into Coop. On 25 May we finalised the acquisition of Huttulan’s factory and business in Finland, which began operations in May 2014. Huttulan has developed a premium concept that is sold to retail and foodservice customers. Finland is an attractive market for chicken products with many similarities to the Swedish market. Integration of the business, now called Kronfågel Oy, is proceeding according to plan and we have started to share best practice from within the Group to improve performance in different areas. The factory is operating at less than 20 percent of total capacity and will be loss-making this year. We are making progress in organising new farming capacity to increase deliveries from next year. On 15 June, we signed an agreement to acquire Lagerbergs, the third largest producer of chicken products in Sweden with sales of approximately MSEK 300. The acquisition is subject to approval by the Swedish Competition Authority. The acquisition would improve our capacity to supply the growing Swedish market and would also create opportunities to improve efficiency in both our facility in Valla, Sweden and the Lagerbergs factory. Leif Bergvall HansenManaging Director and CEO Further informationFor further information, please contact:Leif Bergvall Hansen, Chief Executive Officer.   Tel:  +45 22 10 05 44Jonny Mason, Chief Financial Officer.                 Tel:  +45 22 77 86 18Patrik Linzenbold, Head of Investor Relations. Tel:  +46 708 25 26 30 Financial calendar · Interim report for the third quarter 2015: 26 November 2015 · Fourth quarter and year-end report 2015: 26 February 2016 This interim report comprises information which Scandi Standard is required to disclose under the Securities Markets Act and/or the Financial Instruments Trading Act. It was released for publication at 07:30 CET on 28 August 2015.

Raysearch Laboratories AB (publ) interim report January 1–June 30, 2015

HALF-YEAR (JANUARY–JUNE, 2015) · Net sales for the period amounted to SEK 165.1 M (105.8), of which RayStation® accounted for SEK 106.6 M (50.9) · Profit after tax totaled SEK 22.4 M (5.9) and earnings per share were SEK 0.65 (0.17) · Operating profit amounted to SEK 31.0 M (8.4) · Cash flow was a negative SEK 2.3 M (neg: 11.3) · Order intake excluding service agreements amounted to SEK 158.3 M (101.6), of which RayStation® accounted for SEK 124.4 M (59.1) SECOND QUARTER (APRIL–JUNE, 2015) · Net sales for the period amounted to SEK 77.3 M (51.9), of which RayStation® accounted for SEK 53.9 M (23.6) · Loss after tax totaled SEK 2.6 M (profit: 1.0) and loss per share was SEK 0.08 (earnings: 0.00) · Operating loss amounted to SEK 2.1 M (profit: 2.1) · Cash flow was a negative SEK 10.1 M (neg: 7.9) · Order intake excluding service agreements amounted to SEK 72.0 M (46.8), of which RayStation® accounted for SEK 55.3 M (24.4) · RayStation® order backlog totaled SEK 33.8 M (66.5) SIGNIFICANT EVENTS DURING THE SECOND QUARTER · The first proton therapy treatments with RayStation® for Mevion S250 in the US · Texas Center for Proton Therapy, part of the national collaboration The US Oncology Network, has selected RayStation® · Peter Thysell was appointed new CFO, Björn Hårdemark Deputy CEO, Kjell Eriksson new Chief Science Officer and Victoria Sörving new General Counsel, and all join executive management SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD · RaySearch has secured a number of major orders from some of the world’s largest and most respected cancer clinics, including the University of Texas MD Anderson Cancer Center and the University of Florida Health Proton Therapy Institute in the US, as well as Gustave Roussy in France · Long-term collaboration agreement signed with Accuray regarding the RayCare® Oncology Information System “Our success with RayStation® continues and the strong start to the year remains unabated. During the first half of the year, revenues from RayStation® rose approximately 129 percent to SEK 116.6 M (50.9). Overall, revenues rose 56.0 percent to SEK 165.1 M (105.8) and operating profit increased to SEK 31.0 M (8.4), representing the highest-ever sales and earnings for the first half-year,” says Johan Löf, CEO of RaySearch. “In the third quarter, we have already secured several key orders from some of the world’s largest and most respected cancer clinics, including MD Anderson and the University of Florida Health Proton Therapy Institute in the US, and Gustave Roussy in France. We secured these orders in direct competition with our main competitors, which I consider firm confirmation that our system offers major benefits,” says Johan Löf. The information in the interim report is such that RaySearch is required to disclose publicly in accordance with the Swedish Securities and Clearing Operations Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication on August 28, 2015 at 7:45 a.m. FOR FURTHER INFORMATION, PLEASE CONTACT:Johan Löf, PresidentTel: +46 8 510 530 00johan.lof@raysearchlabs.com

Fabege recruits new talent as part of ongoing robust city district development

Carl Michael Augustsson has been recruited as a business developer and will be involved in the development of the newly acquired Haga Norra city district, located near Arenastaden. His assignment, which will begin in the autumn, will be to develop a sustainable and attractive city district from both a social and environmental perspective. Carl Michael will join Fabege from Mengus, where he is partner. Carl Michael has previously worked at Granen Fastighetsutveckling AB. Niclas Ternstål (formerly Österberg) will assume the role of Market Area Manager for Arenastaden on 1 September. Niclas worked mostly recently as Director of Letting Operations at AMF Fastigheter. He also has previous experience from such companies as Struktur and Vasakronan. Andreas Malmsäter has been appointed as Fabege’s new Director of Letting Operations as of 1 September. Andreas will join the company from Tenant & Partner, where he has held a number of positions, most recently as Senior Manager/Team Manager. “Our focus on city district development has created significant value and been highly successful, and we see excellent potential for continued value creation in our markets, particularly through the ongoing development of our project portfolio. Therefore, I am delighted that we have succeeded in attracting and recruiting these talented employees, who will further strengthen our team,” says Christian Hermelin, CEO of Fabege. Fabege AB (publ)

SCA enhances its organization and invests

“SCA is a global hygiene and forest products company in which we work continuously to enhance the respective operations. The enhancement of the organization and the investment in increased pulp production will secure the long-term competitiveness of the businesses,” says Magnus Groth, President and CEO of SCA. The Forest Products division will encompass all forest industry operations and all forest land currently owned by SCA. The work to realize this consolidation will now begin. There are significant synergies between the forest industry and the ownership of forest land. SCA’s forest products operation has a well-integrated supply chain with production facilities concentrated in Northern Sweden in close proximity to its forest holdings.As of January 1, 2017, the Forest Products division will expand its quarterly financial reporting. To satisfy the growing demand for pulp, SCA has decided to invest in increased capacity for pulp production at the Östrand pulp mill in Timrå, Sweden. The annual production capacity of bleached sulphate pulp will increase from the current level of approximately 430,000 tons to about 900,000 tons. The investment will amount to about SEK 7.8bn over a three-year period. Production is expected to commence in 2018.  “A cohesive forest products operation in a single division further highlights the value created and optimizes synergies between the forest industry and ownership of forest land. Over time, the investment in Östrand will increase sales and competitiveness and create a world-class cost position and higher margins,” says Magnus Groth, President and CEO of SCA. SCA has also decided to enhance the hygiene operation’s organization. Please see separate press release. TeleconferenceA teleconference for the media, investors and analysts will be held today at 9:00 a.m. with President and CEO Magnus Groth.To join the teleconference, please dial: +44 (0)20 7162 0077, +1 334 323 6201 or +46 (0) 8 505 201 10.  NB: This information is such that SCA must disclose in accordance with the Securities Markets Act or the Financial Instruments Trading Act. The information was submitted for publication on August 28, 2015, at 8:00 a.m. CET.

SCA enhances its hygiene organization

· The operations in AfH tissue and incontinence products in Europe and North America will be reorganized into two business units, Away from Home Professional Care and Incontinence Care.Away from Home Professional Care will be led by Don Lewis, currently President of SCA Americas. Incontinence Care will be led by Margareta Lehmann, currently President of SCA Incontinence Care Europe. · Latin America will become a new business unit, SCA Latin America, which will be led by Pablo Fuentes, Vice President of SCA Latin America at present. · Global Hygiene Supply Tissue and Global Hygiene Supply Personal Care are being strengthened through the respective production activities being given direct HR responsibility. · A project organization is being established and is tasked with optimizing and streamlining logistics flows. The project organization will be led by Sune Lundin, currently President of SCA Away from Home Professional Hygiene Europe. Sune Lundin will continue as a member of the Executive Management Team and report directly to the President and CEO. “The new organization provides the preconditions for increasing efficiency, the pace of innovation and profitable growth for our global hygiene operations, which currently comprise about 85% of the Group’s sales,” says Magnus Groth, President and CEO of SCA. The organizational changes have no impact on SCA’s external financial reporting structure. NB: This information is such that SCA must disclose in accordance with the Securities Markets Act or the Financial Instruments Trading Act. The information was submitted for publication on August 28, 2015, at 8:00 a.m. CET.

Precise Biometrics signs license agreement with JP Sensor

The license agreement will generate royalty revenue based on sales of fingerprint sensors from JP Sensor that includes Precise BioMatch Embedded or Precise BioMatch Mobile. Royalty revenues are volume dependant and cannot be forecasted at this point. The agreement also includes a limited initial fixed fee for the right to integrate and use Precise Biometrics’ software and for support & maintenance, which will be recognized starting from the third quarter 2015.”JP Sensor is among other things developing smart cards with integrated touch sensors, initially targeting Chinese banks. This is an ideal application for our fingerprint authentication software Precise BioMatch Embedded. The agreement also includes our software Precise BioMatch Mobile, which further strengthens our position as the leading supplier of fingerprint technology software for mobile devices. We welcome JP Sensor as a partner and appreciate the trust they put in us by selecting our products”, says Håkan Persson, CEO of Precise Biometrics. Precise BioMatchTM Embedded provides easy integration of fingerprint matching functionality for numerous environments and applications through a unique patented hybrid algorithm. The software offers fast, accurate, and secure verification of the user’s identity, creating a convenient user experience when unlocking a device or authenticating to services, while delivering enhanced security.Precise BioMatchTM Mobile provides easy integration of fingerprint matching functionality for smartphones and tablets, and is optimized for small touch sensors in mobile environments through a unique patented hybrid algorithm. The software offers fast, accurate, and secure verification of the user’s identity, creating a convenient user experience for consumers when unlocking their mobile device or authenticating to services, while delivering enhanced security. In a recent market analysis of fingerprint biometrics for mobile devices, Frost & Sullivan praised Precise BioMatch Mobile for providing superior fingerprint authentication for smartphones and tablets. As a result, Precise Biometrics was awarded (http://precisebiometrics.com/news/2015/04/frost-sullivan-awards-leader-in-fingerprint-biometrics/) the “2015 Global Frost & Sullivan Award for Customer Value Leadership in fingerprint biometrics for mobile devices”. JP Sensor is developing various fingerprint authentication systems with integrated embedded CPUs targeting applications such as smart cards, safety boxes, door locks, suitcases, etc. For more information about JP Sensor, please visit; http://www.jpsensor.com.tw/

Arise and other producers do not support a separate new system for offshore wind power

A group of leading Swedish wind power companies and landowners believe a separate new support system for offshore wind power is an expensive as well as unnecessary way to increase the share of renewable energy in Sweden. The same benefits can easily be achieved through onshore wind power. With a strong electricity grid, a sparsely populated country and good wind resources, Sweden has every opportunity to increase the expansion of onshore wind power. The same investment at sea would increase the bill by hundreds of billions of kronor – a cost which would ultimately be borne by Sweden’s electricity customers. And this entirely without need. A transition to a non-fossil fuel economy is of course desirable. Currently by far the fastest and most cost-effective road there is to continue to invest in Swedish onshore wind power. Yet it is imperative that Swedish policymakers quickly decide how to revise of the current support system for renewable energy, known as the electricity certificate system, and also decide to raise the level of ambition for the continued roll-out of cost-effective, non-fossil fuel electricity. Halmstad 28 August, 2015 ARISE AB (publ) For further information, please contact Peter Nygren, CEO Arise AB, +46 706 300 680 The information contained herein constitutes information which Arise AB is legally required to publish under the Swedish Securities Market Act (2007:528) and/or the Swedish Financial Instruments Trading Act (1991:980). The information was released for publication at 09.15 a.m. on 28 August 2015.

Visiting Professor at Karolinska Institutet cleared from suspicions of scientific misconduct

“Now that we have examined the allegations of scientific misconduct in all seven indicted articles, we have found that they contain certain flaws but nothing that can be considered scientific misconduct,” says Vice-Chancellor Anders Hamsten. The complaints against Professor Macchiarini were lodged by four physicians at Karolinska University Hospital who were themselves part of the research environment and, in some cases, co-authors of the articles that were reported for scientific misconduct. The complaints were submitted in June, August and September 2014, prompting an inquiry by Karolinska Institutet’s Vice-Chancellor in accordance with the provisions of the Higher Education Ordinance and the university’s own rules for dealing with cases of alleged scientific misconduct. The first paper describes the manufacture of a synthetic oesophageal prosthesis and its functionality on transplantation into a rat. The concerns raised by the complainants include the conclusions of the functionality of this prosthesis and the interpretation of CT scans.  The six other papers describe transplantations of a synthetic tracheal prosthesis in humans, namely three patients with tracheal diseases who were beyond the help of conventional surgery and who were given synthetic trachea coated with their own bone-marrow derived stem cells at Karolinska University Hospital. Here, the complainants pointed out that the results concerning the patients’ clinical progress as expressed in the papers did not match the patients’ medical records as kept at Karolinska University Hospital, and that there was no evidence that a synthetic tracheal transplant can develop into a functional airway. They also questioned the claim that the first patient had suffered a relapse of his tracheal cancer and that surgery was therefore necessary. As part of the inquiry, a statement of opinion was requested from Professor emeritus Bengt Gerdin, who, on examining the documents and information included in the complaint, Professor Macchiarini’s initial response and the medical records from Karolinska University Hospital, submitted his conclusion in mid-May that the accused was indeed guilty of scientific misconduct. Following the detailed report submitted by Professor Gerdin, Professor Macchiarini and his co-authors submitted over 1,000 pages of comments and documents, including medical records from the first patient’s doctors inIceland, showing that on the crucial points, the description of his condition given in the articles is correct. “Bengt Gerdin’s examination was extremely valuable for the inquiry, but the documents to which he had access lacked significant data on the pre- and postoperative status of two of the patients,” says Professor Hamsten. “The comments sent in by Professor Macchiarini and his co-authors have had a significant influence on how the case has been assessed. Now that we have all the relevant material on hand, we have a much clearer picture of what happened.” In their complaint, the four physicians also criticised Professor Macchiarini for not having obtained a permit from the regional Ethical Review Board and the Swedish Medical Products Agency before the operation. However, Karolinska Institutet did not examine this issue in its inquiry since the Swedish Research Council’s definition of scientific misconduct does not cover breaches of the Ethical Review Act and the Medicinal Products Act. At the same time, Karolinska Institutet concluded that a decision to perform the three operations was taken by the hospital. “Karolinska University Hospital made the decision to operate following a transparent process and in what it saw as the absence of alternative therapeutic solutions,” says Professor Hamsten. “These decisions did not address research aspects.” The inquiry shows that the interaction between Karolinska Institutet and Karolinska University Hospital has not functioned satisfactorily, and the Vice-Chancellor’s decision promises improvements to procedures, regulations and support structures for clinical trials and clinical therapy research. The line between clinical application and research when it comes to experimental therapy will need to be better defined, and clearer guidelines for academic research and academic healthcare will be drafted. Professor Macchiarini has also been instructed to submit errata to the journals that published some of the scientific papers to clarify and rectify the failings that the inquiry has brought to light. “Some aspects of Paolo Macchiarini’s research do not meet our high quality standards,” says Professor Hamsten. “We will now be remedying the deficiencies our inquiry uncovered with him, the heads of his department and representatives fromKarolinskaUniversityHospital.” For further information, contact:Claes Keisu, press officer Karolinska InstitutetTel: + 46 8-524 838 92Mobile: + 46 76-215 29 62Email: claes.keisu@ki.se

Uusi Renault ja Dacia jälleenmyyjä Vaasa / Tervajoki -alueelle

”Olemme iloisia, että saamme aloittaa Renault- ja Dacia- yhteistyön Arton Auton kanssa Vaasa/Tervajoki-alueella. Merkkiemme myynti on Suomessa vahvassa kasvussa; Renault tavara-autojen myynnin kasvu tammi-heinäkuussa viime vuoteen verrattuna on 22 % ja Renault henkilöautoissa kasvu on peräti 43 %! Kasvu jatkuu, sillä kattava tavara-automallistomme on markkinoiden uusimpia ja Renaultin henkilöautomallisto uudistuu ja kasvaa seuraavan vuoden aikana merkittävästi. Tästä esimerkkinä uusi Renault Kadjar, joka tulee markkinoille jo syyskuun alussa. Arton Auto Oy tulee mukaan siis oikeaan aikaan ja olen varma, että heidän asiakaslähtöinen ja yrittäjämäinen toimintatapansa takaa hyvän palvelukokemuksen asiakkaillemme”. sanoo Renault ja Dacia maahantuonnista Suomessa vastaavan Nordic Automotive Services Oy:n toimitusjohtaja Heikki Vuorinen. ”Renault- ja Dacia- tuotemerkit sopivat hyvin yrityksemme tarjontaan; nyt pystymme tarjoamaan ison eurooppalaisen automerkin pitkällä takuulla vanhojen edustustemme rinnalle. Renault Euroopan eniten myytynä tavara-autona tarjoaa asiakkaillemme vahvan vaihtoehdon myös hyötykäyttöön. Nyt kun myös Dacia-mallisto on uudistunut ja laajentunut, on hienoa päästä mukaan merkkien vahvaan kasvuun. Haluan toivottaa tervetulleeksi kaikki niin nykyiset kuin uudetkin Renault- ja Dacia-asiakkaat Arton Autoon syyskuusta lähtien – samoihin aikoihin aloitamme myös myymälälaajennuksen rakentamisen. Myynti aloitetaan työn merkeissä, mutta kyllä syksyllä vielä avajaiskahvitkin tarjotaan, kunhan ehditään saamaan homma käyntiin”, naurahtaa Arton Auton toimitusjohtaja Arto Ulvinen. Lisätietoja:Nordic Automotive Services Oy,Heikki Vuorinen, toimitusjohtaja, 040-7716129, heikki.vuorinen@renault.fi Arton Auto Oy,Arto Ulvinen, toimitusjohtaja, 0400-662066, arto.ulvinen@artonauto.fi

KD Smart Chair is #1 Best Seller on Amazon

MIAMI, FL – KD Smart Chair is proud to announce their Standard model is the #1 Best Seller on Amazon in the electric wheelchair category. The KD Smart Chair is designed to be the most convenient and lightweight power wheelchair on the market today. Amazon customers have rated the chair 4.5 out of 5 stars giving it a high rating due it’s features, ease of use and the value it provides to the users. It is compact, folds in seconds and weighs only 50 pounds with weight capacity of 365 pounds. The convenient size makes it easy for everyday use as well as highly suitable for travel by airplane, car, bus, train and cruise ship. The chair can travel up to 15 miles on a single battery charge with speeds of up to 5 mph. It has the capabilities to easily maneuver indoors and outdoors. Roland Reznik, CEO of KD Smart Chair states, “We are honored to be the number one best seller from hundreds of electric wheelchairs on Amazon. We provide a product that people love along with great customers service and fast shipping. Plus, I believe our design is innovative compared to the other bulkier and heavier chairs on the market. Our team will continue to make our wheelchair models even better to improve people's lives who have mobility issues." KD Smart Chair comes with a 60 day money back guarantee if you are not satisfied. The Standard model comes with a 5 year warranty on the frame, 1 year warranty on the motor, batteries, joystick and the control system. About KD Smart Chair KD Smart Chair is a manufacturer of lightweight foldable power wheelchairs. Their Standard model is an FDA cleared mobility device and is built for durability, safety and reliability for people with mobility issues. It is made of strong aluminum alloy, which gives the chair a total weight of only 50 pounds. To learn more about the company and their available wheelchair models, please visit their website at http://www.kdsmartchair.com

EQT Infrastructure II acquires Mongstad Supply Base

· EQT Infrastructure II has acquired Mongstad Supply Base, a key Norwegian port serving the oil and gas industry in the North Sea · Strategy to support further expansion with Mongstad Supply Base as platform · Thor Håkstad and Tore Thorstensen to join the Board of Directors The EQT Infrastructure II Fund (“EQT Infrastructure II”) has acquired Mongstad Administrasjon AS (“Mongstad Supply Base” or the “Company”) from Wimoh Invest AS, a company ultimately owned and controlled by Marit and Trond Mohn. Mongstad Supply Base outside Bergen is a leading oil and gas port in Norway, strategically located close to an area with high offshore activity. The Company owns land, buildings, storage facilities, piping, roads, quays and other infrastructure at the site, and handles more than 280,000 tonnes over quay per year. The base supports about 20 producing oil and gas installations in the North Sea, and is as such essentially a dedicated port to the industry. The base was established in 1984 as a supply base to Norsk Hydro (now part of Statoil) and has since invested significantly in port infrastructure as well as land and buildings at the site. The Company currently owns over 600,000sqm of developed land and 750m of quay, accommodating over 2,500 ship arrivals per year. Statoil, a main tenant, has recently announced new sailing routes in order to achieve cost and environmental savings, which is expected to almost double the volumes at the base once fully implemented by the end of 2015. The base is operated by CCB. Going forward, the strategy is to invest in new infrastructure and land at Mongstad Supply Base, to grow via acquisitions of infrastructure at other supply bases and acquire other infrastructure assets and properties with similar characteristics. The growth of the Company will be supported by a new Board of Directors consisting of Thor Håkstad (former SVP Norsk Hydro) and Tore Thorstensen (Chairman AF Gruppen and Chairman HusCompagniet). This will bring in significant experience from the oil and gas industry as well as the real estate and construction sectors. “Mongstad Supply Base is critical in serving the oil and gas industry in the North Sea. Oil producers and service companies are consolidating their operations to fewer and larger supply bases, such as Mongstad Supply Base, to realize cost savings. The expected activity increase at the base will require investments in quays, buildings, tanks and other key infrastructure. This makes Mongstad an excellent platform investment, with the key characteristics EQT is looking for: strong market position, hard assets, very long-term contracts with strong counterparties and, most importantly, development potential,” says Masoud Homayoun, Director at EQT Partners AB, Investment Advisor to EQT Infrastructure II. “The oil and gas industry has undergone a shift in recent years, and the increasing activity we are seeing at the base is a result of that. We are very excited that EQT is coming in as new long-term owner with a willingness to invest and expand the infrastructure at the base,” says Tore Notø Johnsen, Managing Director of Mongstad Administrasjon. “EQT, being a reputable private equity player with solid backing from well-known industrial investors, has through the process been a preferred buyer of Mongstad Supply Base. EQT has both shown dedication and willingness to further develop Mongstad Supply Base in the years to come, which will benefit Statoil and the other customers and operators at the base, local stakeholders as well as the employees in the region,” says Trond Mohn. EQT Infrastructure II was advised by Handelsbanken Capital Markets, Selmer, McKinsey, PwC and Pangea Property Partners. Wimoh Invest AS was advised by Saga Corporate Finance, Schjødt and EY. The parties have agreed not to disclose the transaction value. Contacts: Masoud Homayoun, Director at EQT Partners, Investment Advisor to EQT Infrastructure II, +46 8 506 55 348Kerstin Danasten, EQT Press Contact, +46 8 506 55 334 About EQTEQT is the leading private equity group in Northern Europe, with portfolio companies in Europe, Asia and the US with total sales of more than EUR 17 billion and approximately 140,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership.EQT Infrastructure II is the second fund within the infrastructure investment strategy investing in medium-sized infrastructure businesses in the Nordic region, parts of Continental Europe, and North America with total commitments of EUR 1.9 billion. Investment targets are regulated infrastructure, concession-based infrastructure, market-based infrastructure and infrastructure-related services. For further information please visit www.eqt.se

Enea signs a 630 KEUR Enea OSE deal

STOCKHOLM, Sweden, August 28, 2015. Enea (NASDAQ OMX Nordic: ENEA) has signed an agreement worth 630 KEUR over four years with a Russian development company where Enea will provide the Enea OSE RTOS product to be deployed in a rover for a European space exploration program.       “We are very proud that this contractor to a European space exploration program have chosen our operating system. It is exiting that Enea OSE will be running in this rover operating in space and it is yet again underlining the core strengths of Enea OSE like high performance realtime capabilities and meticulous quality throughout the product. I also want to emphasize the ability of our engineering organization that has impressed this customer throughout the prospecting phase and will continue to do so going forward.” said Anders Lidbeck, President and CEO for Enea. This information is such that Enea AB (publ) is to publish in accordance with the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on August 28, 2015 at 13.00 CET. For more information visit www.enea.com/investors or contact: Anders Lidbeck, President & CEOE-mail: anders.lidbeck@enea.com Sofie Dåversjö, Investor RelationsPhone: +46 70 971 40 05E-mail: sofie.daversjo@enea.com About EneaEnea is a global supplier of Linux and real-time operating system solutions, including middleware, tools, databases, and world class services, with a vision to enable communication everywhere. As a trusted and respected player in the embedded software eco system, Enea has for more than four decades delivered value and helped customers develop and maintain ground-breaking products. Every day, more than three billion people around the globe rely on Enea’s technologies in a wide range of applications in multiple verticals – from Telecom and Automotive, to Medical and Avionics. Enea has offices in Europe, North America and Asia, and is listed on NASDAQ OMX Nordic Exchange Stockholm AB. For more information please visit www.enea.com or contact us at info@enea.com Enea®, Enea OSE®, Netbricks®, Polyhedra® and Zealcore® are registered trademarks of Enea AB and its subsidiaries. Enea OSE®ck, Enea OSE® Epsilon, Enea® Element, Enea® Optima, Enea® Optima Log Analyzer, Enea® Black Box Recorder, Enea® LINX, Enea® Accelerator, Polyhedra® Lite, Enea® dSPEED Platform, Enea® System Manager and Embedded for Leaders(TM) are unregistered trademarks of Enea AB or its subsidiaries. Any other company, product or service names mentioned above are the registered or unregistered trademarks of their respective owner. © Enea AB 2015.

Meda comment on US rumors

With regard to the current rumors concerning Meda’s US operations Meda states that business development is a natural part of the business model. This includes amongst others acquisitions, divestments, in-licensing and partnerships. Evaluating the US operations is one project. However, Meda’s policy is not to comment on these activities. For further inquiries, please contact: Paula Treutiger, VP Corporate Communications & Sustainability                                     ph: +46 733-666 599                                                                                                                                                                                                                  paula.treutiger@meda.se Meda AB discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on August 28, 2015, at 13:15 CET. MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.

Next generation of “heat power”, delivering 100% clean electricity from hot water with up to 14% efficiency.

Today, August 31st, Climeon announce it new ranges of Climeon Ocean™ and Climeon Ocean Marine™ products. Based on the successful Climeon Ocean™ 100, these products include more than fifty improvements, including higher efficiency, increase serviceability and more compact design. - We are proud to announce this new sets of products, says Climeon CEO Thomas Öström. With the enhancements in the product line we can now deliver even more value for our customers and contribute even more in global CO2 reductions. Climeon Ocean™ are designed for land-based “heat power” applications such as solar, geothermal, industrial waste-heat and power plant installations. Solutions includes five different models; · Climeon Ocean™ 150, delivering up to 150 kW net electricity · Climeon Ocean™ 300, delivering up to 300 kW net electricity · Climeon Ocean™ 450, delivering up to 450 kW net electricity · Climeon Ocean™ 600, delivering up to 600 kW net electricity · Climeon Ocean™ 1000, delivering up to 1 MW net electricity Climeon Ocean™ Marine are designed for sea-based “heat power”, primarily for installations on ships. Systems are specifically designed to meet the high requirements of the marine markets, including: · Designed to absorb micro-vibrations caused by ship engines · Security classification exceeding requirement set by insurance companies · Marine classified components Solutions includes five different models; · Climeon Ocean™ 150M, delivering up to 150 kW net electricity · Climeon Ocean™ 300M, delivering up to 300 kW net electricity · Climeon Ocean™ 450M, delivering up to 450 kW net electricity · Climeon Ocean™ 600M, delivering up to 600 kW net electricity · Climeon Ocean™ 1000M, delivering up to 1 MW net electricity - Our objective is to maximize energy production, environmental benefits and Return On Investment for our customers, says Climeon CTO Dr. Joachim Karthäuser. The power scalability of Climeon Ocean™ is an important part for reaching these objectives since every heat source is different. All models deliver at best case up to 14% efficiency, or >10% at 90C/20C temperatures (more than half of theoretical max). Shipments will start during 2016.